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PRtFACE 
The rernn-angiotensin-aldosterone system (RAAS) is involved in the 
regulation of sodium-, potassium-, and extracellular fluid volume-balance, 
and participates in blood pressure homeostasis and regional blood flow. 
It is well-known that the increased activity of this system in infancy 
and childhood compared to adults is age-dependent. 
So far, studies or the RAAS vtere mainly limited to separate measurements of 
plasma renin activity (PRA) or concentration (PRC), and plasma aldosterone 
concentration (PA). Only a few studies reported simultaneous measurements. 
Not all components of the RAAS have been investigated, at least not 
concurrently. 
Standardization of sampling conditions is essential, and for comparison 
with data of other laboratories calibration of the renin assay against an 
international standard is indispensable. The validity of our renin assay 
was established. 
We extended the investigation on the basal activity of the RAAS in 
infancy ard chilhood from PRA, PA, and urinary aldosterone excretion to 
simultaneous measurements in plasma of almost all other components of the 
system including angiotensin I and II, angiotensm-converting enzyme 
activity, active arc inactive renn concentration, and renin substrate. 
In addition, the activity of the RAAS was studied after standardized 
stimulation. 
The importance of these studies in clinical practice is illustrated 
by two case studies. One study concerns a patient with low-remn, low-
aldosterone hypertension who was referred because of growth retardation and 
symptoms of aldosteronism. The other study describes the syndrome of 
hyporemnemic hypoaldosteromsm in ar infant who was referred because of 
salt-wasting. 
Measurements of PRA ard PA are also required for the differential 
diagnosis and for the evaluation of therapy of other diseases e.g. salt-
wasting of various origins including renal and adrenal, Bartter's syndrome, 
aldosteronism, and hypertension. 
The role of the RAAS in the maintenance of blood pressure was studied in 
the experimental part of this work. The effects of angiotensin II blockade 
by saralasin or, the blood pressure were evaluated in the canine puppy. 
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In addition, the plasma renin half-life was determined in the canine 
puppy. 
Finally, the influence of the stress of venepuncture on PRA values was 
studied in an attempt to explain the greater scatter of levels of the 
components of the RAAS observed at young age. 
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CHAPTER I 
SHORT SURVEY OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM 
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I. SHORT SURVEY OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM 
The renin-angiotensin-aldosterone system (RAAS) has attracted so much 
research interest, and so many reports are published yearly on this subject, 
that it is relatively easy to find completely contradictory statements. For 
more detailed information the reader is referred to several more extensive 
reviews (1-4). 
1.1. INTRODUCTION 
In 1898 Tigerstedt and Bergman called renin that component of intra­
venously injected crude kidney extract which increased blood pressure. The 
classic experiments of Goldblatt in 1934, who produced hypertension by renal 
artery constriction, renewed interest in renin. Renin is still subject of 
intense research activity. 
Renin itself is not the vasoconstrictive agent. It is a proteolytic 
enzyme that catalyzes the cleavage of the leucyl -leucyl bond in the 
substrate (angiotensinogen) to release angiotensin I (Fig 1). Recently it 
has been reported that renin cleaves a leucyl -valyl bond in human 
angiotensinogen (4). Angiotensin I is cleaved by converting enzyme to 
angiotensin II, the major active compound of the renin-angiotensin system 
(RAS). Angiotensin II is further degraded by aminopeptidases to smaller 
fragments. 
Aspv-Arg-Val — Туг—lieu—His—Pro — Phe^His—Leu^-Leu—Val—Туг—Ser—R 
-RENIN SUBSTRATE (ANGIOTENSINOGEN)-
ANGIOTENSIN I (AD 
ANGIOTENSIN Π (ΑΠ) 
[RENIN! 
CONVERTING ENZYME 
PEPTIDASE 
-ANGIOTENSIN Ш(АШ)-
Fig.l. Schematic representation of the sequence in the generation of 
angiotensins from renin substrate. Cleaving points for the enzymes are 
shown by the arrows. 
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Renin acts on its substrate in the peripheral blood-stream. The 
reaction can also be demonstrated at other sites, for example in renal lymph, 
and might occur within the vessel wall. Locally generated angiotensin might 
have considerable physiological effects. 
1.2. THE JUXTAGLOMERULAR APPARATUS 
The juxtaglomerular apparatus (Fig 2) is the part of the nephron located 
at the hilus of the glomerulus and consists of a vascular and a tubular 
component. 
The vascular component includes the afferent and efferent arterioles 
and the extraglomerular mesangium, which is connected with the glomerular 
mesangium. Juxtaglomerular cells are the granular cells of the vascular 
component. These cells have functional and morphological features of 
endocrine as well as of smooth-muscle cells, and are considered as modified 
smooth-muscle cells. Juxtaglomerular cells predominate in the afferent 
arteriole, while the extraglomerular mesangium is poor in granular cells. 
Renin is synthesized by the juxtaglomerular cells and stored in the 
numerous membrane-bound secretory granules. Most of the renin is released 
into the blood-stream. 
Fig.2. Relationship between tubular and vascular components of the juxta-
glomerular apparatus. 
AA: afferent arteriole; EA: efferent arteriole; PT: proximal tubule; 
DT: distal tubule; MD: macula densa; G: glomerulus; EM: extraglomerular 
mesangium; JG: juxtaglomerular cells. 
Fig.2a. modified from Barajas (5); Fig.2b. from Davis and Freeman (1). 
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The tubular component consists of that part of the distal tubule which 
runs between the afferent and efferent arterioles and is in contact with the 
vascular component. This region is called the macula densa, which cells are 
packed closer together then elsewhere in the distal tubule and have their 
Golgi apparatus located in the basal region. 
Three dimensional reconstructions obtained by serial section studies 
in the rat showed a long and constant association between the distal tubule 
and the efferent arteriole (Fig 2a) and only a short contact between the 
distal tubule and the afferent arteriole (5). The extraglomerular mesangium 
was most consistently in contact with the macula densa. 
The macula densa hypothesis of control of renin release and the role of 
the juxtaglomerular apparatus in the control of single nephron glomerular 
filtration rate (tubuloglomerular feedback) rely heavily on a close 
anatomical relationship between the tubular and vascular component of the 
juxtaglomerular apparatus. A model with variable contacts was suggested by 
Barajas (5). 
The juxtaglomerular region has a rich adrenergic innervation. Nerve 
endings occur on juxtaglomerular cells, on smooth-muscle cells in the 
arterioles, and on tubular cells in this region. The same axon can innervate 
all components of the juxtaglomerular apparatus and therefore may affect 
renin secretion, vasoconstriction of the arterioles, and tubular function. 
1.3. THE COMPONENTS OF THE RENIN-ANGIOTENSIN SYSTEM 
1.3.1. RENIN 
It is impossible to give a comprehensive review of all the data 
concerning high-molecular weight renins, inactive renins, and active renins 
since the primary structure of kidney renin is not yet known. 
The pH optimum of active renin is between 5.5 and 6.5. The half-life 
of renin in the circulation is from 30 to 90 minutes and inactivation 
takes place in the liver. 
There is an inactive renin present in the human kidney, in amniotic 
fluid, and plasma. This inactive renin can be irreversibly activated by 
limited proteolysis and reversibly activated by acidification. Activation 
is also possible by exposure to cold (cryoactivation). 
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Inactive plasma renin has a molecular weight of 55,000 to 56,000 
daltons. The molecular weight of pure active renin in the human kidney is 
40,000, but larger molecular-weight active renins have been demonstrated in 
the kidney and in plasma. Activation of inactive into active renin can 
occur without significant change in molecular weight. 
The biochemical properties of inactive renin compared to active renin 
are described by Corvol et al (6). 
Active renin has no known physiological effect other than the 
proteolysis of angiotensinogen. 
1.3.2. RENIN SUBSTRATE (ANGIOTENSINOGEN) 
The site of synthesis of this protein appears to be the liver. The 
concentration of angiotensinogen in plasma is regulated by a number of 
factors. Glucocorticoids and estrogens increase the rate of its synthesis 
and plasma concentration. Pregnancy and the administration of oral 
contraceptives are associated with marked elevations of angiotensinogen. 
Angiotensin II and bilateral nephrectomy also augment the plasma renin 
substrate concentration. 
Renin substrate isolated from human plasma has a molecular weight of 
58,000 to 61,000 daltons. Human renin cleaves angiotensinogen of most 
species studied, but non-primate renins do not release angiotensin I from 
human substrate. 
1.3.3. ANGIOTENSINS 
Angiotensin I (AI) is derived from renin substrate by the enzyme 
renin. No unique functions can be described to A I at present. Most 
reported effects occur at much higher concentrations than those of 
physiologically effective concentrations of angiotensin II. Angiotensin I 
is largely and rapidly converted to angiotensin II by converting enzyme. 
The octapeptide angiotensin II (A II) has a potent effect on many organ 
systems (see section 1.5). The synthesis of A II and various analogues has 
been accomplished. Angiotensin II is further degraded by peptidases either 
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in plasma or in tissues and it has a very short biological half-life. The 
pressor response after intravenous injection lasts for only 1 to 3 minutes. 
It is generally accepted that the first step in A II action is binding 
to a cell membrane receptor. The exact phenomena occurring after binding of 
A II to its receptor is at present unclear. Alterations in calcium ion 
fluxes appear to play a role. 
Angiotensin II receptors have been described in a number of tissues. 
It has been shown that A II increases the number of its receptors in the 
adrenal, and decreases the number in smooth-muscle. Salt depletion raises 
the level of angiotensin, which in turn increases the number of adrenal 
receptors and decreases the number of vascular receptors (7). 
Angiotensin III (A III) is a main product of A II metabolism. This 
heptapeptide des-Asp -angiotensin II manifests all the activities of A II, 
and may be more important in certain organs e.g. the adrenal cortex. 
Angiotensin III is found in small amounts in human plasma as compared to A II. 
Doubt, however, remains about the physiological role of A III since inter-
conversion between A II and A III readily occurs in the presence of the 
abundant aminopeptidases in plasma. Effective in vivo inhibitors of A III do 
not exist. 
1.3.4. ANGIOTENSINASES 
Degradation of the angiotensins I, II, and III to inactive peptides 
occurs very rapidly in the circulation and in various tissues by a large 
number of endo- and exo-peptidases named angiotensinases. The half-life 
of A III is probably two to three times shorter than that of A II. 
1.3.5. CONVERTING ENZYME 
Converting enzyme is a rather non-specific dipeptidyl carboxypeptidase, 
which cleaves the carboxy-terminal dipeptide from a variety of substrates. 
The molecular weight is approximately 130,000 daltons. The enzyme is metal 
dependent, the main prosthetic group is zinc, and it can be inhibited by 
chelating agents. 
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By removal of the C-terminal histidyl -leucine group from A I the 
latter is converted to biologically active A II. Converting enzyme is not 
specific for A I but also cleaves the phenylalanyl-arginine dipeptide from 
the nonapeptide bradykinin, and is therefore identical to kininase II. The 
vasodilator is thereby inactivated. Thus, the converting enzyme which 
produces the most potent pressor substance also inactivates a potent 
vasodepressor substance. 
In vivo angiotensin I is largely and rapidly metabolized by converting 
enzyme to A II. Conversion occurs in tissues all over the body including 
the kidney and the systemic vascular beds, but a major site for conversion 
is the lung which contains high concentrations of the enzyme. Nearly all A I 
is converted in one passage through the lungs. The enzyme is widely 
distributed on endothelial plasma-membranes and is present in plasma, for 
which pulmonary endothelial cells may be the source. 
Inhibitors of angiotensin converting enzyme activity play an important 
role in the treatment of hypertension. 
1.4. THE CONTROL OF RENIN RELEASE 
The mechanisms controlling renin release have been extensively 
investigated and recently reviewed (4). The term renin release refers to 
the net movement of renin from the juxtaglomerular cells into the renal 
circulation. Only the most important data are discussed in this section. 
For more details the reader is referred to the recent review. 
The control of renin release includes 3 groups of mechanisms: 
1. Two intrarenal receptors: the vascular receptor in the afferent arteriole 
and the macula densa. 
2. The renal sympathetic nerves and a beta-adrenergic receptor. 
3. Several humoral agents the most important of which are the catecholamines, 
the angiotensins, the prostaglandins, antidiuretic hormone, and sodium, 
potassium, and calcium ions. 
In most situations the renin release is controlled by a variety of 
factors. 
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1.4.1. THE INTRARENAL VASCULAR RECEPTOR 
Studies in adrenalectomized dogs with a single, denervated nonfiltering 
kidney revealed that both suprarenal aortic constriction and hemorrhage 
produced a striking increase in renin secretion. Since the intrarenal 
infusion of papaverine blocked this secretion, the intrarenal receptor is 
probably located in the afferent arteriole. In this model the influences of 
the macula densa receptor, the renal nerves, and the circulating 
catecholamines are excluded. 
The precise nature of the signal to the vascular receptor is not comple-
tely understood. It is generally accepted that the intrarenal vascular 
receptor (baroreceptor) responds to changes in afferent arteriolar wall 
tension so that decreased tension stimulates renin release. Fray (3) 
attempted to develop a mathematical approach of the various factors that 
influence the intrarenal vascular receptor. The elasticity of the arteriolar 
wall, the transmural pressure gradient, and the afferent arteriolar radii 
were considered to be important inputs for renin release. This mathematical 
model, however, appeared of limited value. In Fray's opinion decreased 
stretch hyperpolarizes the cell membrane of the juxtaglomerular cells, 
decreases the calcium permeability, lowers the intracellular calcium level 
(see section 1.4.5), and stimulates renin release. The renal baroreceptor 
stimulation of renin release appears not mediated by the prostaglandin system. 
1.4.2. THE ROLE OF THE MACULA DENSA 
Morphological and physiological studies strongly suggest a functional 
relationship between the macula densa and glomerular function (tubulo-
glomerular feedback). One important role of the juxtaglomerular apparatus 
could be the anatomic pathway for the transfer of information from distal 
tubular fluid to the glomerular vascular pole. When the flow rate entering 
the loop of Henle is elevated, the filtration rate of the associated 
glomerulus (single nephron glomerular filtration rate) is noted to fall. 
There is enough evidence that the signal leading to the feedback response 
is the concentration-dependent active transport of sodium chloride across 
the macula densa cells (8). The local juxtaglomerular renin is activated by 
increased macula densa sodium chloride concentration. The proposition can 
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be made that the renin-angiotensin system in the juxtaglomerular apparatus 
acts as a local, humoral mediator between the signal perceived at the macula 
densa and the response of the glomerulus (9). Local activation of renin 
activity or local formation of angiotensins does not necessarily imply 
altered release into the systemic circulation. 
In humans as well as in rats plasma renin activity was suppressed by 
sodium chloride but not by sodium bicarbonate infusion. Selective chloride 
depletion in rats stimulates the renin release (10). These authors suggest 
that renin secretion is inversely related to the magnitude of chloride 
transport in the ascending limb of the loop of Henle. This is still an 
unresolved problem. Diuretics that inhibit chloride transport in the 
ascending limb such as furosemide and ethacrynic acid stimulate renin 
release, even if volume contraction is prevented (10). In the experimental 
work described by Schnermann and Briggs the feedback response of the single 
nephron filtration rate can be completely blocked by furosemide (8). 
1.4.3. NEURAL CONTROL OF RENIN RELEASE 
The juxtaglomerular region is quite rich innervated with sympathetic 
nerve endings. 
Increase in renin secretion can be produced by renal nerve stimulation 
indepently of changes in arterial pressure, renal hemodynamic function, or 
urinary sodium excretion. This increase in renin release is blocked by 
1-propranolol, suggesting that the neural stimulation of renin release is 
mediated by a beta-adrenergic receptor mechanism. Isoproterenol, a beta-
adrenergic receptor agonist, causes a marked increase in renin release when 
administered directly into the kidney. 
Activation of discrete areas within the brainstem and hypothalamus can 
lead to reflex stimulation or suppression of renin release mediated over 
the renal nerves. 
There is no consensus as to the nature and importance of alpha-
adrenergic receptors in the regulation of renin release. 
It is suggested that adrenergic stimulation of renin release is related 
to alterations in calcium transport of the juxtaglomerular cells. 
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1.4.4. HUMORAL REGULATION OF RENIN RELEASE 
Angiotensin II suppresses plasma renin activity and the rate of renin 
release probably by a direct effect on the juxtaglomerular cells (short-loop 
negative-feedback mechanism). 
Antidiuretic hormone also appears to inhibit renin release by a direct 
action on the juxtaglomerular cells. 
Hypernatremia lowers the plasma renin activity, presumably via an 
increase in extracellular volume. In the nonfiltering kidney acute intrarenal 
infusion of hypertonic sodium chloride did not change renin release (1). 
Acute and chronic potassium loading inhibit renin release. How potassium 
exerts its effect has been remained elusive. As administration of potassium 
chloride does not inhibit renin release in a nonfiltering kidney, the macula 
densa mechanism is probably involved. 
The suppressive effect of mineraloeorticoids is due to the expansion 
of the extracellular fluid. 
Arachidonic acid stimulates renin release via its conversion to one or 
more prostaglandins. This stimulation is observed in the intact animal and 
in several in vitro systems. A number of prostaglandins stimulate renin 
release but PGI? and PGE? have been most frequently studied. Prostaglandins 
appear not to be involved in the renin release mediated by the intravascular 
receptor, the macula densa or the beta-adrenergic receptor mechanism. 
Finally, dopamine may also inhibit renin release, since the 
administration of the dopamine antagonist metoclopramide increases the 
plasma renin level (11). 
1.4.5. CALCIUM FLUX HYPOTHESIS 
Peart (2) hypothesized that the cellular mechanisms for control of 
renin release are analogous to those for control of the contractile state 
of vascular smooth-muscle cells. This seems plausibly because juxta-
glomerular cells appear to be derived from vascular smooth-muscle cells. 
Increased net influx of calcium ions increases the intracellular calcium 
levels, resulting in smooth-muscle contraction and inhibition of renin 
release from the juxtaglomerular cells. 
Arguments for this hypothesis can be found in studies in dogs with a 
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nonfiltering kidney and in studies in isolated perfused kidneys (4). Calcium 
chloride infused intrarenally into sodium-deplete dogs with a single non-
filtering kidney decreased renal blood flow and renin secretion. When 
isolated kidneys from salt-depleted rats were perfused with solutions 
containing various concentrations of calcium, an inverse relationship 
between the cumulative perfusate renin activity and the perfusate calcium 
concentration was demonstrated. A direct action of calcium on the juxta-
glomerular cell was suggested. 
Although there have been no direct measurements of intracellular 
calcium levels in juxtaglomerular cells in association with changes in 
renin release, the hypothesis that calcium is part of a final common pathway 
for renin release remains attractive. 
Recently, Hackenthal et al (12) discussed the intracellular control 
mechanisms for renin release. A central role in the mediation of renin 
release was attributed to intracellular cyclic adenosinemonophosphate (cAMP). 
Intracellular calcium provided the essential inhibitory signal for renin 
release. 
1.5. PHYSIOLOGICAL ROLE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM 
The physiological role of the renin-angiotensin-aldosterone system 
(RAAS) can be divided in three parts: 
1. Effect on peripheral vascular resistance 
2. Regulation of renal hemodynamics 
3. Control of renal sodium excretion 
1.5.1. EFFECT ON PERIPHERAL VASCULAR RESISTANCE 
Angiotensin II is a powerful constrictor particularly of arteriolar 
smooth-muscle, and reduces blood flow in a large number of vascular beds 
including the mesenteric, cutaneous, coronary, cerebral, and renal vessels. 
Under normal circumstances the RAAS seems to play only a minor role 
in the maintenance of blood pressure in adults as various blocking agents, 
such as saralasin, appear not to have any effect on arterial pressure. 
However, when the RAAS is activated as during sodium restriction or 
hemorrhage, the same blockers induce a fall in arterial pressure. 
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1.5.2. REGULATION OF RENAL HEMODYNAMICS 
Several investigators have demonstrated that infusion of A II in 
"physiological" amounts directly into the renal artery causes a reduction 
in renal blood flow as well as antidiuresis and antinatriuresis (13). It is 
possible, however, that the renal effects of exogenous A II may not mimic 
those of endogenously formed angiotensin. 
The use of A II antagonists has provided other means for evaluating the 
RAAS in controlling renal function. In sodium depleted dogs intrarenal 
1 8 infusion of the competitive antagonist Sar , Ile -A II caused marked 
increases in renal blood flow, urine flow, urinary sodium and potassium, and 
smaller increases in glomerular filtration rate (13). The efferent arterioles 
of the kidney are more sensitive to the action of A II than the afferent 
arterioles (14). The rise in sodium excretion could not be explained by 
changes in plasma aldosterone concentration. It is possible that A II 
stimulates directly the sodium transport in the renal tubules at a low dose 
(15). In high doses A II can increase the fractional excretion of sodium. 
Angiotensin in mildly pressor doses leads to reductions in glomerular 
capillary ultrafiltration coefficient and glomerular plasma flow, but 
simultaneously raises efferent arteriolar resistance and glomerular 
capillary hydraulic pressure (16). The net effect is that both single 
nephron glomerular filtration rate and total kidney glomerular filtration 
rate remain unchanged. 
1.5.3. CONTROL OF SODIUM EXCRETION 
This has already been discussed in the previous section. 
By an action on the adrenal cortex to stimulate synthesis of aldosterone, 
both A II and possibly A III have indirect effects on the kidney to increase 
sodium reabsorption and augment potassium secretion at the distal nephron. 
In addition to A II and sodium and potassium, neurotransmitters such as 
dopamin and serotonin, and pituitary hormones mainly ACTH, play a role in 
regulating the rate of aldosterone secretion. For an extensive review on 
the aldosterone secretion we refer our reader to a recent chapter written 
by Williams and Dluhy (11). 
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1.5.4. MISCELLANEOUS 
It is clear that the physiological role of angiotensin II has only been 
discussed briefly and incompletely in this chapter. 
Angiotensin II stimulates the renal prostaglandin synthesis, and the 
release of catecholamines, which might influence the sodium excretion. 
Endogenous brain angiotensin II appears to be important for the 
maintenance of high blood pressure in experimental hypertension. 
A dipsogem'c action of A II by stimulating "drinking centers" in the 
brain has been reported. 
The widespread distribution of components of the renin-angiotensin system 
in the brain suggests as yet unknown biological functions. 
1.6. REFERENCES 
1. DAVIS JO, FREEMAN RH. Mechanisms regulating renin release. Physiol Rev 
56: 1-56, 1976 
2. PEART WS. Renin 1978. Johns Hopkins Med J 143: 193-206, 1978 
3. FRAY JCS. Stimulus-secretion coupling of renin. Role of hemodynamic and 
other factors. Circ Res 47: 485-492, 1980 
4. FREEMAN RH, DAVIS JO. Factors controlling renin secretion and metabolism. 
In Genest J, Kuchel 0, Hamet P, Cantin M (eds). Hypertension, Physio-
pathology and Treatment, 2nd ed. McGraw-Hill, New York, pp 225-250, 1983 
5. BARAJAS L. Anatomy of the juxtaglomerular apparatus. Am J Physiol 237: 
F333-F343, 1979 
6. C0RV0L P, GALEN FX, DEVAUX C, MENARD J. Biochemical characteristics of 
human and animal renin. In Genest J, Kuchel 0, Hamet P, Cantin M (eds). 
Hypertension, Physiopathology and Treatment, 2nd ed. McGraw-Hill, 
New York, pp 184-194, 1983 
7. GOODFRIEND TL. Angiotensin receptors and specific functions of 
angiotensins I, II, III. In Genest J, Kuchel 0, Hamet P, Cantin M (eds). 
Hypertension, Physiopathology and Treatment, 2nd ed. McGraw-Hill, 
New York, pp 271-279, 1983 
8. SCHNERMANN J, BRIGGS J. Concentration-dependent sodium chloride transport 
as the signal in feedback control of glomerular filtration rate. Kidney 
Int 22 (suppl 12): S82-S89, 1982 
27 
9. THURAU К, GRÜNER A, MASON J, DAHLHEIM H. Tubular signal for the renin 
activity in the juxtaglomerular apparatus. Kidney Int 22 (suppl 12): 
S55-S62, 1982 
10. KOTCHEN ТА, LUKE RG, OTT CE, GALLA JH, WHITESCARVER S. Effect of chloride 
on renin and blood pressure responses to sodium chloride. Ann Intern Med 
98. 817-822, 1983 
11. WILLIAMS GH, DLUHY RG. Control of aldosterone secretion. In Genest J, 
Kuchel 0, Hamet P, Cantin M (eds). Hypertension, Physiopathology and 
Treatment, 2nd ed. McGraw-Hill, New York, pp 320-338, 1983 
12. HACKENTHAL E, SChWERTSCHLAG U, TAUGNER R. Cellular mechanisms of renin 
release. Clin Exp Hypertens A5: 975-993, 1983 
13. HALL JE, GUYTON AC, TRIPPODO NC, LOHMEIER TE, McCAA RE, COWLEY AW. 
Intrarenal control of electrolyte excretion by angiotensin II. 
Am J Physiol 232: F538-F544, 1977 
14. HALL JE, GUYTON AC, COWLEY AW. Dissociation of renal blood flow and 
filtration rate autoregulation by renin depletion. Am J Physiol 232: 
F215-F221, 1977 
15. HARRIS PJ, Young JA. Dose-dependent stimulation and inhibition of 
proximal tubular sodium reabsorption by angiotensin II in the rat 
kidney. Pflügers Arch 367: 295-297, 1977 
16. BRENNER BM, BADR KF, SCHOR Ν, ICHIKAWA I. Hormonal influences on 
glomerular filtration. Miner Electrolyte Metab 4: 49-56, 1980 
28 
CHAPTER II 
MATERIALS AND METHODS OF THE RENIN ASSAY 
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II. MATERIALS AND METHODS OF THE RENIN ASSAY 
11.1. SAMPLE COLLECTION AND HANDLING 
Blood is collected in prechilled plastic tubes, containing 10 mg 
potassium ethylenediaminetetraacetic acid (EDTA) as anticoagulant and enzyme 
inhibitor, and the sample is kept in an ice bath prior to centrifugation. 
Plasma is immediately separated in a refrigerated centrifuge (15 min, 2000 g, 
40C) and kept stored at -20oC until time of assay. 
The renin assay is generally performed within 1 month, but not later 
than 3 months after sampling. Frozen samples are thawed in an ice bath and 
mixed thoroughly. 
11.2. PRINCIPLES OF THE PLASMA RENIN ASSAY 
Plasma renin activity (PRA) is estimated as the rate of angiotensin I 
(A I) generation from endogenous renin substrate (substrate) present in the 
plasma sample. The result is expressed as the amount of A I generated per 
ml plasma per hour (ng A I/ml/h). 
The substrate concentration in human plasma is below the concentration 
that is required to saturate the enzyme and, therefore, has a distinct effect 
on the kinetics of the renin-substrate reaction. The reaction velocity (PRA) 
reflects the concentration of both enzyme and substrate. 
Plasma renin concentration (PRC) describes the angiotensin I generation 
rate during incubation in the presence of excess homologous or heterologous 
substrate. Under these conditions only renin is the rate-limiting variable 
for the reaction velocity. 
The renin determination involves an initial incubation step of plasma 
to generate A I followed by the quantification of A I by radioimmunoassay. 
Inhibitors are added to the incubation mixture to prevent the destruction 
of A I and its conversion to angiotensin II (A II). 
The generation of A I depends on different factors such as pH, 
temperature, duration of generation, enzyme inhibitors, and plasma dilution. 
Therefore, the conditions of the assay have to be strictly controlled. 
The PRA and PRC are quantitatively determined with a commercial kit 
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(GammaCoat ( I) Plasma Renin Activity Radioimmunoassay Kit, Clinical 
Assays, Division of Travenol Laboratories, Inc., Cambridge, Massachusetts) 
with minor modifications. 
11.3. INCUBATION AND GENERATION OF ANGIOTENSIN I 
The pH optimum of the human renin-substrate reaction is between 
5.5 and 6.5. The kit provides a maléate buffer pH 5.7 for generation at 
pH 6.0, the usual pH of plasma samples after addition of the buffer. The 
buffer contains maléate, sodium EDTA, sodium azide, and neomycin sulfate. 
Phenylmethylsulfonyl fluoride (PMSF) and EDTA are used as enzyme 
inhibitors. 
Dilution of plasma samples has to be avoided because of the substrate 
dependency of the renin-substrate reaction. A minor dilution of plasma is 
obtained by mixing 300 μ] of plasma with 3 μ! of the inhibitor solution and 
30 μ] of the maléate buffer. 
The temperature of the incubation is 370C in a water bath. 
A generation time of 90 min is used to provide the estimation of initial 
velocity of the reaction. The selection of the generation time is a 
compromise between sufficient generation of A I on the one hand and minimal 
substrate consumption on the other hand. When the renin activity of a plasma 
sample is expected to be higher than 37 ng A I/ml/h (which corresponds with 
the highest A I concentration provided for the preparation of the standard 
curve, 50 ng/ml), shorter incubation times are selected. At the end of the 
generation period the tubes are immediately transferred to an ice bath. 
11.4. THE RADIOIMMUNOASSAY OF ANGIOTENSIN I 
The method is a competitive binding type of radioimmunoassay using 
antibody coated tubes. The radioimmunoassay of A I standards and patient 
samples is performed in duplicate. Hundred μ! of each incubation mixture 
or of A I standard are pipetted into the antibody coated tube, and 1.0 ml 
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of the I angiotensin I tracer-0.01 M phosphate buffer reagent is 
immediately added and mixed. These mixtures are incubated for 3 hours at 
room temperature. The liquid contents are then aspirated and the tubes 
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are counted for 10 min (count rate at least 10,000 counts) in a gamma counter 
125 (Searle) with the window adjusted for Iodine. 
The radioimmunoassay procedure includes the preparation of a standard 
curve for every run with A I standards calibrated at 0.2; 0.8; 3.0; 10.0, 
and 50.0 ng/ml by the manufacturer. The unknown A I content in the test 
sample is determined with a calculator (logit-log program). 
11.5. CALCULATION OF PLASMA RENIN ACTIVITY (PRA) 
PRA is expressed as A I generated per ml plasma per hour (ng A I/ml/h). 
Appropriate volume corrections are applied. 
volume of incubation mixture 
ng A I per coated tube (plasma sample+buffer+inhibitor) 
PRA = χ 
size of sample assayed in the plasma volume 
coated tube 
ng A I 0.333 ml 
χ 
0.1 ml 0.3 ml 
= = ng A I χ 7.40/ml/h 
1.5 h 
In general, the PRA of a plasma sample is taken as the difference of 
the PRA value of the sample incubated at 37ο0 and the corresponding PRA 
value of the sample incubated at 0° or 40C. This correction is not made 
in this study (see section II.6.7.). 
11.6. EVALUATION AND STANDARDIZATION OF THE PRA ASSAY 
11.6.1. SENSITIVITY, PRECISION, AND QUALITY CONTROL 
According to the manufacturer the cross-reactivity of the antiserum, 
expressed as the ratio of A I to the cross-reacting substance concentration 
at 50% inhibition of maximum binding, is 100% for A I, and <0A% for angio­
tensin II and III. 
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Sensitivity of the radioimmunoassay is calculated as the amount of 
unlabeled A I required to depress binding to 90% of maximal binding of the 
125 
I - A I in the standard curve. In the routine setting 20 pg of A I 
produces 10% deflection. Therefore, the sensitivity of the PRA assay is 
0.15 ng A I/ml/h. 
The kit provides a PRA control plasma. As a quality control index 
for the entire assay performance the control sample of the kit and three 
laboratory controls are routinely included in every run. The laboratory 
controls consist of 3 pooled plasma samples stored in aliquots at -70oC. 
The within-assay reproducibility in different ranges of PRA values 
is calculated from duplicate values. The results are shown in Table 1. 
Table 1. Intra-run precision of the angiotensin I (A I) concentration in 
the PRA assay calculated from duplicate values in the radioimmunoassay 
A I range number of standard coefficient of 
(ng A I/ml) duplicates deviation variation (%) 
0.2 - 1 
1 - 2 
2 - 3 
3 - 10 
10 - 20 
20 - 30 
30 - 40 
40 - 50 
29 
30 
20 
28 
28 
29 
21 
16 
0.13 
0.22 
0.26 
0.27 
0.25 
1.11 
1.10 
2.02 
22 
15 
10 
4.2 
1.7 
4.4 
3.1 
4.5 
The inter-assay reproducibility is determined from consecutive assays 
of the 3 laboratory control plasmas over a period of four years, subdivided 
in the first and the following two years (Table 2 ) . The coefficient of 
variation does not differ substantially between the 3 control plasmas, and 
does not change during the entire period. The PRA level of two control 
plasma samples (H,L) decreases gradually in time. 
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ω Table Ζ. Inter-run precision of the PRA assay obtained from consecutive determinations in a 4 years period of 
three control plasma samples H, Z, and L stored in aliquots at -70oC 
Plasma pool Η Ζ L 
Period in years 0-2 2-4 0-4 0-2 2-4 0-4 0-2 2-4 0-4 
Mean PRA (ng A I/ml/h) 
Number of assays 
Standard deviation 
Coefficient of variation 
Standard error of the mean 
29.5 
35 
2.6 
8.7 
0.44 
27.2 
31 
2.4 
8.6 
0.43 
28.4 
66 
2.7 
9.4 
0.33 
10.8 
36 
0.7 
6.4 
0.12 
10.8 
33 
1.0 
9.2 
0.17 
10.8 
69 
0.8 
7.8 
0.10 
7.8 
32 
0.5 
7.0 
0.09 
7.1 
30 
0.6 
8.5 
0.11 
7.5 
62 
0.7 
9.0 
0.09 
II.6.2. LINEARITY OF ANGIOTENSIN I GENERATION IN TIME 
Six plasma samples were incubated for different periods. As can be seen 
in Fig 1, a linear relationship between A I generation and time at least up 
to 90 min was found. From the experiments with renin addition to plasma 
samples (see section II.6.6, Table 6 ) it appears that the generation rate of 
A I during 90 min incubation is constant for PRA values up to 40 ng A I/ml/h. 
Because the highest A I standard is 50 ng/ml, shorter incubation times are 
selected when the PRA of a sample is expected to be higher than 37 ng A I/ml/h, 
instead of diluting the test sample. During short incubation the generation 
of A I increased also directly proportionally with time. 
Angiotensin I (ng /ml) 
— ι 1 1 I I ' 
40 80 120 (min) 
Fig.l. The amounts of angiotensin I generated from six plasma samples during 
different incubation periods. 
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II.6.3. THE INFLUENCE OF SAMPLE COLLECTION AND STORAGE ON PRA 
Conditions of collection and storage of plasma samples may influence 
the PRA. Because of conflicting results reported we performed the following 
experiments. Blood samples were taken from five infants and six children, 
chosen at random. Conditions of sampling were not standardized for salt 
intake and posture of the subjects. Two series for renin assay were prepared, 
cold and warm. 
Cold series (C): blood was, as usually, collected in ice-chilled tubes 
and remained in an ice bath until subsequent separation of plasma in a 
refrigerated centrifuge. PRA determinations were performed immediately 
(0-value) and after storage in aliquots at -20oC for 1 and 2 weeks, and 
for 1, 2, and 4 months. 
Warm series (W): blood was collected in a non-precooled tube, maintained 
for 3 hours at room temperature and then centrifuged. Subsequently, the 
sample was assayed (0-value) or stored in aliquots for 1 week and for 
4 months at -20oC. 
W -
Ю-, 
6-
/ 
— s 
• s 
4-
/ 
2- Ζ' 
2 4 6 8 IO 
С 
Fig.2. Values of PRA (ng A I/ml/h) 
immediately determined after 
collection and handling of the plasma 
in ice (C) or at room temperature (W). 
Dashed line: Y=X. 
4 months-
10-
ΘΗ 
6 
4 4 
2 
.« cf 
J' 
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er 
k
— i — l i l i — ι — l i l i 
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o-value 
Fig.3. Values of PRA (ng A I/ml/h) 
after collection and handling either 
in ice (·) or at room temperature (o) 
and determined immediately after col­
lection (0-value) or after storage at 
-20oC for 4 months. Dashed line: Y=X. 
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Table 3. Influence of sampling, handling, and storage of plasma on PRA (ng A I/ml/h). Sampling and handling 
either in ice (C) or at room temperature (W). PRA was determined immediately after sampling (0-value) or 
after storage at -20°C for various periods 
ω 
Nr 
INFANTS 
1 
2 
3 
4 
5 
CHILDREN 
6 
7 
8 
9 
10 
11 
Age 
(years) 
0.5 
0.1 
0.2 
0.5 
0.4 
12.6 
10.6 
17.2 
7.8 
11.0 
12.1 
0-value 
С 
1.5 
1.6 
2.7 
4.5 
10.0 
1.1 
1.9 
2.2 
2.3 
3.6 
5.7 
W 
1.5 
1.7 
2.9 
4.9 
10.6 
1.2 
2.0 
2.4 
2.4 
3.6 
6.4 
1 week 
С 
1.4 
1.7 
2.8 
4.2 
8.3 
1.1 
2.0 
2.3 
2.3 
3.2 
5.6 
W 
1.7 
2.0 
3.6 
4.6 
8.5 
1.1 
2.0 
2.5 
2.6 
3.4 
5.8 
2 weeks 
С 
1.6 
1.5 
2.7 
4.2 
8.5 
1.0 
1.7 
2.1 
2.2 
3.5 
5.5 
1 month 
С 
1.4 
1.6 
2.7 
4.1 
8.2 
1.2 
1.8 
2.1 
2.2 
3.3 
4.9 
2 months 
С 
1.5 
1.6 
2.7 
4.2 
8.1 
1.1 
1.9 
2.2 
2.2 
-
5.5 
4 mor 
С 
1.5 
1.6 
2.6 
4.1 
7.7 
1.2 
1.9 
-
2.2 
-
5.2 
iths 
W 
-
1.6 
2.9 
-
-
1.2 
2.0 
2.4 
2.5 
3.4 
5.1 
The values for PRA determined immediately after sampling (0-value) and 
after storage for various periods are summarized in Table 3 and Figs 2 and 
3. The 0-values for PRA of the warm series (Fig 2, Table 3) in 9 samples 
are higher than those of the cold series, but the difference is very small. 
Two samples had the same PRA. After storage of cold and warm samples (n=17) 
at -20oC for 4 months (Fig 3, Table 3) PRA is higher in 2 samples, lower in 
8 samples, and unchanged in 7 samples compared to the corresponding 0-values. 
The changes are generally small. 
DISCUSSION 
PRA values of plasma samples collected and handled under cold conditions 
were only slightly lower than collected at room temperature. Similar results 
were reported by others (1-3). Therefore, sampling at room temperature hardly 
influences PRA values. Because of wide fluctuations in "room temperature" 
sample collection and handling on ice is still recommended (3). 
An increase in PRA is reported after prolonged storage of plasma at 
-20oC (4). PRA was higher in 13 out of 15 samples after storage for 3 months. 
After storage for 4 months all 6 samples had a higher PRA. The increase in 
PRA was assumed to be due to activation of an inactive form of renin by 
cryoactivation. We found no significant influence of storage of plasma 
samples at -20oC for 4 months on PRA values. An increase of PRA especially 
was not observed. Therefore, no cryoactivation of inactive renin occurred 
under these conditions. Moreover, most samples showed either no change or a 
slight decrease in PRA. The latter might be the result of a decrease in 
substrate reactivity as has been reported by Sealey et al (4). 
After the first report of influence of storage at -20oC on PRA values, 
some authors (3,5,6) found no cryoactivation of renin in plasma samples 
stored for up to 15 months without thawing and refreezing, while others 
observed an increase of PRA (1,2,4). As can be seen from Table 2, storage 
of our 3 control plasma samples at -70oC during 4 years did not result in 
an increase of the PRA values of the aliquots. 
11.6.4. CRYOACTIVATION AND EFFECTS OF FREEZING AND THAWING 
Because no increase in PRA was seen during storage at -20aC for 4 months 
(see section II.6.3), it was examined whether we could confirm the phenomenon 
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of cryoactivation under optimal conditions. In addition, we examined whether 
freezing and thawing influenced the PRA value of the plasma samples, as with 
freezing and thawing the optimal temperature for cryoactivation is passed. 
Arbitrer1ly chosen plasma samples which were thawed only once prior to 
renin assay (first PRA), were subsequently stored for a few weeks up to 7 
months at -20oC, thawed again and reassayed (second PRA). In addition, 
after the secord thawing the samples were reassayed after further storage 
at -40C during 4 days (cryoactivation). 
The results are presented in Table 4. The cryoactivation procedure 
stronaly increased all PRA values. Freezing and thawing caused no increase 
in PRA. On the contrary, PRA values in 11 of the 12 second determinations 
were lower compared to the first assay. These results are in accordance 
with those described in the previous section (II.6.3). As cryoactivation of 
inactive renin occurs optimally at -4°C and is a very slow process, the 
period of freezing and thawing seens too short to influence distinctly the 
PRA value of the plasma sample. 
Table 4. PRA values (ng A I/ml/h) from plasma samples after 1 and 2 times 
freezing and thawing (1st and 2nd PRA), and after storage for 4 days at -40C 
(cryoactivation). The 2nd PRA values were all determined in a single run 
* 
Sample 1st PRA time 2nd PRA cryoactivation 
5.3 
6.9 
0.4 
4.7 
0.5 
9.7 
9.7 
8.7 
1.5 
0.3 
1.6 
3.7 
4 
4 
4 
5 
5 
10 
10 
14 
18 
28 
29 
33 
5.1 
6.8 
0.3 
4.5 
0.3 
8.9 
8.1 
8.2 
1.2 
0.4 
1.0 
3.0 
10.5 
11.3 
0.7 
7.2 
1.9 
12.3 
12.7 
8.8 
2.6 
3.0 
1.4 
8.8 
time interval in weeks between 1st and 2nd PRA. 
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11.6.5. COMPARISON OF THE CLINICAL ASSAYS AND MRC ANGIOTENSIN I STANDARDS 
Important differences in iimuno-reactivity between various preparations 
of A I have been reported (7-9). We determined the relative potency of the 
Clinical Assays A I standards compared to the Medical Research Council 
Standard A (MRC code 71/328) for A I (7). 
One ampoule MRC 71/328 contains 9/ig of freeze-dried synthetic Asp ,Ileu 
angiotensin I. The solid content of the ampoule was dissolved in 0.50 ml 
sterile bidistilled water (7), subdivided into aliquots and stored at -70oC. 
Dilutions were made with 0.01 M phosphate buffered 0.9% sodium chloride 
pH 6.2, which is the pH of all A I standard solutions of the kit. Freshly 
prepared dilutions with a final A I concentration of 0.80; 1.67; 2.50; 3.00; 
3.57; 5.0; 10.0; 20.0; 30.0, and 50.0 ng/ml were used in duplicate for the 
radioimmunoassay standard curve. The A I standards of Clinical Assays were 
measured in the concentrations 0.8; 3.0; 10.0, and 50.0 as provided by the 
manufacturer. Linear regression between given A I concentration of Clinical 
Assays standards and the corresponding A I concentration found (Fig 4) is 
described by the equation Y = -0.003 + 0.85X (X = given A I, Y = found A I). 
We conclude that both A I preparations behaved identically in the radio­
immunoassay system, and that the relative potency of Clinical Assays A I 
standards is 85 % compared to the MRC A I preparation. Therefore, 1 ng A I 
in our assay equals 0.85 ng MRC A I. 
Found AI (ng /ml) 
50 η 
40- / ° 
30- / 
20- / 
10- / 
Ο - " — ι 1 1 1 1 r 
5 10 20 30 40 50 
Given AI (ng/ml) 
Fig.4. Relation between given angiotensin I (A I) concentration of the 
Clinical Assays standards and the corresponding A I concentration found 
when calibrated against the MRC A I standard in the radioimmunoassay. 
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II.6.6. CALIBRATION OF THE RENIN ASSAY AGAINST THE WHO STANDARD PREPARATION 
OF HUMAN RENIN 
The activity of the First International Reference Preparation of Human 
Renin of the WHO, coded 68/356 (7), was evaluated in our renin assay system. 
The standard was provided by the National Institute for Biological Standards 
and Control, Holly Hill, Hampstead, London, NW3 6RB, England. One ampoule 
coded 68/356 contains by definition 0.1 international unit (Goldblatt Unit) 
of human renin. 
The freeze-dried content of the ampoule was dissolved in 0.5 ml sterile 
bidistilled water and subsequently diluted with 24.5 ml 1% heat-inactivated 
(30 min at 560C) bovine serum albumin in the maléate generation buffer of 
Clinical Assays. This standard renin solution (4x10 μΐυ renin/ml) was 
subdivided in aliquots of 0.5 ml, snap frozen in a mixture of acetone and 
dry ice, and stored at -70oC. 
Plasma samples of 20 adults and of 11 infants 3 weeks to 6 months of 
age were analyzed in duplicate without and after the addition of 66.6 and 
133.2 μΐυ of the standard renin to 1.0 ml plasma. The volume of maléate 
generation buffer was corrected for the added volume of the renin solution. 
The results are shown in Tables 5 and 6. The mean increase in PRA 
per μΐυ renin was essentially the same after addition of 66.6 and 133.2 μΐϋ 
renin to samples of both adults and infants. In addition, the results were 
not different between adults and infants. As can be seen from both tables 
the generation of A I per μΐυ renin is constant within each individual 
during the 90 min incubation period. Between individuals, however, 
differences can be observed, probably because of differences in substrate 
concentration or in the activity of activators or inhibitors of the renin-
substrate reaction. 
In our assay system a PRA of 1 ng A I/ml/h in the samples of the adults 
corresponded to 11.0 μΐυ renin/ml ± 1.4 (SD) and 11.0 ± 1.5. In infants 
these values were 10.5 ± 1.9, 10.5 ± 1.7, and 10.8 ± 1.8 after the addition 
of 66.6, 133.2, and 199.8 μΐυ renin, respectively. 
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Table 5. Effects of the addition of 66.6 and 133.2 /iIU of Standard Renin 
(MRC 68/356) to 1.0 ml plasma of adults on the PRA (ng A I/ml/h) 
Sample PRA PRA after addition of renin PRA per μΐυ renin 
66.6 133.2 66.6 133.2 
1.1 
1.0 
1.9 
2.4 
1.6 
1.6 
1.0 
2.6 
0.8 
0.9 
4.7 
1.5 
2.1 
2.6 
4.5 
5.7 
0.6 
1.7 
4.3 
1.0 
6.5 
7.4 
7.1 
8.1 
7.9 
7.7 
7.7 
10.2 
6.9 
6.8 
9.5 
7.9 
9.4 
8.1 
11.0 
10.9 
5.6 
9.3 
9.8 
6.6 
12.2 
13.9 
13.4 
14.3 
14.1 
14.0 
15.0 
17.2 
13.1 
12.5 
13.4 
14.8 
18.4 
13.9 
17.7 
15.7 
11.5 
13.8 
14.7 
12.7 
0.082 
0.096 
0.078 
0.086 
0.095 
0.093 
0.099 
0.114 
0.093 
0.088 
0.072 
0.097 
0.110 
0.084 
0.096 
0.079 
0.075 
0.113 
0.082 
0.085 
0.084 
0.097 
0.086 
0.089 
0.093 
0.093 
0.105 
0.109 
0.093 
0.087 
0.066 
0.100 
0.122 
0.085 
0.099 
0.075 
0.082 
0.091 
0.077 
0.088 
mean: 0.091 0.091 
SD: 0.012 0.012 
Conversion 1 ng A I/ml/h to jUlU renin/ml ± SD: 11.0 ± 1.4 11.0 ± 1.5 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Table 6. Effects of the addition of 66.6; 133.2, and 199.8 /iIU of Standard 
Renin (MRC 68/356) to 1.0 ml plasma of 3 weeks to 6 months old infants 
on the PRA (ng A I/ml/h) 
Sample PRA PRA after addition of renin PRA per μΙΙΙ renin 
66.6 133.2 199.8 66.6 133.2 199.8 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
8.2 
1.6 
1.7 
2.8 
30.7 
9.2 
8.6 
4.1 
0.5 
0.8 
7.1 
14.6 
6.0 
9.5 
9.4 
36.2 
16.6 
16.7 
10.6 
5.5 
7.5 
13.1 
19.9 
10.1 
17.2 
15.8 
42.0 
22.0 
23.8 
16.1 
11.3 
14.7 
20.2 
24.3 
14.4 
23.5 
21.9 
48.5 
27.5 
30.9 
22.5 
16.7 
23.1 
_ 
0.086 
0.067 
0.117 
0.099 
0.083 
0.110 
0.122 
0.098 
0.075 
0.100 
0.090 
0.088 
0.065 
0.117 
0.097 
0.084 
0.096 
0.114 
0.090 
0.081 
0.104 
0.098 
0.080 
0.064 
0.109 
0.095 
0.089 
0.091 
0.112 
0.092 
0.081 
0.112 
_ 
mean: 0.095 0.094 0.093 
SD: 0.017 0.015 0.015 
Conversion 1 ng A I/ml/h to μΐυ renin/ml ± SD: 10.5±1.9 10.5±1.7 10.8±1.8 
II.6.7. COMPARISON OF PRA VALUES AFTER INCUBATION AT 370C AND 0oC 
(SAMPLE BLANK) 
The radioimmunoassay of A I offers the advantage of high sensitivity. 
Direct radioimmunoassay of plasma samples, however, may introduce 
inaccuracies. 
First, the amount of A I present in the plasma sample contributes to the 
calculated PRA. Basal plasma A I concentrations in 1 week to 13 years old 
children range from 63 pg/mi in the oldest children to 468 pg/ml in the 
youngest infants (see chapter IV). The calculated contributions of these 
A I levels to the PRA are 0.04 ng A I/ml/h for the corresponding lowest PRA 
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(0.9 ng A I/ml/h) and 0.28 ng A I/ml/h for the highest PRA (23.8 ng A I/ml/h). 
Because circulating A I levels correlate well with PRA values (see chapter IV), 
and the amount of circulating A I is low relative to the A I generated in 
the PRA assay, the circulating A I levels will have little effect on the 
accuracy of the PRA values. 
The very low levels of A II and A III present in the plasma sample might 
theoretically contribute to the calculated PRA. The cross-reactivity of A II 
and A III with antibodies to A I is, however, less than 0.1%. 
A third inaccuracy in the PRA assay is introduced by nonspecific 
substances in plasma that interact with antibodies to A I. 
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Fig.5. PRA values after incubation of a plasma sample at different 
temperatures. 
Regression line 1: measured PRA values (x) without correction for the 
"sample blank", and omitting the value at 0°C. 
Regression line 2: after correction of measured PRA values for a "sample 
blank" (o), and including the value at 0°C. 
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The inaccuries of the PRA assay described are generally circumvented by 
subtracting a sample blank value which is obtained by incubation at 0oC. 
However, even at this low temperature some activity of renin may be expected, 
and this will be proportional to the PRA value at 370C. The relation between 
enzyme activity and temperature of incubation was experimentally determined. 
Aliquots of a plasma pool with PRA of about 17 ng A I/ml/h were incubated 
for 90 min at 11 different temperatures (± 0.ГС) between 0° and 47 0C, and 
the A I generated was measured in the radioimmunoassay. The results are 
presented in a semi-logarithmic plot in Fig 5. A regression line (nr 1) was 
calculated omitting the value at 0oC. Subsequently, the values of A I 
measured at all temperatures were iteratively corrected for a constant 
contribution in the radioimmunoassay until the value of 0oC also fitted on 
a new regression line (nr 2). The constant contribution which was subtracted, 
is composed of aspecific activity (aspecific blank) in the radioimmunoassay, 
and the amount of A I present in the sample before incubation (specific 
blank). The second regression line exclusively describes the effect of 
temperature on the enzyme activity, and is characterized by the equation: 
Y = -0.37 + 0.042X (X=temperature of incubation, Y=log PRA). From this 
equation a Q.Q = 2.66 for renin, measured in plasma, is obtained. Therefore, 
the enzyme activity at 0°C is 2.7% of the activity at 370C. 
Some 200 plasma samples were incubated at both 370C and 0 oC for 90 min. 
The calculated PRA values are shown in Fig 6. There is a good correlation 
between both measurements (r=0.78, n=203). The linear regression equation is 
described by: Y = 0.27 + 0.040X (X=370C value, Y=0oC value). After correction 
for the enzyme activity at 0 oC (Y=0.027X) the resulting equation, 
Y = 0.27 + 0.013X, describes the mean sum of aspecific and specific blank. 
The Y-intercept of the regression line has a mean value of 0.27 ng A I/ml/h 
and 95% confidence limits 0.22-0.32. This value represents a nearly constant 
contribution of the aspecific blank to the calculated PRA. The second 
contribution to the last mentioned equation represents the specific blank 
which is positively correlated with the corresponding PRA (see chapter IV). 
The frequently applied subtraction of a sample blank value, obtained 
after incubation at 0°C, is not completely accurate. A correction for the 
enzyme activity at 0oC should be made. The most accurate correction of the 
370C value is: - 0oC value + 0.027 χ 370C value. 
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Fig.6. PRA values (ng A I/ml/h) of plasma samples incubated at 370C versus 
values after incubation at 0 oC (sample blank). For description of the 
regression lines: see text. 
We decided for our investigations not to run a sample blank at 0 oC and 
to estimate only PRA values at 370C without any corrections, for the 
following reasons. First, the amount of blood required could be halved. 
Second, the value of the sample blank is located on a part of the standard 
curve where accurate interpretation is difficult. The accuracy of the 
determination is unfavourably influenced, and greater error might be 
introduced when 2 less precise measurements are subtracted. This applies 
especially to PRA values in the lower range ( < 2 ng A I/ml/h). In the 
higher range the proportional contribution of the blank value is small, 
and decreases with higher PRA values. Third, although less important, the 
cost and the workload of the PRA determination could be halved. 
Our procedure will have little effect on the accuracy of the values 
normally measured in infancy and childhood since the A I generation at 370C 
at young age is high relative to the generation of A I at 0oC. However, for 
very low values when the values of the sample blank may be high relative to 
the amount of A I generated at 370C, or in situations where extreme accuracy 
is required, it may be advisable to subtract a sample blank value. 
An alternative is prolongation of the incubation period so that the amount 
of A I generated at 370C is high relative to that generated at 0CC. 
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II.7. PLASMA RENIN CONCENTRATION ASSAY IN DOGS 
Plasma renin concentration (PRC) describes the reaction velocity of the 
renin-substrate reaction during incubation of plasma with excess substrate. 
Under this condition only renin is the rate-limiting variable for the 
reaction velocity. 
Estimates of PRC in adult dogs and in puppies (see chapter IX and X) 
were performed with the addition of excess homologous renin substrate. Dog 
plasma containing renin substrate and virtually no renin (substrate plasma) 
was obtained by exsanguination of an adult dog under pentobarbital 
anesthesia 48 hours after bilateral nephrectomy. The blood was collected in 
potassium EDTA and centrifuged at 4 0C. The plasma was divided in small 
aliquots and stored at -20°C. The renin activity of the substrate plasma was 
0.6 ng A I/ml/h after incubation at 37 0C for 90 min. 
The influence of substrate on the generation rate of A I was tested 
by adding increasing amounts of substrate plasma to 1 μΐ plasma of 6 puppies. 
The mixtures were assayed as usually. The results are shown in Fig 7. 
P R A ( n g A I / m l / h ) -
3 0 0 
2 0 0 
100-? 
— ι 1 1 1 1 1 1 1 r 
20 30 4 0 5 0 6 0 
μ\ substrate plasma added to 1 jj.1 test plasma 
ι 
10 
Fig.7. Influence of the amount of substrate plasma on the generation rate 
of angiotensin I in plasma samples of six puppies. 
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It appears that maximum generation rate of A I is reached at a test 
plasma to substrate plasma ratio of 1:30. The results for plasma samples 
with PRC values up to 3000 ng A I/ml/h were similar whith a ratio of either 
1:30 or of 1:299. In the final assay we used 10 μΐ test plasma plus 300 μ\ 
substrate plasma. 
The undiluted substrate plasma has always been included in every run 
as sample blank at 37 0C, and the resulting value was subtracted from the 
PRC values of the test plasma samples. 
Because of the 31 fold dilution of the test sample, the sensitivity 
of the PRC assay is limited to 5 ng A I/ml/h. 
The standard deviation of PRC values up to 40 ng A I/ml/h appeared 
to be essentially constant. The within-run precision of the PRC assay for 
values up to 40 ng A I/ml/h is therefore given as the standard deviation 
of ± 1.0 ng A I/ml/h (n=60). 
For PRC values from 40 ng A I/ml/h the coefficient of variation did not 
vary. The within-run precision of the PRC assay for values higher than 40 
ng A I/ml/h is therefore given as the coefficient of variation of 3.5 % 
(n=90). 
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III. THE RtNIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN INFANCY AND CHILDHOOD 
IN BASAL CONDITIONS AND AFTER STIMULATION 
111.1. ABSTRACT 
Plasma renin activity (PRA), aldosterone (PA), sodium and potassium 
concentration were measured in 107 healthy infants and children in basal 
conditions of normal diet and recumbency. Urinary aldosterone (U., . ), 
sodium and potassium were also measured (n=51). A significant (P<0.001) 
age-related decrease in PRA (r=-0.67), PA (r=-0.67), and U., . (r=-0.56) 
was observed, with a striking scatter of values especially in infancy. 
The renin-angiotensin-aldosterone system (RAAS) was also studied after 
stimulation by standardized sodium restriction during four days, followed 
by acute postural change (n=40). After salt restriction a rise of PRA and 
U., . was noted, but a rise in PA could not be demonstrated in children 
aged 0-6 months. The influence of postural change on the RAAS seems more 
important in older children. 
The reported values not only in basal but also in stimulated conditions 
allow to study the RAAS in diseases such as salt-loss and hypertension. 
111.2. INTRODUCTION 
The renin-angiotensin-aldosterone system (RAAS) has an important 
function in the regulation of sodium and potassium balance, and participates 
in blood pressure homeostasis. The age-dependent increased activity of this 
system in infancy and childhood compared to adults, is well documented for 
plasma renin activity and concentration (4, 5, 11, 13, 17, 19, 21, 33, 36, 
42), for plasma aldosterone concentration (16, 20, 30, 34, 38), for the 
simultaneous measurement of plasma renin activity and plasma aldosterone 
concentration (1, 8, 12, 37, 43, 47), for aldosterone secretion (7, 48) and 
aldosterone excretion (1, 27, 28, 40). 
Most studies are limited to the activity of the system in basal 
conditions of normal diet and recumbent posture. Data of both plasma renin 
activity (PRA) and plasma aldosterone concentration (PA) during standardized 
salt deprivation in infancy and childhood are not available. 
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In this study not only the basal values of PRA, PA and urinary 
aldosterone excretion (U., , ) are presented, but also the values after 
standardized stimulation by salt deprivation and upright, sitting posture 
in both infants and children. This allows to study the RAAS in infancy and 
childhood in both basal and stimulated conditions. 
III.3. MATERIALS AND METHODS 
Basal values of PRA, PA, serum sodium (Na) and potassium (K) were 
measured in 107 infants and children, 66 boys and 41 girls, aged between 
1 week and 16 years. 24 Hours urinary aldosterone excretion, urinary sodium 
(LIJM ) and potassium (IL) excretion were also measured in 51 of them. 
Stimulation of the RAAS was performed on 40 children. 
All children were hospitalized and recovering from minor diseases or 
minor operations. They had normal blood pressure and showed no evidence of 
either renal, cardiovascular and endocrine diseases, or disorders of acid-
base or electrolyte metabolism, and were without medication. The children 
were arbitrarily divided in the following age groups: 1 week-3 months; 
3-6 months; 6-9 months; 9-12 months; 1-4 years; 4-8 years; 8-12 years, and 
12-16 years. 
Venous blood samples for basal values were taken at 8.30-9.00 A.M. 
Children had taken nothing by mouth and had been in a controlled supine 
posture since midnight. Infants were not fed later than 3 hours prior to 
sample collection and remained at least 3 hours in controlled supine 
posture. The venepuncture was performed as quickly as possible and with 
a minimum of discomfort. Blood collection was completed within one minute 
from the insertion of the needle. If not, the collected sample was discarded. 
A 24 hours urine collection was started on the morning of the blood sampling. 
The child stayed in its supine posture during that period. All children were 
on an unrestricted hospital diet. 
On the second and following days the salt intake was restricted to 
10 mmol sodium per 1.73 m2 per day for stimulation of the RAAS. Posture was 
free on day 2, 3 and 4. 24 Hours urine collection on these days was only 
made in children older than approximately 5 years. On the morning of day 5 
(after 3 days of salt restriction) blood samples (sample II) and urine 
collections were made as on day 1. With about a similar salt restriction 
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the sodium output in the urine has been reported to be always less than the 
intake after the third day of sodium restriction and "sodium-loss" ceased by 
the fourth day at the latest (6). Therefore, the following morning the third 
blood sample (day 6, sample III) was drawn. Afterwards the child was placed 
on a chair and infants fixed in a baby-chair in strictly upright posture with 
the legs hanging down. 90 Minutes later the last blood sample was collected 
(day 6, sample IV). 90 Minutes sitting posture was chosen because peak 
levels of PRA and PA after upright activity have been reported after this 
period (46). 
Because of the limited number of infants and children available for the 
stimulation test, the age groups were restricted to 0-6 months; 6-12 months; 
1-4; 4-8, and 8-16 years. 
Two ml blood for PRA and PA were collected in ice-chilled, plastic tubes 
containing 10 mg potassium EDTA. Plasma was immediately separated in a 
refrigerated centrifuge and kept stored frozen at -20oC until time of assay. 
PRA was measured with a commercial kit (Clinical Assays), in which the 
enzymatical step was scaled down to one third of the volumes prescribed by 
the manufacturer. Briefly, the sample was incubated at pH 6.0 using the 
maléate buffer, in the presence of phenylmethylsulfonyl fluoride, for 90 min 
at 370C. The angiotensin I (A I) generated was measured by radioimmunoassay. 
The results are expressed in ng A I ml" h" . 
Comparison of the Medical Research Council Research Standard A for A I 
coded 71/328 (3) with the standard used in the kit revealed a potency of 85% 
of the latter compared to the MRC standard. 
For standardization purposes of the PRA determinations, we used the 
WHO International Reference Preparation of Human Renin MRC Renin Standard 
68/356 (3). To twenty different plasma samples of adults with PRA ranging 
from 0.6 to 5.7 ng A I ml" h" , 67 and 134 μΐυ renin per ml plasma were 
added. From these 2 series a PRA equivalence resulted of 1 ng A I ml" h" 
with 11.0 μΐυ renin ml" 1 ± 1.4 (SD) and with 11.0 /¿IU renin ml"1 ± 1.5(SD), 
respectively. 
Addition of the same amounts of renin to 11 different plasma samples of 
infants (3 weeks-6 months, PRA range 0.5 to 30.7 ng A I ml" h" ), resulted 
in a similar generation of A I. From these 2 series a PRA equivalence 
resulted of 1 ng A I ml'1 h"1 with 10.5 /¿IU renin ml"1 ± 1.9 (SD) and with 
10.5 μΐυ renin ml" + 1.7(SD), respectively. 
Aldosterone concentration in plasma was measured by a direct radio-
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irrniunoassay (23). 24 Hours urine samples were collected in ice and acidified 
to pH 4-5 with 10 mol 1~ HCl and stored at -20oC until assay for aldosterone. 
Urinary aldosterone excretion was measured by direct radioimmunoassay after 
hydrolysis of aldosterone-18-glucuronide (22). 
Urinary excretions of aldosterone, sodium, and potassium were adapted 
for body surface area or body weight. 
The venepuncture for measurement of basal values was only performed in 
infants and children when this puncture was required for another reason. 
The stimulation test was performed after consent of the parents and the 
older children, mostly in combination with other routine clinical studies. 
STATISTICAL ANALYSIS 
All statistical methods (44) were undertaken on logarithmically 
transformed data because of the skew distribution of the raw data within 
the age groups and the heterogenous variances between the age groups. 
The mean value after transformation was transformed back to the model 
median (in this case equal to the geometric mean) of the raw data. 
In calculating the Pearson's coefficient of correlation and the partial 
correlation eliminating the effect of age, logarithmic transformation of 
age was also performed to obtain a better linear relation. 
When plasma or urine values were not different in contiguous age groups 
according to Duncan's test, these groups were joined. 
Differences between independent samples were tested with one-way 
analysis of variance. If there was a significant difference in case of more 
than 2 samples, the simultaneous method of Scheffé indicated which of the 
samples differed from the others. 
Differences between paired values within each group were tested with 
Student's paired t-test using the pooled standard deviation of the different 
age groups. The 95% confidence interval for the median percental increase 
was also formed using the pooled standard deviation. 
All tests were performed at a significance level of 0.05. 
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III.4. RESULTS 
III.4.1. BASAL VALUES 
After the Duncan analysis a new subdivision of age groups was made. 
For plasma values the age groups were now: 1 week-3 months; 3 months-1 year; 
1-4; 4-8, and 8-16 years; for urinary values: 2 weeks-3 months; 3-6, and 
6-12 months; 1-4; 4-8, and 8-16 years. 
The same conclusions were obtained when urinary data were adjusted to 
body surface area or body weight. All urinary values are expressed per 1.73 m 2 
body surface area. 
PRA and PA were not different (P>0.05) between boys and girls in the 
various age groups. 
The age-related decreases in PRA, PA, and U., . are shown in Figs 1-3. 
The data about PRA, PA, and serum К are presented in Table 1. Data about 
UAldo' ^ a ' anc' ^K a r e P r e s e n t e d ^η Table 2. 
Correlations of the various data with age are presented in Table 3. 
For the whole group there is a significant inverse relationship between age 
and PRA, PA, U., . and serum K. U N is also related to age. U» (Tables 2 
and 3) increases until about one year of age followed by a decrease. 
Differences between age groups are indicated in Table 1. 
PRA in infants under 1 month of age (model median 15.0 ng A I ml" h" , 
n=6) is significantly (P<0.001) higher than in infants aged 1-3 months 
(7.4 ng A I ml" 1 h" 1, n=9). 
In contrast to PRA values, no significant (P=0.80} difference is noted 
for PA between infants under 1 month of age (70 ng dl" , n=6) and infants 
aged 1-3 months (63 ng dl" , n=10). 
Serum К for the children younger than 4 years is significantly higher than 
for children older than 4 years. No significant (P= 0.85) difference is 
seen between infants under 1 month of age (5.5 rmiol 1~ , n=6) and infants 
aged 1-3 months (5.4 mmol l" , n=6). 
U., . (Table 2) until 4 years of age is significantly higher compared to 
the age group of 8-16 years. No differences exist between the age groups 
under 4 years contrary to the results reported for PA. 
The scatter of PRA and PA levels (Figs 1 and 2) observed in the 
youngest age group is striking. 
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Fig.l. Plasma renin activity (PRA) in different age groups. 
Model median and the one-standard deviation range are indicated. 
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Fig.2. Plasma aldosterone concentration in different age groups. 
Model median and the one-standard deviation range are indicated. 
Conversion traditional to SI units: 0.36 ng = 1 pmol. 
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Fig.3. Urinary aldosterone excretion in different age groups. 
Model median and the one-standard deviation range are indicated. 
Conversion traditional to SI units: 0.36 μς = 1 nmol. 
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Table 1. Model median (Med) and observed range of plasma renin activity (PRA), plasma aldosterone 
concentration (PA), and serum К in different age groups. 
Conversion traditional to SI units-angiotensin I: 1,297 ng = 1 nmol; 1 ng A I ml h 
0.36 ng aldosterone = 1 pmol 
lu-1 11.0 μΐυ renin ml -1 
Age group 
PRA (ng A I ml"1 h"1) 
Med range 
PA (ng dl"1) 
Med range 
К (mmol Г 1 ) 
Med range 
Iw - 3 m 
3 - 12 m 
1 - 4 y 
4 - 8 y 
8 - 16 y 
15 
32 
20 
17 
19 
9.8 
4.5 
4.4 
2.9 
2.0 
1 * 
* 
J_ 
4.0-23.8 
1.5-10.2 
1.7-11.8 
0.9- 9.2 
0.9- 7.6 
16 
32 
20 
17 
20 
66 
24 
16 
14 
10 
Ί 
* 
J 
25-213 
7-108 
3- 77 
5- 44 
4- 22 
12 
25 
18 
15 
18 
5.5
Ί 
4.9-η 
4.9 J 1 
* 4.2
Π 
4.2J 
4.7-6.6 
3.7-5.6 
4.1-6.3 
3.7-5.1 
3.4-5.5 
+ : w: week; m: months; y: years 
§ : significantly higher compared to the other age groups 
* : significant difference between age groups 
Table 2. Model med (Med) and observed rai 
excretion (IL) in different age groups. 
Conversion traditional to SI units: 0.36 
UAldo to 2 4 ^ 
1.73 m" 2 kg"1 
Age 
group η Med Range Med 
2w- 3 m 
3 - 6 m 
6 -12 m 
1 - 4 y 
4 - 8 y 
8 -16 y 
9 
5 
8 
10 
9§ 
10 
14.3 
10.4 
13.4 
11.5 
5.3 
2.9 
6.1-46.3 
4.0-23.6 
4.3-30.5 
4.1-26.1 
1.7-10.6 
1.0- 7.9 
0.50 
0.30 
0.39 
0.29 
0.13 
0.06 
+ : w: weeks; m: months; y: years 
§ : for U N a and UK: n=10 
* : significantly lower compared to the 
ige of urinary aldosterone (U 
¿ig aldosterone = 1 nmol 
U N a (mmol 24 h"1) 
1.73 m"2 kg 
Range Med Range Med 
0.19-1.40 
0.11-0.69 
0.12-1.02 
0.11-0.65 
0.05-0.28 
0.02-0.15 
11 
24 
54 
96 
94 
134 
5- 25 
14- 38 
15-120 
33-227 
32-266 
20-319 
0.3 
0.7 
1.6 
2.4 
2.3 
2.6 
age groups between 2 weeks and 4 
, sodium (IL ), and potassium 
IL (mmol 24 h"1) 
1.73 m"2 kg 
Range Med Range Med Range 
0.1-0.8 
0.4-1.1 
0.4-3.6 
0.9-5.9 
0.9-6.2 
0.4-6.0 
30 
73 
114 
101 
89 
55 
16- 55 
42-130 
76-154 
56-155 
68-147 
21-108 
1.1 
2.1 
3.4 
г,.2 
2.1 
1.1 
0.7-2.1 
1.2-3.6 
2.1-5.0 
1.3-3.9 
1.5-3.9 
0.4-2.0 
years 
Table 3. Correlation of age with plasma renin activity (PRA), plasma aldosterone concentration (PA), serum К 
and Na, urinary excretion of aldosterone (U,udo)> sodium (UN ), and potassium (LL) in basal conditions. 
Correlations and partial correlations between these parameters. 
r: Pearson's correlation coefficient; pr: partial correlation coefficient eliminating the effect of age 
PRA 
PA 
К 
Na 
UAldo 
UN
a 
UK 2 
1 
w- 1 
-16 
y§ 
У 
Age 
η 
103 
105 
88 
92 
51 
52 
22 
30 
r 
** 
-0.67 
** 
-0.67 
** 
-0.65 
-0.03 
** 
-0.56 
** 
0.77 
** 
0.87 
** 
-0.48 
PRA 
η 
103 
86 
89 
46 
47 
17 
29 
r 
** 
0.62 
** 
0.51 
0.16 
** 
0.63 
** 
-0.48 
-0.37 
0.35<*) 
pr 
0.30 
0.14 
0.18^*^ 
** 
0.47 
0.19 
OA^*^ 
0.14 
PA 
η 
87 
90 
46 
47 
17 
29 
r 
** 
0.53 
-0.08 
** 
0.66 
** 
-0.69 
-0.49* 
О . З б ^ 
pr 
0.16 
-0.13 
** 
0.51 
-0.30* 
0.01 
0.27 
UAldo 
η 
44 
47 
51 
22 
29 
r 
** 
0.51 
0.05 
** 
-0.41 
0.04 
0.45* 
pr 
0.29(*) 
0.04 
0.04 
0.13 
0.23 
(*): 0.05<P<0.10; *: 0.01<P<0.05; **: P<0.01 
§ : w: week; y: year 
Mutual correlation and partial correlation eliminating the effect of 
age are presented in Table 3. 
PRA correlates positively with PA. The partial correlation of PRA with PA is 
also significant. PRA and PA are significantly correlated with U.·, , , also 
after correction for age. 
The correlation between serum К and PRA or PA is not significant after 
correction for age. U., is inversely correlated with PA, but the partial 
correlation is much weaker and marginally significant. The correlations 
between U.. and PRA, between LL and PA, and between LL, . and LL or U., are 
not significant after correction for age. 
III.4.2. STIMULATION 
Sodium excretion in the urine was less than or equal to the daily sodium 
intake in most subjects after 3 days of salt restriction (day 4). Many older 
children had higher sodium excretion on day 5 compared to day 4 due to the 
assumption of the supine posture during urine collection on day 5. 
Basal U N per 24 h and 1.73 m
2
 in infants under 3 months of age ranged 
between 5-25 mmol Na (Table 2) and was lower than or equal to 10 mmol Na in 
6 of the 9 infants. The three infants of this age group subjected to the salt 
-1 -2 
restriction protocol had basal U,, of 5, 10, and 25 mmol Na 24 h 1.73m . 
In all of them U N on day 5 was lower than basal U., , while Ufl-iJ. increased 
clearly in 2 of them. The two months old infant with the lowest basal U,. , 
and lower than the sodium intake during "restriction", had the highest 
basal U.·, . which was similar to the value on day 5 (Fig 4). Therefore, salt 
restriction according to our protocol might not always be an adequate 
stimulus for the RAAS in infants under 3 months of age. 
Fig 4 shows basal U., . and the significant increase on the fourth day 
of salt restriction for all age groups. The age group 8-16 years has 
significantly lower U.·, . than children under 4 years of age both in basal 
conditions and after salt restriction. Although the absolute increase in 
this group is less than in the other age groups, the percental increments 
are not different (P= 0.06) between the various groups. 
Potassium excretion increases only significantly after sodium 
restriction in infants 0-6 months old. 
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Urinary aldosterone excretion 
0-6 6-12 1-4 4-8 8-16 
months years 
Fig.4. Basal urinary aldosterone excretion (day 1) and on the fourth day of 
sodium restriction (day 5) in different age groups, о о : model median. 
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Fig.5. Plasma renin activity (PRA) and plasma aldosterone concentration 
after stimulation by sodium restriction and change in posture. 
Day 1, I: basal values; day 5, II: after 3 days sodium restriction; 
day 6, III: after 4 days sodium restriction; day 6, IV: after 4 days sodium 
restriction and 90 min of sitting posture. 
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months years 
Plasma aldosterone (ng/100ml) 1 
I П Ш Е І П Ш Е І D m G Z I П Ш Е І a m i s 
0 - 6 6-12 1-4 4 - 8 θ-12 
months years 
Fig.6. Plasma renin activity (PRA) levels and plasma aldosterone 
concentrations of individual subjects in different age groups during 
stimulation by sodium restriction and change in posture. 
I: basal value; II: after 3 days sodium restriction; III: after 4 days 
sodium restriction; IV: after 4 days sodium restriction and 90 min of 
siitng posture, о о : model median. 
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Figs5 and 6 show the basal levels (day 1, I) of PRA and PA, and the 
values after stimulation by sodium restriction (day 5, II; day 6, III) and 
postural change (day 6, IV). 
The scatter of values increases after stimulation. 
No significant difference can be established between PRA or PA after 3 
days (II) and after 4 days (III) of salt restriction (Fig 6). Serum К and Na 
levels did not change after stimulation. 
On sodium restriction PRA increases (II or III versus I) in almost all 
children older than б months (Fig 6). In the age group 0-6 months 5 of 8 
infants show a rise, although there are some divergent patterns. The percental 
increment of PRA by salt restriction (III vs I) is significant in all age 
groups, and one-way analysis of variance indicates differences, but the 
simultaneous method of Scheffé does not show significant differences between 
pairs of age groups. 
PA increases after salt restriction except in the age group 0-6 months 
(Fig 6), while U., . in this group increases strikingly (Fig4). There is no 
difference between the percental increases of PA by salt restriction in the 
various age groups. 
Postural change (IV vs III) increases PRA in all groups (Figs 5 and 6) 
except in the youngest infants 0-6 months. The percental increases are not 
different in the various groups. The influence of posture on PA is only 
significant above 4 years of age. 
It has to be noted that children under one year of age especially show 
a wide variation in PA response after stimulation by salt restriction and 
postural change. 
During sodium restriction (II,III) the correlation between PA and age 
(r=-0.63 and r=-0.68) remains approximately unchanged contrary to the 
correlation of PRA with age (r=-0.26 and r=-0.43). The correlation of U.-, . 
with age is weaker (r=-0.45) but still significant. After change in posture 
(IV) PRA and PA are no longer related to age. 
The correlation coefficient between PRA and PA is smaller after 
stimulation (r values at I, II, III, and IV are 0.63; 0.42; 0.56, and 0.42, 
respectively), but the partial correlation is stronger (pr values 0.28; 0.35; 
0.40, and 0.42, respectively). After salt restriction (II, H I ) and also 
after change in posture (IV), PA seems more dependent on PRA than in basal 
conditions (I). 
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III.5. DISCUSSION 
Our data confirm the well known increased activity of the RAAS during 
infancy and childhood. A variety of explanations have been considered to 
account for this increased activity, such as the influence of a different 
plasma half-life of renin, renin substrate concentration, blood pressure, 
A II receptors, sodium balance, proximal and distal tubular function, the 
sympathetic nervous system (47), prostaglandins (18), and kinins (26). 
The plasma half-life of renin was neither different between young and 
more mature piglets (29) nor between puppies and adult dogs (10). Immature 
hepatic metabolism is probably not responsible for the higher PRA. 
In man the renin-renin substrate reaction is limited by the substrate 
concentration (39). As the plasma renin substrate concentration decreases 
with age (4), this decline could contribute to the lowering of PRA with age. 
In spite of the reported higher substrate levels at young age, addition of 
the same amounts of MRC renin standard to plasma samples of adults and 
infants resulted in a similar generation of A I. Not only PRA but also plasma 
renin concentration is significantly higher in children than in adults (4). 
The high level of PRA might be stimulated by the lower blood pressure 
observed during childhood (25). In the children as a group systolic (1) and 
diastolic (1, 5) blood pressure are inversely correlated with PRA. After 
correction for age the correlation between systolic or diastolic blood 
pressure and PRA is no longer significant (1). 
A lower number of angiotensin II receptors in the vessel wall of the 
infant and young child compared with the adult, might also stimulate the 
renin-angiotensin system. This reduced number of A II receptors could also 
be the consequence of the increased plasma A II level at this age (9). In 
the fetal and newborn rabbit, however, PRA increases concomittantly with an 
increasing number of A II receptors (32). 
Increased PRA and PA might be related to the low intake of sodium in 
relation to body weight or body surface area (20, 33). After correction for 
age we found no significant correlation between PRA and U.. related to 
body size, a marginally significant correlation between PA and UN , but no 
correlation between IL and U., . . Others also found no partial correlation 
between PRA and U.. related to body size (1, 13) or a weak correlation (8), 
nor between PA and UN (1, 8, 34). Therefore, sodium within the range of 
normal dietary intake does not seem to influence basal levels of PRA and PA. 
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An increased sodium load to the macula densa area, due to the lower 
proximal tubular sodium reabsorption in the first two years of life, could 
stimulate renin release and enhance distal sodium reabsorption by aldosterone 
(35). In children older than two years of age this plays no role for the 
still increased PRA, as found in this study and by others. 
Insensitivity of the renal tubule to aldosterone, noted in young preterm 
infants (2, 15, 45), and decreased renal cortical perfusion in infancy (41) 
might contribute to the increased activity of the RAAS at this age. 
Although PA values decreased during the first four years of life, 
urinary excretion of aldosterone corrected for body weight or body surface 
area, showed no significant decline. The aldosterone secretion corrected for 
body surface area, however, decreases with age (20, 48). Several explanations 
are possible. The excretion of aldosterone in the urine as aldosterone-18-
glucuronide is not always an adequate reflection of the secretion of 
aldosterone (48). As the level of PA is determined by the secretion rate of 
aldosterone and its metabolic clearance rate (MCR), changes of this MCR 
with age will also influence the urinary excretion. No accurate data are 
available about the MCR of aldosterone at different ages. 
We observed a significant, although weak, partial correlation between 
PRA and PA in basal conditions in contrast to the results reported by others 
(1, 8), and between PRA and U.·, . , too. Therefore, PRA is considered to be 
one of the factors involved in the control of aldosterone concentration in 
basal conditions. This is clearly more evident when the RAAS is stimulated. 
The disappearance of the correlation of PRA with age after postural change 
suggests a stronger influence of posture on PRA as age increases. An 
increasing degree of sympathetic activity with age could play a role in the 
response to postural change. 
The correlation between serum К and either PRA or PA is no longer 
significant after correction for age. Calculation of the partial correlation 
is required before the suggestion can be made that aldosterone secretion in 
the 3- to 12-month-old child is regulated by the circulating level of К (37). 
The RAAS has been stimulated by various methods in children of different 
ages such as sodium restriction (11, 31, 48), furosemide administration (1) 
and change in posture (1, 11, 21). During salt restriction (48) an increase 
of aldosterone secretion of 319% was noted with a range of 134 to 600% in 
12 infants and children. In 17 children an elevation of PA was observed (31) 
from 7.0 ng dl" 1 ± 4.3 (SD) to 21.3 ± 18.0 on the third day of low sodium 
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intake. Other studies about PA during sodium restriction were limited to 
smaller age ranges (24, 34). 
PRA was not formerly studied during standardized salt deprivation. By 
-2 -1 imposing a low salt diet (10 mmol Na 1.73 m day ) we measured the activity 
of the RAAS at comparable degrees of salt depletion in different age groups. 
This is a more physiological stimulation than obtained by the use of diuretics 
(14). Our results indicate that salt restriction according to this protocol 
might not always be an adequate stimulus for the RAAS in infants under 
3 months of age. In the salt depleted state a second stimulus by postural 
change was applied. 
In this study we established the normal physiological profile of the 
RAAS in infancy and childhood both in basal conditions and after standardized 
stimulation. This allows a better assessment of the role of the RAAS in 
disease states such as salt-loss and hypertension in infancy and childhood. 
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IV.LEVELS OF RENIN, ANGIOTENSIN I AND II, ANGIOTENSIN-CONVERTING ENZYME AND 
ALDOSTERONE IN INFANCY AND CHILDHOOD 
IV.1. ABSTRACT 
Basal plasma renin activity (PRA), angiotensin I and II (A I, A II), 
angiotensin-converting enzyme (ACE) activity and plasma aldosterone (PA) 
and sodium and potassium concentration were simultaneously measured in 55 
healthy recumbent children aged between 1 week and 13 years. A significant 
(P<0.001) age-related decrease for PRA (r=-0.73), A I (r=-0.72), A II 
(r=-0.51) and PA (-0.71) was observed but not for ACE (r=0.26, P=0.06). 
After correction for age the correlation between PRA or PA and A I or A II 
was still significant (P<0.005). The strong correlation between A I and 
A II in the group as a whole (r= 0.82, P<0.001) and also in separate age 
groups, and an A I to A II ratio which was not different between the various 
age groups suggest that ACE activity in this age range is not rate-limiting 
for A II generation. 
IV.2. INTRODUCTION 
Angiotensin II (A II) is the biologically active component of the 
renin-angiotensin system. The increased plasma renin acivity (PRA) and 
plasma aldosterone concentration (PA) in infancy and childhood as compared 
to adults are well documented. A I (7) and A II levels (2,6,12,17) in cord 
blood are high. A I levels beyond the neonatal period are as yet not 
described as far as we know. Plasma A II concentration in the neonate 
decreases in the first week of life (3,16) but still remains higher between 
2 months and 12 years as compared to adults (4). In the rat, plasma A II 
concentration increases between 3 and 6 weeks of age and this has been 
reported to result probably from an age-related increase in the rate of 
conversion of angiotensin I (A I) to A II (21). In man angiotensin-
converting enzyme (ACE) activity might also be rate-limiting in the 
generation of A II at a younger age. Plasma levels of ACE in newborns and 
children are reported to be lower (1), equal to (17) or higher (8,15,18,19) 
than in adults. 
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Using semi-micromethods we have been able to measure simultaneously 
the basal plasma levels of PRA, PA, A I, A II, and ACE activity in recumbent 
infants and children. This allows us to obtain a more complete insight into 
the renin-angiotensin-aldosterone system in infancy and childhood. 
IV.3. MATERIALS AND METHODS 
Basal levels of PRA, PA, plasma A I and A II concentration and ACE 
activity, serum sodium (Na) and potassium (K) were measured in 55 infants 
and children, 32 boys and 23 girls, aged between 1 week and 13 years. 
All children had normal blood pressure and showed no evidence of either 
renal, cardiovascular and endocrine diseases, or disorders of acid-base or 
electrolyte metabolism. They were without medication. The children were 
arbitrarily divided into the following age groups: 1 week-3 months; 3-6; 
6-9, and 9-12 months; 1-4; 4-8, and 8-13 years. Venous blood samples were 
taken at 08.30 - 09.00 A.M. Children had taken nothing by mouth and had 
been in a supine posture since midnight. Infants were not fed later than 3 h 
prior to sample collection and remained at least 3 h in a supine posture. 
The venepuncture was performed as quickly as possible with a minimum of 
discomfort. All children were on an unrestricted hospital diet. The vene-
puncture was only performed when this puncture was required for routine 
examinations. When the venepuncture was extremely difficult the blood 
sample was excluded from the present study. 
Blood was collected into ice-cooled tubes. The tubes for determining 
A I and A II contained as inhibitors 0.125 M EDTA and 0.025 M 0-phenan-
throline in distilled water (0.25 ml per 7 ml blood). For PRA and PA the 
tubes contained 10 mg potassium EDTA, and heparin in the case of ACE. 
Plasma was immediately separated in a refrigerated centrifuge, quickly 
frozen and kept stored frozen at -20oC until the time of assay. PRA was 
measured with a commercial kit (Clinical Assays), using a micromodifi-
cation (5). Briefly, the sample was incubated at pH 6.0 and 370C in the 
presence of angiotensinase inhibitors, and the A I generated was measured 
by radioimmunoassay. Aldosterone concentration in plasma was measured by a 
direct radioimmunoassay (13). Endogenous A I concentration in plasma was 
measured by radioimmunoassay after extraction on a Dowex-resin column at 
pH 7.4 (10). A II was measured by a direct radioimmunoassay in unextracted 
77 
plasma (11). Plasma ACE activity was measured using hippuryl-L-histidyl-
L-leucine as the artificial substrate. The end product hippuric acid was 
extracted twice with ethylacetate and measured spectrophotometrically at 
228 nm (9). ACE activity is expressed as U ml" , being the amount of 
hippuric acid (nmol) formed per minute at 370C per ml plasma under the 
standard conditions of this assay. 
STATISTICAL ANALYSIS 
The distribution of the raw data within the age groups was skew, but 
the logarithmically transformed data were, according to the Shapiro Wilk 
test, of approximately normal distribution. In addition, after logarithmic 
transformation, the variances in the age groups were in general homogeneous. 
Therefore all statistical methods were undertaken on logarithmically trans-
formed data. The mean and the one-standard deviation range after trans-
formation were transformed back to the model median (in this case equal to 
the geometric mean) and the one-standard deviation range of the raw data. 
The Pearson's coefficient of correlation and the partial correlation 
eliminating the effect of age were calculated after logarithmic trans-
formation, also of age. A better linear relation of the parameters with age 
was obtained in this way. When plasma values were not different between 
contiguous age groups, according to Duncan's test, these groups were joined. 
Differences between boys and girls were tested with Student's t-test 
within each age group. 
With one-way analysis of variance an investigation was made of whether 
age groups were different from each other. If there was a significant 
difference the simultaneous method of Scheffé indicated which of the age 
groups differed from each other. 
All tests were performed at a significance level of 0.05. 
IV.4. RESULTS 
Because the Duncan analysis made no distinction between some age 
groups, a new subdivision was made: 1 week-3 months; 3 months-1 year; 1-4; 
4-8; 8-13 years. 
Results for PRA, PA, Na and К in a group of 107 infants and children, 
aged between 1 week and 16 years, including the 55 of this study have been 
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reported elsewhere (5). 
In general no significant (P>0.05) difference was found between boys 
and girls in the various age groups of the PRA, PA, A I, A II and ACE levels. 
The age-related decrease for PRA, PA, A I and A II are shown in Figs 1-3 
and 5. The ACE levels are shown in Fig 4. Table I presents the model median 
and observed range of these values in the different age groups. 
Infants aged between 1 week-3 months have higher levels of PRA and AI 
than older infants and children. Children 3 months-4 years have higher levels 
than children 8-13 years. Values for A I of the latter group are higher 
than reported for adults in sitting posture (10). 
Angiotensin II levels in infants 1 week-3 months are higher than in 
children above 4 years of age. Values in children 8-13 years are comparable 
to adults in sitting posture (11). 
ACE is not significantly different in the various age groups, and the 
levels are comparable to adult values (9). 
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Fig.l. Plasma renin activity in the different age groups examined. 
Model median and the one-standard deviation range are indicated. 
Conversion traditional to SI units: angiotensin I: 1,297 ng = 1 nmol. 
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Fig.2. Plasma angiotensin I concentration in the different age groups. 
Model median and the one-standard deviation range are indicated. 
Conversion traditional to SI units: angiotensin I: 1,297 ng = 1 nmol. 
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Fig.5. Plasma aldosterone concentration in the different age groups. 
Model median and the one-standard deviation range are indicated. 
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Table 1. Model median (med) and observed range of plasma angiotensin I and II concentration and of plasma 
angiotensin-converting enzyme activity in different age groups 
Age A I (pg ml" 1) A II (pg ml" 1) ACE (U ml" 1) PRA (ng A I m l ' V 1 ) PA (ng dl"1) 
* 
group 
η Med Range η Med Range η Med Range η Med Range Med Range 
lw-3 m 
3-12 m 
1- 4 y 
4- 8 y 
8-13 y 
9 
16 
10 
9 
10 
302 
157 
133 
99 
100 
161-468 
94-244 
83-312 
63-183 
70-212 
9 
16 
11 
9 
10 
58 
37 
27 
20 
22 
30-117 
12- 82 
8- 93 
6- 51 
12- 67 
9 
16 
10 
8 
10 
21.6 
28.9 
25.8 
34.6 
31.5 
12.1-32.9 
15.5-51.1 
16.0-53.1 
16.3-61.7 
10.5-57.2 
9 
16 
11 
9 
9 
12.0 
5.7 
5.1 
2.5 
2.5 
7.1-23.8 
2.2-10.2 
2.2-11.8 
0.9- 6.4 
1.5- 7.6 
62 
18 
15 
11 
8 
30-201 
7- 39 
3- 77 
5- 20 
4- 17 
* : w: week; m: month; y: year. 
**: For ΡΑ: η = 10. 
Table 2. Correlation of age with AI, A H , ACE, PRA and PA. Correlation (r) and partial correlation (pr) 
coefficient eliminating the effect of age between these parameters, π = 53-55. 
CD 
u 
A I 
A I I 
ACE 
PRA 
PA 
( * ) : 
Age 
r 
** 
-0.72 
** 
-0.51 
0.26^*^ 
** 
-0.73 
** 
-0.71 
0.05<P<0.10; 
PRA 
r 
*+ 
0.84 
** 
0.71 
** 
-0.36 
** 
0.74 
pr 
** 
0.70 
** 
0.57 
-0.25**) 
** 
0.46 
*: 0 . 0 1 < P < 0 . 0 5 ; **: 
PA 
r 
** 
0.71 
** 
0.59 
-0.22 
P<0.01 
pr 
** 
0.43 
** 
0.38 
-0.06 
ACE 
r 
** 
-0.46 
** 
-0.38 
pr 
** 
-0.40 
-0.30* 
A I I 
r 
** 
0.82 
pr 
** 
0.76 
The striking scatter of basal PRA and PA levels at younger age is also 
present for A I and A II levels. 
Correlation of the various data with age, mutual correlation and 
partial correlation eliminating the effect of age are presented in Table 2. 
PRA, PA, A I and A II correlate inversely with age. ACE is not related to 
age. 
Table 2 and Figs 6 and 7 show a strong, positive correlation between 
PRA and A I, and between A I and A II. These correlations are also high and 
significant after eliminating the influence of age (Table 2). The A I to A II 
ratio was not different in the various age groups and for all children the 
model median A I to A II ratio amounted to 4.8 with a one-standard deviation 
range 3.2-7.0. The correlation between serum Na and A II was not significant 
(r=0.09, P=0.56). The correlation between serum К and A II (r=0.33, P=0.03) 
disappeared once age had been taken into account(r=-0.00, P=1.00). Within 
separate age groups, however, the correlation between A II and serum К was 
almost significant in infants 1 week-3 months (r=0.64, P=0.07, n=9). In these 
infants,however, neither the correlation of serum К with age (r=0.07, P=0.83, 
n=12) or with PRA (r=0.16, P=0.63, n=12) or with PA (r=0.46, P=0.14, n=12), 
nor between serum К and A I (r=0.38, P=0.31, n=9) was significant. 
IV.5. DISCUSSION 
A II levels in cord blood are high (2,6,12,17) and plasma A II 
concentration in the neonate decreases in the first week of life (3,16). 
There has been, however, only one report on the simultaneous measurement of 
PRA and A II in infancy and childhood (4). A II levels in this study were 
higher than adult values. A I levels in infancy and childhood have not been 
reported until now. 
We measured simultaneously the levels of PRA, A I, A H , PA and plasma 
ACE activity. PRA, A I, A II and PA showed an age-related decrease and very 
high levels in the first 3 months of life, with a striking scatter. 
Broughton Pipkin et al (4), however, found no difference for mean A II 
levels in girls under and above 8 years of age, while mean A II levels in 
boys older than 8 years were higher than in boys under 8 years. 
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As can be seen in Table 1 the median A II level in the age range 1-13 years 
is almost equal. The mean age in the children examined by Broughton Pipkin 
was 8.1 ± 0.6 (SEM) years for boys and 7.3 ± 0.5 years for girls. These 
data suggest that only a minority of infants were represented in the group 
examined. In infants especially the highest values of A II are observed. 
Moreover, the unstandardized posture might have increased the basal levels. 
Postural change has a stronger influence on PRA with increasing age (5). 
Also in contrast to Broughton Pipkin et al. (4) we found no difference for 
PRA or A II between boys and girls in the different age groups, and no 
correlation between these values and serum Na. The correlation between 
serum К and A II was no longer significant after correction for age. 
Blood levels of ACE activity in infants and children have been reported 
to be lower (1), equal to (17) or higher (8,15,18,19) than in adults. We 
found no significant correlation with age, and values in infants and children 
were in the same range as reported for adults (9). ACE is the final enzyme 
involved in the generation of A II. Blood levels of ACE are believed to 
originate mainly from the lungs (8), although ACE is present in the vascular 
endothelium of nearly every tissue (20). Closely parallel increases in 
ACE activity of serum and lungs have been reported in mice exposed to 
chronic alveolar hypoxia (14). It is however questionable whether plasma 
ACE activity reflects the A I conversion capacity of the lungs. Although 
the lung is the major site of A II generation for the systemic circulation, 
conversion of A I to A II in the systemic vascular bed during cardiopulmonary 
bypass was sufficient in dog and man to maintain an appropriate equilibrium 
between A I and A II even when PRA was high (17). The strong correlation 
between A I and A II also in separate age groups, and the constant A I to 
A II ratio suggest that ACE activity, whatever blood levels may be, is not 
rate-limiting in the generation of A II in vivo, supposing that angio-
tensinase activity is not age-related. This is also strongly suggested by the 
relatively high activity of plasma ACE as compared to PRA. The value of the 
lowest model median ACE activity in plasma (21.6 U ml , Table 1) was about 
10 times higher than the highest model median PRA (9.8 ng A I ml" h" ) if 
converted to the same units. In rats the increase in A II between 3 and 6 
weeks after delivery in combination with declining PRA, without change in A I 
levels, and with an age-dependent increase in the rate of A II degradation, 
might reflect the age-related increase in the rate of conversion of A I to 
A II (21).In the present study we found no indication of an age-related 
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change in the rate of conversion of A I to A II. 
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V. THE BASAL LEVELS OF ACTIVE AND INACTIVE PLASMA RENIN CONCENTRATION 
IN INFANCY AND CHILDHOOD 
V.l. SUMMARY 
1. Basal plasma renin activity and active and inactive plasma renin 
concentration were measured in 89 healthy recumbent children aged 
between 1 week and 16 years. 
2. A significant (P<0.001) age-related decrease for active (r=-0.60), 
inactive (r=-0.59), and total renin concentration (r=-0.66) was observed. 
3. After correction for the influence of age, active renin concentration 
correlated with plasma renin activity (r=0.81) but not with inactive 
renin concentration (r=0.18). 
4. The proportions of active and inactive renin were not related to age, 
and the overall percentage of inactive renin was 79%. 
V.2. INTRODUCTION 
Inactive renin is a large molecular weight form of renin without 
intrinsic activity but which can be converted in vitro into an active form 
of renin (1, 2). Inactive renin, often called "prorenin", is present in 
plasma of adults in much higher concentrations than active renin and 
accounts for between 70% and 95% of the total circulating renin (3). In 
contrast to adults, there is almost no information on inactive renin in 
childhood (4-6). 
The aim of this paper is to present basal levels of active and 
inactive renin concentrations in infants and children between 1 week 
and 16 years of age. Trypsin was used for activation (7). 
V.3. METHODS 
Basal levels of plasma renin activity and active and inactive plasma 
renin concentrations were measured in 89 healthy infants and children, 
54 boys and 35 girls, aged between 1 week and 16 years. 
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All children were hospitalized and recovering from minor diseases or 
minor operations. They had normal blood pressure and showed no evidence of 
either renal, cardiovascular and endocrine diseases, or disorders of acid-
base or electrolyte metabolism. They were without medication. 
The children were arbitrarily divided in the following age groups: 
1 week-3 months (n=ll); 3-6 (n=10); 6-9 (n=9), and 9-12 months (n=8); 
1-4 (n=18); 4-8 (n=15); 8-12 (n=10), and 12-16 years (n=8). 
Venous blood samples were taken at 8.30 - 9.00 a.m. Children had taken 
nothing by mouth and had been in a controlled supine posture since midnight. 
Infants were not fed later than 3 hours prior to sample collection and 
remained at least 3 hours m a supine posture. The venepuncture was performed 
as quickly as possible with a minimum of discomfort. All children were on 
an unrestricted hospital diet. The venepuncture was only performed when this 
puncture was required for routine examinations. 
Blood was collected into ice-cooled tubes containing 10 mg potassium 
EDTA. Plasma was immediately separated in a refrigerated centrifuge, quickly 
frozen and kept stored at -20oC until time of assay. 
Plasma renin activity was measured with a commercial kit (Clinical 
Assays). Briefly, the sample was incubated at pH 6.0 using the maléate 
buffer, in the presence of phenylmethylsulfonyl fluoride, for 90 minutes 
at 370C. The angiotensin I generated was measured by radioimmunoassay. 
The results are expressed in ng ANG I h~ ml" . 
The assay of active and inactive plasma renin concentrations has been 
reported (7). Inactive renin was measured as the difference between the 
renin concentration after activation of the test sample (total renin con-
centration) and the concentration before activation (active renin concentra-
tion). Inactive renin was activated by Sepharose-bound trypsin in a final 
concentration of 0.25 mg trypsin/ml for 24 h at 40C. In this assay renin 
activity reached a stable plateau. Plasma renin concentration was measured 
after incubation of the plasma sample with sheep renin substrate in a final 
5 
concentration 2.5 nmol H e -ANG I equivalents/ml, which corresponds with 
about 10 times К , in the presence of 8-hydroxy-quinoline, phenylmethyl­
sulfonyl fluoride and aprotimn, for 3 h at pH 7.5 and at 37°C. 
Renin concentration is expressed as micro-units of the WHO human kidney 
renin standard, lot MRC 68/356, per ml. 
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STATISTICAL ANALYSIS 
All Statistical methods (8) were undertaken on logarithmically transformed 
data because of the skew distribution of the raw data within the age groups. 
The mean and the one-standard devfation range after transformation 
were transformed back to the model median and the one-standard deviation 
range of the raw data. 
In calculating the Pearson's coefficient of correlation and the partial 
correlation eliminating the effect of age, logarithmic transformation of age 
was also performed to obtain a better linear relation. 
When plasma values were not different between contiguous age groups 
according to Duncan's test, these groups were joined. With one-way analysis 
of variance an investigation was made of whether age groups were different 
from each other. If there was a significant difference the simultaneous 
method of Scheffé indicated which of the age groups differed from each other. 
All tests were performed at a significance level of 0.05. 
V.4. RESULTS 
Since the Duncan analysis made no distinction between some age groups, 
a new subdivision was made: 1 week-3 months; 3-12 months; 1-4; 4-8, and 
8-16 years. 
The age-related decrease for circulating active and inactive renin is 
shown in Figs 1 and 2 and in the Table. Correlation with age is significant 
(P<0.001) for active (r=-0.60), inactive (r=-0.59), and total plasma renin 
concentration (r=-0.66). Differences between age groups are indicated in 
the Table. 
Values for plasma renin activity are strongly correlated with active 
renin levels (r=0.88) (Fig 3) also after correction for the influence of 
age (r=0.81). The correlation is not different between infants (r=0.86) and 
children (r=0.83). 
Active plasma renin concentration is related to inactive renin concen-
tration (r=0.47, P<0.001), but this correlation is not longer significant 
after correction for the influence of age (r=0.18, P=0.09). 
92 
ACTIVE PLASMA RENIN CONCENTRATrON-
(jjOJ/ml) 
1 8 0 -
1 6 0 
1 4 0 -
1 2 0 -
100-
8 0 
6 0 
4 0 
2 0 -
* . 
О ' ι ι Ι ι ι ι ι ι ι ι ι I 1 1 1 \ 1 1 1 ι Ι 1 — ι Γ 
1 3 6 9 12 2 4 6 8 10 12 14 16 
months years 
η = 11 η = 27 η = 18 η = 15 η = 18 
Fig.l. Circulating levels of active renin in different age groups. 
Model median and the one-standard deviation range are indicated. 
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INACTIVE PLASMA RENIN CONCENTRATION-
(μυ/ml) 
ΙΟΟΟπ 
8 0 0 -
6 0 0 -
4 0 0 
2 0 0 
-V-r-
¡ ¡ ö j i ^ ^ Ä -
0 ' I I I I I 1 M ι ι ι ι — ι — ι — l — ι — ι — г 
1 3 6 9 12 2 4 6 
months 
n=11 n = 27 n»18 n=15 
._t__. 
- i — ι — ι — ι — ι — г 
10 12 14 16 
years 
n=18 
Fig.2. Circulating levels of inactive renin in different age groups. 
Model median and one-standard deviation range are indicated. 
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Table. Model medians and observed ranges (between brackets), expressed in/*U/ml, for active (APRC), inactive 
(IPRC), and total (TPRC) plasma renin concentration, and proportion of active renin in different age groups 
3 - 12 m 27 
4 y 18 
8 y 15 
8 - 16 y 18 
61.8 -
(20 - 144) 
38.0 
(10 - 93) 
32.1 
(11 - 97) 
49.7 
(21 - 130) * 
248.2 
(78 - 689) 
169.7 * 
(84 - 459) 
161.8 — 
(91 - 296) 
172.6 
(105 - 297) 
322.8 
(164 - 830) 
225.7 
(139 - 541) 
205.4 
(ПО - 389) 
208.8 
(131 - 345) 
Age group" 
Iw- 3 m 
η 
11 
APRC 
110.3+ 
(66 - 172) 
IPRC 
521.5+ 
(281 - 941) 
TPRC 
637.3''' 
(347 - 1058) 
w * l00% 
17 
(11 - 26) 
19 
(7 - 63) 
(9 
(5 
22 
- 14) 
19 
- 39) 
15 
(8 - 42) 
ADULTS 17 23 (14 - 43) 
196 
(138 - 312) 
10.9 
(4.3 - 17.5) 
(О 
„ : w: week; m: month; y: year. 
+ : Significant higher than the other age groups. 
* : Significant difference between age groups. 
§ : Adults (Derkx et al (7)) not included in statistical evaluation. 
PLASMA RENIN ACTIVITY-
(ng ANG I h"1 ml"1) 
14-
12 
10-
о < 1 y r 
. >1 y r 
. :
о%*: . 
ι о · - о • о · - « 
. · • · . 
. . « · ·ο 
о · / О 
τ — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — г 
0 20 4 0 60 80 100 120 140 160 1Θ0 
ACTIVE PLASMA RENIN CONCENTRATION(μυ/ml) 
Fig.3. Relation between plasma renin activity and plasma concentration of 
active renin in children aged between 1 week and 16 years. 
Conversion of traditional to SI units-angiotensin I: 1,297 ng = 1 nmol. 
The proportion of renin in the active or in the inactive form is not 
related to age (r=-0.09 and r=0.07, respectively) and no significant 
differences between the various age groups are found (Table). For the whole 
group of infants and children 19% of renin was in the active form, and 79% 
in the inactive form. The 95% confidence intervals were 17-20% and 76-81%, 
respectively. 
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V.5. DISCUSSION 
The higher activity of the renin-angiotensin-aldosterone system in 
infancy and childhood compared to adult values is well known (9, 10). Our 
data not only confirm the age-related decrease in plasma renin activity and 
active renin concentration in childhood, but also show consistently higher 
levels of plasma inactive renin than of active renin. In addition, circulating 
levels are decreasing with maturation. 
When the renin-angiotensin system is stimulated such as during chronic 
sodium depletion, chronic diuretic therapy a-nd chronic converting enzyme 
blockade, prorenin as well as active renin increase, but prorenin levels seem 
to increase proportionally less than active renin (2). 
Active renin is a higher percentage of total renin in infancy and 
childhood compared to the value in adults measured by the same methods (7). 
This is what can be expected in a stimulated system. The percentage of active 
renin in infancy, however, is the same as in older children (Table). An age-
dependent difference in the proportion of intracellular converted inactive 
to active renin (renal kallikrein?) before release into the circulation may 
explain this discrepancy. 
High levels of inactive renin are reported in newborns (4, cryoactiva-
tion) and in 1-15 years old children (6, trypsin activation). In the latter 
group, orthostasis for 30 min resulted in an increase in active renin and 
in a decrease in inactive renin while, total renin did not change. These 
results are in conflict with the results reported in adults after such a 
short stimulus. The same authors (6) found no inactive renin at all in 
infants under 1 year of age when active renin was high. Not enough informa-
tion about the activation methods used (cryoactivation or trypsin activation) 
in the three published abstracts (4 - 6) about prorenin in childhood is 
provided to allow comment on the results. 
The plasma concentration of active renin declines progressively with 
age, and the mean levels in children 8-16 years old are still higher than 
those reported in adults and measured with the same methods (7). This decline 
is in agreement with the reported age-related levels of circulating angio-
tensin I and II (10). However, the levels of inactive renin reach values in 
adults at a younger age. The mean values and observed ranges for plasma 
inactive renin in children older than one year are similar to the values 
reported in adults (7). 
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When inactive renin is the cellular intermediate of renin biosynthesis, 
the high plasma level of inactive renin at young age may reflect a higher 
rate of biosynthesis. 
Plasma renin activity is a function of the concentrations of both renin 
and renin substrate (11). The reaction between renin and its substrate (12) 
is dependent on substrate concentration (first order reaction). Both renin 
and renin substrate concentration are higher at a young age compared to adult 
values (9, 13). The relationship between plasma renin activity and active 
plasma renin concentration reflects the rate of conversion between active 
renin and endogenous substrate. As this relationship is not different between 
infants under one year of age and children 1 to 16 years old (Fig 1), basal 
plasma renin activity seems not significantly influenced by the reported 
age-related decrease in renin substrate concentration. This is supported by 
our earlier findings that the addition of the same amounts of WHO standard 
preparation of human renin, lot MRC 68/356, to plasma samples of infants 
and adults resulted in a similar generation of angiotensin I. 
The presented data about the concentrations of circulating active and 
inactive renin are required to evaluate the renin-angiotensin system in 
infancy and childhood in a more complete way. 
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VI. INFLUENCE OF THE STRESS OF VENEPUNCTURE ON BASAL LEVELS OF PLASMA RENIN 
ACTIVITY IN INFANTS AND CHILDREN 
VI.1. ABSTRACT 
The influence of venepuncture on plasma renin activity (PRA), Cortisol, 
and serum noradrenaline and adrenaline concentration in infants and children 
was evaluated by comparing values obtained immediately on insertion of an 
indwelling intravenous line (venepuncture value) and 5 and 60 minutes later. 
PRA values 5 min after venepuncture in the total group of infants and 
children were significantly higher (P<0.001) than venepuncture values. 
There was no significant difference between PRA values at 60 min compared 
to venepuncture or 5 min values. A well performed venepuncture does not 
systematically affect the PRA values obtained. 
A significant difference between values for noradrenaline, adrenaline and 
Cortisol at the various points of time could not be demonstrated. The number 
of lower values for noradrenaline and adrenaline at 60 min, however, prevailed. 
The stress of a well performed venepuncture is not an explanation for 
the greater scatter of basal PRA levels in infants and young children. 
VI.2. INTRODUCTION 
A great scatter in basal levels of plasma renin activity (PRA) exists 
especially in infants and younger children. This might be due to the stress 
of blood sampling (1) when other factors which stimulate renin release, such 
as posture and salt depletion, are well-controlled. 
Emotional arousal and pain stimuli activate the sympathetic nervous 
system and adrenal medulla (2,3). Venepuncture can be a stimulus for 
sympathetic neuronal or adrenomedullary discharge (4-6). 
Increased activity of the sympathetic nervous system and circulating 
catecholamines stimulate renin release via beta-adrenergic receptors (7-10). 
Therefore, the emotion and pain of venepuncture might stimulate renin release 
by this mechanisms (11). 
The influence of the stress of venepuncture was evaluated by comparing 
the values for PRA, noradrenaline, adrenaline and Cortisol measured in 
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samples obtained immediately on insertion of an indwelling catheter (vene-
puncture value) and 5 and 60 min later. 
VI.3. MATERIALS AND METHODS 
PRA and plasma Cortisol (PC) were measured in 15 healthy infants and 
17 children. Serum noradrenaline (NA) and adrenaline (A) were in addition 
measured in 7 infants and 8 children. All subjects had been recumbent and 
had taken nothing by mouth since at least 3 hours before the sample col-
lection. Between 8.30 - 9.00 AM an indwelling venous catheter was introduced 
percutaneously into the hand, elbow or foot and the first sample (vene-
puncture sample 0 min) was taken. The catheter used was an "Abbott-T" intra-
venous cannula. Catheters were flushed with glucose 5% at a rate 5 ml/h. 
A second and third sample were obtained from the catheter 5 and 60 minutes 
later (sample 5 and 60 min). Simultaneous measurements of PRA, serum NA 
and A, and PC in samples collected at 0, 5 and 60 minutes were performed in 
7 subjects. The others had a second sample at 5 or 60 min. 
Blood collection was completed within 1 min. An amount of 2 ml blood was 
collected for each sample. The procedure was only performed when venepuncture 
was required for some purposes or another and after consent of the parents. 
During the procedure the child was put at his ease as much as possible. 
Blood was collected into ice-cooled tubes. For PRA the tubes contained 
10 mg potassium EDTA. Plasma and serum were immediately separated in a 
refrigerated centrifuge at 40C, quickly frozen and kept stored at -20oC 
until time of assay. PRA was measured with a commercial kit (Clinical Assays) 
using a micro-modification.Briefly, the sample was incubated at pH 6.0 
and 370C in the presence of angiotensinase inhibitors, and the generated 
angiotensin I (A I) was measured by radioimmunoassay. Serum NA and A were 
measured by the radioenzymatic C0MT assay according to Da Prada and Zürcher 
(12). PC was measured by radioimmunoassay with a commercial kit (Clinical 
Assays). 
Sensitivity of the assay for PRA was 0.15 ng A I/ml/h, for NA and A 
0.02 ng/ml, and for Cortisol 0.02 /xmol/l. The within-run coefficient of 
variation for the PRA assay at leveKlO ng A I/ml/h was 5%, and 4% at level 
>10 ng A I/ml/h. For NA it was 11.2« and for A 12.2%, both at level 1 ng/ml; 
for Cortisol 9% at leveKO.15/xmol/l and 3% at level >0.15/¿mol/1. 
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STATISTICAL ANALYSIS 
The one-sided sign test was used for testing the difference between 
values at the various points of time. To be sure that for each variable 
the overall significance level for testing the hypothesis of no influence 
of venepuncture is less than 0.05 we performed each sign test (0 vs 5; 
5 vs 60, and 0 vs 60 min) at a significance level of 0.05/3. 
VI.4. RESULTS 
The values for PRA, PC, serum NA and A are presented in Table 1, and 
PRA values are shown in Fig 1. In Table 2 these values at the different 
points of time are compared. 
PRA(ng Al / m l / h ) . 
35.3->Э7 6 * 36 3 
time in min 
infants < 1 year children > 1 year 
F i g . l . Plasma renin a c t i v i t y (PRA) in infants and chi ldren immediately on 
insert ion of an indwell ing catheter (0 min) and 5 and 60 min l a t e r . 
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In infants and in the total group of infants and children PRA values 
5 min after insertion of the catheter were significantly higher than vene-
puncture values. Eight children had an increase of PRA value and two had a 
decrease. This difference was not significant (P= 0.055) for this small 
group. The absolute increment in PRA, however, is generally small and mostly 
less than 1 ng A I/ml/h. The largest increments are usually seen in infants 
with the highest PRA values during venepuncture. PRA levels 60 min after 
venepuncture are not significantly different from values obtained either at 
the time of venepuncture or 5 min later. No other conclusions are obtained 
when sampling was performed 90 min after venepuncture (n=5). 
The number of higher and lower values for plasma Cortisol 5 min after 
venepuncture compared to the venepuncture values are about the same. Infants 
show more often a rise in PC than children (one-sided P<0.05, Fishers exact 
test for 2 x 2 table). PC levels 60 min following venepuncture are higher 
or lower than the venepuncture or 5 min value in about half of the infants 
and children. 
The number of lower NA or A levels 5 min after venepuncture compared to 
venepuncture levels is about the same as the number of higher levels. 
The number of NA or A values lower at 60 min compared to venepuncture 
or 5 min values is not significantly larger than the number of higher or 
unchanged levels. 
VI.5. DISCUSSION 
Pain stimuli and emotional arousal (2, 3) and venepuncture (4-6) can 
activate the sympathetic nervous system and adrenal medulla. Therefore, the 
stress of venepuncture might immediately increase NA and A levels. On the 
other hand, increased activity of the sympathetic nervous system and 
circulating catecholamines stimulate renin release (7-10). 
Samples 5 min after venepuncture are taken because these can reflect 
the influence of the acute stress of venepuncture and of a prolonged or 
repeated venepuncture. 
If the greater scatter of basal PRA levels in infancy and childhood 
is due the stress of venepuncture, the PRA at venepuncture will be higher 
than 60 min later when the catheter sample is taken without pain and with 
as little arousal as possible. The influence of circadian rhythm and half-
life of renin on our data has to be considered. 
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о 
-J 
* 
Age 
1 
2 
2 
2 
2 
3 
3 
4 
4 
4 
6 
6 
7 
7 
7 
9 
9 
* 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
: 
8 
1 
2 
4 
2 
6 
7 
9 
И 
2 
8 
2 
w: 
m 
m 
m 
m 
m 
m 
m 
m 
m 
m 
m 
m 
week: 
PRA (ng 
0 
3.7 
2.9 
4.0 
2.7 
2.6 
1.5 
1.3 
3.5 
3.2 
2.5 
4.1 
7.9 
9.0 
5.0 
0.9 
5.5 
4.9 
; m: mon 
A I/ml/h) 
5 
4.7 
3.3 
4.6 
-
3.0 
1.5 
1.6 
-
-
2.5 
-
7.2 
-
5.1 
1.1 
5.3 
5.3 
th; y: 
60 
5.7 
3.8 
-
2.4 
-
1.3 
-
3.0 
2.1 
-
7.7 
-
5.0 
-
1.0 
4.7 
-
year 
Cortisol (/шоі/l) 
0 
0.26 
0.16 
0.30 
0.73 
0.72 
0.19 
0.13 
0.45 
-
-
0.42 
0.15 
0.19 
0.36 
0.68 
0.19 
0.08 
5 
0.26 
0.16 
0.28 
-
0.72 
0.18 
0.12 
-
-
-
-
0.15 
-
0.37 
0.61 
0.16 
0.08 
60 
0.38 
0.30 
-
0.72 
-
-
0.12 
0.45 
-
-
0.15 
-
0.33 
-
0.48 
0.08 
-
Noradi 
0 
0.60 
0.22 
0.29 
-
-
0.36 
0.05 
-
-
-
-
-
-
-
0.56 
0.34 
0.56 
renal i ne 
5 
1.20 
0.17 
0.26 
-
-
0.24 
0.22 
-
-
-
-
-
-
-
0.37 
-
0.73 
(ng/ml) 
60 
0.31 
0.13 
-
-
-
0.22 
-
-
-
-
-
-
-
-
0.24 
0.64 
-
Adrena 
0 
0.10 
0.23 
0.24 
-
-
0.15 
0.02 
-
-
-
-
-
-
-
0.32 
0.18 
0.14 
line (ng/ml) 
5 
0.81 
0.07 
0.11 
-
-
0.05 
0.06 
-
-
-
-
-
-
-
0.18 
-
0.16 
60 
0.04 
0.02 
-
-
-
0.06 
-
-
-
-
-
-
-
-
0.12 
0.17 
-
Table 2. Changes in plasma renin a c t i v i t y (PRA), Cortisol concentration, serum noradrenaline and adrenaline 
at d i f f e r e n t points of time 
5 vs 0 min 
infants 
children 
total 
PRA 
η 
14 
12 
•¿ь 
ί
§ 
** 
12 
8 
** 20 
= 
0 
2 
2 
I 
2 
2 
4 
Corti so 
η 
14 
11 
25 
ί 
7 
1 
8 
1 
= 
2 
5 
/ 
I 
5 
5 
10 
Noradrenal 
η 
6 
7 
13 
t 
2 
3 
5 
= 
0 
0 
0 
ine 
I 
4 
4 
8 
Ad 
η 
6 
7 
13 
renal 
î 
2 
3 
5 
ine 
= 
1 
0 
1 
I 
3 
4 
7 
60 vs 0 min 
infants 
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Circadian rhythms for PRA in supine adults show decreasing or nearly 
unchanged values in the period of time studied by us (13-17). For supine 
infants and children these values are not available (18). 
Following nephrectomy the disappearance of endogenous renin from the 
circulation has been studied in man (19-21). There was a fast and a slow 
component to the disappearance curves of renin (20). The rapid component, 
representing the distribution of renin into a non-plasma compartment from 
the plasma compartment, had a half-time of 13 min. The slow component of 
the disappearance curve of renin, representing its metabolic degradation, 
had a half-time of 280 min. The disappearance via redistribution is by far 
the most important component. The comparison of values obtained after 60 min 
with values obtained at venepuncture for the study of the influence of 
stress on PRA values although not perfect, is acceptable. 
Under recumbent conditions repeated samples in adults withdrawn from 
an indwelling catheter show a variability of NA values during the first 
30 min (22). Thereafter values for NA are very similar and reproducible for 
a given individual (4, 22). Our results for NA and A suggest that vene-
puncture in infants and children is a stressful procedure which immediately 
stimulates the sympathetic-adrenomedullary system as has been reported for 
adults (4-6). It has been supposed that venepuncture for children more 
often than for newborns or adults can represent an iatrogenic stress (23). 
We observed no difference between infants and children in the effect of 
venepuncture on NA and A. 
Although PC values 5 min after venepuncture compared to venepuncture 
values were more often increased in infants than in children, our data 
indicate that PC is not a useful parameter for the immediate stress of 
venepuncture. We are unaware of Cortisol measurements early (5 min) after 
initiation of the stress situation, although measurements at later points 
of time have been reported (24, 25). 
PRA values 5 min after insertion of an indwelling catheter are higher 
than levels during venepuncture. However, the number of lower PRA values 
60 min after venepuncture compared to the value during venepuncture or 
5 min later is about the same as the number of higher values. The absolute 
or relative increments or decrements are usually small. These data 
demonstrate that venepuncture in infants and children can stimulate renin 
release. Stress of a normal venepuncture, however, is not an explanation 
for the greater scatter of basal levels of PRA (26) and angiotensin I or 
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angiotensin II concentration (27) in infants and younger children. Moreover, 
it seems unnecessary to withdraw samples for basal PRA estimates from an 
indwelling catheter. A deft and precise venepuncture sample is entirely 
adequate for purposes of PRA measurements. When the venepuncture, however, is 
extremely difficult or when the child has been in an emotional arousal state 
during a longer period before venepuncture no meaningful data can be obtained 
and sampling via an indwelling intravenous line has to be considered. 
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VII. LOW-RENIN, LOW-ALDOSTERONE HYPERTENSION AND ABNORMAL 
CORTISOL METABOLISM IN A 19-M0NTH-0LD CHILD 
VILI. ABSTRACT 
A 19-month-old boy presented with failure to thrive and polydipsia. 
Low-renin hypertension was diagnosed by the presence of hypertension, 
hypokalaemic alkalosis, suppressed plasma renin activity and low plasma 
aldosterone. Plasma levels and urinary excretion of other mineralocorti-
coids and glucocorticosteroids were low or normal. Urinary tetrahydrocor-
tisol (THF) was increased relative to tetrahydrocortisone (THE) and also 
the plasma Cortisol to cortisone ratio was elevated. These findings are 
suggestive of a decreased activity of cortisol-11 j8-hydroxysteroid 
dehydrogenase. 
Hypertension and hypokalaemia were not influenced by spironolactone 
and dexamethasone. Triamterene normalised serum potassium, but addition of 
furosemide was required for lowering blood pressure. With this treatment 
catch-up growth was observed. 
VII.2. INTRODUCTION 
In 1963, Liddle et al. (1) described a familial hypertensive disorder 
which simulated primary aldosteronism, but with negligible secretion of 
any known mineralocorticoid. As the primary defect, they postulated a 
renal tubular abnormality with an unusual tendency of the kidney to 
conserve sodium and waste potassium, even in the virtual absence of 
mineralocorticoids. Triamterene, but not spironolactone, corrected the 
hypokalaemic alkalosis and hypertension in the original patients of Liddle 
et al. (1) as well as in additional reported cases (2-6). Correction by 
spironolactone in some similar cases (7,8) favours the presence of an 
unknown mineralocorticoid. Exhaustive search, however, failed to reveal 
overproduction of an unknown steroid factor (9,10). Ulick et al. (11) first 
demonstrated an abnormality in Cortisol metabolism in a 3-year-old child, 
characterised by a relatively increased urinary dihydrocortisol fraction 
with an abnormal predominance of the Sa-dihydro isomer. Later reports 
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(10,12,13) considered an 11/3 -hydroxysteroid dehydrogenase deficiency as 
the biochemical hallmark of this syndrome. 
In this report we present a 19-month-old child with low-renin 
hypertension, in whom the urinary steroid excretion and plasma cortico­
steroid pattern suggest the same defect in Cortisol metabolism. 
VI1.3. CASE REPORT 
A 19-month-old firstborn male child ofunrelated healthy parents was 
referred because of failure to thrive and anorexia. Pregnancy was 
uneventful except for hypertension. Delivery was spontaneous at the 38th 
week of gestation. The newborn was small for date: weight 2,170 g and 
length 43 cm. Poor appetite became apparent after the 1st month of life. 
Later on he preferred liquid foods to soli^ foods and was always eager for 
drinking water. Psychomotoric development was slightly retarded. Family 
history revealed hypertension in his mother's father and brother and in 
two sisters during pregnancy. The mother had a subluxation of the ocular 
lens. 
On admission, growth retardation was found: height 73.0 cm (-3.4 SD); 
weight 7.7 kg (P3 = 9.7 kg). Blood pressure was 150/110 mm Hg. 
Funduscopic examination showed full venae and tortuous arteriolae without 
haemorrhages, exudations or cotton wool aspect. The same subluxation of 
the ocular lens as in his mother was seen. 
Investigation showed: persistently low serum К 2.6-3.0 mEq/1; 
Na + 140-145 mEq/1; Cl" 104-108 mEq/1; HC0 3" 25.1-28.0 mEq/1; base excess 
1.2-4.9 mEq/1; capillary pH 7.42-7.49. Normal values were measured for 
serum creatinine, urea, Ca, Ρ, Mg, uric acid, amino acids and total protein. 
The creatinine clearance, /3p-microglobulin clearance and phosphate 
reabsorption were normal. Urinary excretion of Ca was normal (2.4-3.9 
mg/kg/day). The DDAVP test revealed an impaired renal concentrating 
capacity (251 mosm/kg; normal>807). Despite pronounced and persistent 
hypokalaemia, daily urinary К excretion on free diet was 7-12 mEq. 
Prostaglandin Ep excretion was distinctly increased (120-152 ng/day). 
Prostaglandin F» excretion was in the high normal range (960-1,400ng/day). 
Plasma renin activity, 0.4 ng /ml/h, and plasma aldosterone, 3 ng/dl, were 
extremely low. Sweat Na was 13 mEq/1 and К 31.9 mEq/1 with a decreased 
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Na/K ratio 0.41. Plasma volume measured with I-labelled albumin was 
expanded: 68 ml/kg (14). Bone age according to Tanner and Whitehouse was 
1.5 year. Intravenous pyelography showed somewhat dilated calices. On 
electrocardiography, signs of left ventricular strain and also of hypo-
kalaemia with prolongation of QT and flat S-T segments were seen. 
Both parents had normal blood pressure, normal serum К and normal 
urinary Cortisol metabolites. 
VI1.4. LABORATORY AND EXPERIMENTAL PROCEDURES 
LABORATORY PROCEDURES 
All venous blood samples were taken at 8.30-9.00 a.m., when the 
patient had been in supine position for at least 3 h, and collected in ice. 
Plasma was immediately separated in a refrigerated centrifuge and kept 
frozen at -70oC until the time of assay. Urine samples were collected in 
ice and kept frozen at -20oC until time of assay. 
Plasma renin activity (PRA) was measured by radioimmunoassay with a 
kit from Clinical Assays. Aldosterone in plasma was measured by a direct 
radioimmunoassay (15). Plasma steroid analysis was performed by Sippell et 
al. (16). Urinary steroid analysis was performed by gas chromatography-mass 
spectrometry (13). 
EXPERIMENTAL PROCEDURES 
Salt restriction: daily constant diet containing 2.6 mEq Na/day 
(10 mEq Na/1.73 m2/day) and 39.7 mEq K/day was given during 4 days. 
Therapeutic trials: the daily diet contained 10.5 mEq Na 
(1.5 mEq/kg/day) and 26 mEq K. Triamterene 3 χ 20 mg/day (8 mg/kg/day) 
was given during 9 days; spironolactone 3 x 5 mg/day (2 mg/kg/day) during 
7 days followed by 4 days 3 χ 15 mg/day (6 mg/kg/day); dexamethasone 
4 χ 0.125 mg/day (0.07 mg/kg/day) during 8 days. 
The rapid ACTH test was performed according to Dluhy et al. (17). 
Blood samples for measurement of Cortisol and aldosterone were obtained at 
time zero and 30 min after intramuscular injection of 0.25 mg Synacthen 
(Ciba). 
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VII.5. RESULTS 
Salt restriction: after 4 days of salt restriction urinary Na 
excretion was still 8 mEq/day. This defect of sodium conservation can 
probably be explained by the expansion of the extracellular volume. Serum 
К tended to increase. Plasma aldosterone and PRA remained suppressed, also 
after postural stimulation. Body weight and blood pressure did not change. 
Corticosteroid levels in plasma were determined after 3 days of salt 
restriction and are listed in Table 1. 
Table 1. Plasma levels of corticosteroids (ng/ml) after 3 days of salt 
deprivation 
Patient Normal children (1-3 years) 
on normal diet, ambulant 
11-Desoxycorticosterone 
Corticosterone 
Aldosterone 
Progesterone 
17-OH-progesterone 
11-Desoxycortisol 
Cortisol 
Cortisone 
0.012 
2.44 
<0.019 
<0.017 
<0.005 
0.096 
134.0 
0.517 
0.01 • 
0.05 • 
0.10 • 
0.06 • 
0.03 • 
0.21 -
17 -
2.7 -
• 0.33 
- 8.5 
- 0.79 
- 0.74 
- 0.95 
- 1.44 
- 137 
• 26.1 
The aldosterone level was undetectable and levels of other known potent 
mineralocorticoids, desoxycorticosterone and corticosterone, were normal or 
even low considering the salt restriction. An 11-hydroxylase deficiency can 
be excluded. All glucocorticoid levels were also low except for Cortisol. 
Another striking feature was the abnormally increased Cortisol to cortisone 
ratio, suggesting a disorder of the conversion of Cortisol to cortisone. 
During dexamethasone suppression, plasma Cortisol decreased to 10.4 ng/ml 
and the plasma cortisone level was 0.793 ng/ml. This resulted in a marked 
lowering of the Cortisol to cortisone ratio. 
The rapid ACTH test resulted in normal Cortisol response (94-203 ng/ml), 
while aldosterone failed to rise. 
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Urinary steroid excretion (Table 2, Fig 1): urinary tetrahydrocorti-
sone (THE) excretion was extremely low, while tetrahydrocortisol (THF) 
excretion was in the normal range, resulting in a very high THF to THE 
ratio. The ratio of 5 a - to 5/3 reduced metabolites (e.g. 5a-THF to 5/3-THF, 
and 5a-THB to 5/3-THB) was not higher than in age-matched controls. 
Table 2. Urinary steroid excretion (/ig/24 h) of patient with strong evidence 
of 11/3-hydroxysteroid dehydrogenase defect and of age-matched controls 
Patient 
19 months 
8 
250 
110 
2.35 
72 
5 
14.4 
13.75 
Normal 
18 months 
792 
626 
186 
3.37 
131 
11 
11.9 
0.23 
22 months 
891 
550 
265 
2.08 
273 
23 
11.9 
0.30 
24 months 
605 
182 
122 
1.49 
69 
10 
6.9 
0.20 
Tetrahydrocortisone (5/3THE) 
Allotetrahydrocortisol (5aTHF) 
Tetrahydrocortisol (5/3THF) 
5aTHF/5/3THF ratio 
Al 1 otetrahydrocorti costerone( 5a THB ', 
Tetrahydrocorticosterone (5/3 THB) 
5aTHB/5/3THB ratio 
THF/THE ratio (5aTHF/5/3THE) 
CORTISOL(F) CH он CORTISONE(E) сн он 
SßTHF SaTHF THE 
Fig.l. Simplified scheme of Cortisol metabolism. 
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THERAPEUTIC TRIALS 
The results are presented in Fig 2. Triamterene corrected hypokalaemia 
and diminished potassium excretion. No effect on body weight and blood 
pressure was seen. PRA and plasma aldosterone remained suppressed. Spirono­
lactone had no influence at all. Dexamethasone administration resulted in 
adequate adrenal suppression (Cortisol 10.4 ng/ml) but had no effect on 
serum К , on Na and К excretion, on PRA and plasma aldosterone, while 
blood pressure even slightly increased. 
TREATMENT TRIAMTERENE SPIRONOLACTONE DEXAMETHASONE 
3x20mg/day 3x5mg/day 3x15mg 4x0.125mg/day 
Serum Na* mEq/l 1 60-1 
1 4 0 j 
Serum K* mEq/l 4 
2 
Days of treatment 
Ι Ι Ι' Ι Ι Ι Ι Ι Ί Ι Ι Ι Ι Ι Ι Ι Ι Ι Ι Ί I I M I I I I 
12 4 6 8 10 12 14 16 18 2022 24 26 28 30 32 34 36 38 
Fig.2. Results of treatment by triamterene, spironolactone and 
dexamethasone 
FOLLOW-UP STUDY 
Finally (Fig 3), we treated the child with triamterene 3 χ 25 mg/day, 
and added furosemide, 2 χ 10 mg/day, in order to lower the blood pressure. 
After U year on this treatment, the blood pressure is 120/80 mm Hg. 
PRA and plasma aldosterone remain suppressed. Catch-up growth occurred 
(Fig 4). At the age of 40 months, height is 98.0 cm (-0.8 SD) and weight 
12.4 kg (P3 = 13.4 kg). The child seems less thirsty. 
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TREATMENT FUROSEMIDE 
TRIAMTERENE-in^^xlOmg/day 
3x25 mg/dayt^: V ' 
Serum Na* mEq /I 
Serum K* mEq /I 
150q' 
ISO1" 
URINARY · 
OUTPUT 2 0 : 
Na+ В 4 0 
mEq/day 
К* mEq /day 
Volume 
ml/day 4 0 0 
D 8 0 0 
J fli н В H -у/-
20 
4 0 : 
"Ж" 
- /-
Plasma renin ng/ml/hr 
Plasma aldosterone ng/100ml 
160 
Blood pressure , „ „ 
8 0 
Days of treatment 12 4 6 8 10 12 14 16 
F i g . 3 . Results o f t r e a t m e n t by t r i a m t e r e n e and furosemide. 
length-(cm ) 
100 
9 0 
Θ0 
7 0 
6 0 
5 0 
start of 
therapy 
6 12 18 2A 30 3 6 «2 
months 
Fig.4. Height growth before and during therapy. 
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VII.6. DISCUSSION 
Liddle et al. (1,18) documented a familial autosomal-dominant syndrome 
of apparent mineralocorticoid excess in which patients are hypertensive and 
hypokalaemic, but aldosterone secretion is very low. Triamterene corrected 
hypokalaemia and lowered blood pressure when sodium intake was decreased, 
while spironolactone was ineffective. The hypoaldosteronism (and hyporenin-
aemia) was presumed to be secondary to a chronic surfeit of sodium, resulting 
from an unusual tendency of the kidney to conserve sodium. It was possible 
to stimulate aldosterone production, although to subnormal levels (18). 
Clinical symptoms and biochemical data in our patient were consistent 
with low renin hypertension. No abnormalities could be demonstrated in the 
parents however (unpubl.). 
While in some cases of "Liddle's syndrome" only triamterene was 
effective and spironolactone was ineffective (2-6), in other reported 
similar cases (7,8,13,19), hypertension and hypokalaemia responded also to 
spironolactone. This suggested the existence of an unknown mineralocorticoid. 
Ulick et al. (9,10) in their exhaustive search of patient L.K. described by 
New et al. (19), failed to reveal overproduction of an unknown steroid 
factor. In the patients reported by New et al. (19) and Winter and McKenzie 
(20) plasma mineralocorticoid activity as measured by mineralocorticoid 
radioreceptor assay, was abnormally low, as was the measured level of known 
sodium-retaining steroids. The detection of an unknown mineralocorticoid 
factor in the plasma of these patients depends, however, on the competitive 
inhibition of labelled aldosterone binding to kidney slices. The possibility 
of a steroid acting through another receptor system cannot be excluded. 
An excessive sensitivity to mineralocorticoids remains also a possibility 
(21). Ulick and Ramirez (9) and Ulick et al. (11) suggested a possible 
relationship between the patient's syndrome of mineralocorticoid excess 
and abnormal Cortisol metabolism, consisting of incomplete reduction of 
the A ring. This resulted in a relative increase in urinary excretion of 
dihydrocorti costereid metabolites. 
In the 4,5-dihydro fraction, the Sa-form predominated relative to the 
5/8-isomer. Ulick et al. (10) reported in 1979 that the incomplete A ring 
reduction defect improved with time. Sa-Dihydrocortisol was no longer 
increased. Hypertension and hypokalaemic alkalosis, however, still 
persisted. Sa-Dihydrocortisol, which was proposed as the responsible 
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mineralocorticoid in this syndrome, can no longer be accepted as the active 
component. In our patient, the BaTHF/SßTHF ratio was normal compared to 
age-matched controls. This ratio is lower in adults (23). New et al. (12) 
and Ulick et al. (10) also found a decreased rate of conversion of Cortisol 
to cortisone with an altered equilibrium position in favour of Cortisol 
causing a prolonged half-time of disappearance of Cortisol. The urinary 
THE to THF ratio was markedly decreased. The prolonged Cortisol half-life 
is thought to be responsible for long-term suppression of the pituitary-
adrenal axis. The same defect in Cortisol metabolism was subsequently 
reported by Shackleton et al. (13) in their own patient and in the patient 
earlier reported by Werder et al. (7). The shift in the cortisol-cortisone 
equilibrium point was also evident in the plasma of our patient (table 1). 
Although the biochemical abnormalities in the reported patients seem 
to be similar, the results of different drugs are surprisingly divergent. 
The patient of Shackleton et al. (13) responded to spironolactone, 
triamterene and partially to dexamethasone. In our patient, however, only 
the treatment by triamterene normalised serum К , and addition of furosemide 
on a low-sodium diet was required for lowering of the blood pressure. 
It is as yet unclear how to relate the abnormal metabolism of Cortisol 
to the abnormality of sodium transport in erythrocytes (3,5,6,22). 
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Vili. HYPORENINEMIC HYPOALDOSTERONISM IN INFANCY 
VIII.l. ABSTRACT 
Hyporeninemic hypoaldosterom'sm was observed in an infant at the age of 
3 months. Persistent hyperkalemia, hyperchloremic acidosis, and salt-wasting 
were present. All abnormal electrolyte values were corrected by the 
administration of fludrocortisone. Both active and inactive renin were 
lowered. This infant had also an unexplained spastic quadriplegia and 
psychomotor retardation. 
Hyporeninemic hypoaldosterom'sm should be considered to be one of the 
causes of salt-losing in infancy. 
VI11.2. INTRODUCTION 
The syndrome of hyporeninemic hypoaldosterom'sm (SHH) is the most 
common form of isolated mineralocorticoid deficiency in the adult. 
Hypoaldosterom'sm is explained by the insufficient stimulation of the 
adrenal gland by the renin-angiotensin system. The syndrome is associated 
with chronic renal disease usually of the tubulointerstitial type in most 
of the patients. Diabetes mellitus is frequent in this syndrome (Vaamonde 
et al., 1981). Persistent hyperkalemia is present. Hyperchloremic acidosis 
is found in about 50% of the patients. Salt-wasting is distinctly uncommon 
(Defronzo, 1980). 
Recently, hyporeninemic hypoaldosterom'sm was reported in an infant 
with lactic acidosis, deafness and mental retardation (Shuper et al., 1982). 
We want to report the second infant suffering from SHH. This infant 
presented with unexplained spastic quadriplegia and psychomotor retardation. 
Both infants had a marked sodium-wasting. 
VIII.3. CASE REPORT 
Gravidity and delivery were normal for Μ., the second child of healthy 
unrelated parents. At the age of 3 months she was seen by the local 
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pediatrician because of psychomotor retardation and growth failure. Because 
of severe electrolyte disturbances she was referred to our clinic at the 
age of 5 months. 
Clinical examination revealed spastic quadriplegia, strabismus convergens, 
hip luxation at the right side, psychomotor retardation and normal blood 
pressure. At the age of 17 months she is unable to sit without support, she 
is not talking although good contact is possible. 
Extensive investigations failed to indicate the cause of spastic 
quadriplegia and psychomotor retardation. Lactid acid and pyruvic acid 
values were normal in serum, urine and cerebrospinal fluid. Examination of 
urine for organic acids (gas chromatography) indicated no abnormal pattern. 
Some cortical atrophy was present on computer tomography of the brain. 
Investigation of the brain by somatosensory evoked response (SSER) evoked 
no potentials; investigation by brain stem auditory evoked response (BER) 
showed probably no response at the left side and a delayed response at the 
right side. The funduscopic examination of the eye was normal. 
The older sister of our patient (7 years old) has also psychomotor 
retardation and spastic quadriplegia. Her blood urea (22.8 mmol/l) and 
serum creatinine (106μηιο1/1) are increased. Her serum electrolyte values 
are: Na 140 mEq/1, К 5.0 mEq/1, CI 105 mEq/1, HC03 19.1 mEq/1. Future 
studies are planned. 
The abnormal routine laboratory findings of M. are presented in table 1. 
A moderate elevation for urea and creatinine, an elevation of potassium, and 
metabolic acidosis are shown. An intravenous urogram was normal. The 
excretion in urine of 17-hydroxycorti'coids (4/¿mol/l/Z4h) and the plasma 
Cortisol were normal. The excretion of PGE? was 11-28 ng/24h (low normal 
range) and of PGFp 120-210 ng/24h (normal>500ng/24h at this age). 
Even in salt-depleted state (Na 130 mEq/1) the urinary excretion of 
sodium was 19-20 mEq/24h. The sweat chloride content was normal (30 mEq/1). 
D0CA injection (2x1 mg/24h) lowered the sodium excretion to 12 mEq/24h. 
Fludrocortisone administration together with extra natrium chloride 
normalized all abnormal electrolyte values (table 1). The permission to 
perform a renal biopsy was not obtained. 
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Table 1. Laboratory values on different regimens 
On admission During treatment 
Fludrocortisone (mg) 
2 χ 0.02b 2 χ 0.0375 
NaCl additional (mg) 
3 χ 500 3 χ 500 3 χ 500 
Na, mEq/1 
К, mEq/1 
Cl, mEq/1 
HC03, mEq/1 
Base excess, mEq/1 
pH 
Urea, mmol/l 
Creatinine, μπιοΐ/ΐ 
125-129 
5.9-6.3 
98-100 
14.5-19 
-13,-6 
7.24-7.31 
11.5 
53-61 
139 
6.6 
112 
15.1 
-11.4 
7.24 
141 
5.2 
106 
17.4 
-7.5 
7.32 
142 
4.4 
100 
24.2 
+0.2 
7.41 
RENAL FUNCTION TESTS 
Table 2 shows the results of the different renal function tests. The 
glomerular filtration rate is moderately diminished. The function of the 
proximal tubule and the concentrating capacity appear to be normal. The 
results of the renal handling of water and sodium during hypotonic saline 
diuresis are striking. The distal sodium delivery (CH η + C N ) is normal. 
The proportion of the sodium load reabsorbed di stal ly (C
u
 _ / C
u n
 + C.
r
 ) 
"2*-' "20 na 
was distinctly decreased. 
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Table 2. Renal function tests 
Endogenous clearance of creatinine ml/min/1.73 m 2 SA: age 6 months 47 
age 10 months 46 
age 16 months 48 
No aminoaciduria, no glucosuria, no proteinuria 
^„-Microglobulin/creatinine clearance: 0.11% 
Clearance phosphate/creatinine clearance: 7% 
DDAVP test at age 6 months: 704 mosm/kg 
Hypotonic saline diuresis according to Rodriguez-Soriano et al.(1981) 
Patient Normal (mean±SD) 
180 51.8 ± 12.8 
19 22.8 ± 3.6 
13 4.3 ± 1.3 
6 18.5 ± 2.9 
10.7 1.9 ± 0.8 
21.8 19.9 ± 12.0 
15.1 2.7 ± 1.1 
16.7 20.4 ± 2.9 
36 90.8 ± 4.5 
21.05 21.2 + 3.1 
28.5 87.2 ± 5.3 
^НгО
 T
 ''CI 
GF = Glomerular f i l t r a t e . 
U
o s m
, mosm/kg 
V, ml/dl GF 
C
osm·
 m l/ d l G F 
C H 0, ml/dl GF 
CN^, ml/dl GF 
C K, ml/dl GF 
C
c l, ml/dl GF 
CH 20
 + CNa' m l / d l G F 
CH 20 
χ 100, % 
CH 20
 + CNa 
C H , 0 + C C 1 ' "Ч/dl GF 
Ί2 
С 
н2о 
χ 100, % 
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM 
The results of the study of the renin-angiotensin-aldosterone system 
are demonstrated in table 3. Even in the salt-depleted state, the plasma 
renin activity was decreased and the plasma aldosterone concentration was 
low. Angiotensin II infusion augmented the plasma aldosterone concentration. 
Both active and inactive renin concentrations are decreased. 
Table 3. Rem'n-angiotensin-aldosterone system 
1. In salt-depleted state: 
Na: 
K: 
Plasma renin activity: 
Plasma aldosterone: 
Aldosterone excretion: 
129-134 mEq/1 
6.3-5.9 mEq/1 
0.9-1.2 ng angiotensin I/ml/h (normal 8.2+3.0) 
7-12 ng/100 ml (normal 95+28)* 
1.7-4 μg/1.73m2 SA/24h (normal 46.7+11.8)* 
2. Angiotensin II infusion, 10 ng/kg/min 
Plasma aldosterone: 0 min: 7 ng/100 ml 
20 min: 73 ng/100 ml 
30 min: 55 ng/100 ml 
3. Forms of plasma renin by trypsin activation (Derkx et al., 1981): 
on a diet supplemented with 3 χ 500 mg NaCl 
Active renin Inactive renin 
1.3/iU/ml 42^U/ml 
Controls of the same age 49.8 
35.5 
42.7 
216 
245 
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Normal values for infants 6-12 months old after 3 days of salt 
restriction. 
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Vili.4. DISCUSSION 
The laboratory findings in this infant are in complete agreement with 
the diagnosis of SHH. Even in the salt-depleted state, the plasma renin 
activity and aldosterone were low. This hypoaldosteronism leads to the well-
known features of SHH, i.e. hyperkalemia, metabolic acidosis, but with a 
normal sodium balance in the adult unless the dietary sodium intake is 
markedly reduced. In the two reported infants, a severe salt-wasting was 
evident. In normal children fractional proximal reabsorption of water and 
sodium increases progressively during the first year of life, whereas it 
remains constant in children beyond 2 years of life. Fractional distal 
reabsorption of sodium is significantly increased in early life and 
decreases with the diminution of distal sodium delivery (Rodriguez-Soriano 
et al.,1981). The increased fractional distal reabsorption of sodium can be 
explained by the high plasma aldosterone concentration (Aperia et al., 1979). 
It is logical that aldosterone deficiency in infancy induces a severe salt-
wasting state because of an increased distal delivery of sodium due to 
immaturity of the proximal tubule and the lack of the compensatory increased 
fractional distal reabsorption of sodium. 
Numerous factors are considered for the pathogenesis of hyporeninemia in 
SHH: juxtaglomerular apparatus damage, expansion of the extracellular volume, 
impaired sympathetic activity (Vaamonde et al., 1981), defective conversion 
of inactive renin to active renin (Tan et al., 1980), a deficiency of renal 
prostaglandin synthesis (Hahn et al., 1980) or kallikrein deficiency (Hahn 
et al., 1981). In our patient, both active and, to a lesser degree, inactive 
renin were decreased. A defect in the conversion or activation of inactive 
renin could contribute to the SHH in our patient (Antonipillai et al.,1981). 
Although a lowered excretion in the urine of PGFOQ! was noted in our patient, 
lowered prostaglandin excretion in the urine is not a consistent finding in 
SHH (Hahn et al., 1980, 1981). 
In the infant described by Shuper et al. (1982) chronic lactic acidosis 
could be demonstrated. This child was deaf and mentally retarded. Pyruvate 
and lactate were normal in our patient. Gas chromatography revealed no 
abnormal organic acid. We have no explanation for the mental retardation 
and spastic quadriplegia in our patient. 
The differential diagnosis of salt-wasting in infancy is extensively 
discussed by Dillon (1981) and Schwartz and Spitzer (1978). The pathological 
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states associateci with urinary salt-wasting are considered under the headings 
of renal disease, adrenal disease and miscellaneous. Urinary sodium-wastage 
of adrenal origin is due to congenital adrenal hypoplasia, congenital adrenal 
hyperplasia, isolated defects in the biosynthetic pathway of aldosterone 
and renal tubular unresponsiveness to endogenous aldosterone or pseudohypo-
aldosteronism. Plasma renin activity is raised in these different disorders. 
The syndrome of hyporemnemic hypoaldosteronism should be considered as a 
new cause of salt-losing in infancy. Mineralocorticoid treatment is effective 
in this disorder. 
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IX. EFFECTS OF ANGIOTENSIN II BLOCKADE IN THE CANINE PUPPY 
UNDER DIFFERENT SALT-INTAKE 
IXЛ. ABSTRACT 
Plasma renin activity (PRA) and active plasma renin concentration (PRC), 
plasma aldosterone (PA), hematocrit, serum sodium (S,, ), potassium (S..) and 
osmolality (S 0 ) were measured in unanesthetized normal, salt-loaded and 
salt-depleted puppies aged 9-30 days, and in adult dogs. Salt-loading was 
performed by daily intraperitoneal administration of 10 mEq sodium/kg body 
weight for 5 days; salt-depletion by furosemide injections. 
Basal PRA and PRC were high and S». , S,,, SQ and hematocrit were low 
in the normal puppies compared to the adult dogs. PA in puppies increased 
with advancing age, whereas PRA did not change. Salt-loading depressed PRA 
and PRC but not to adult values. 
Saralasin infusion 6 /¿g/kg/min during 60 min significantly decreased 
arterial pressure (MAP) and increased PRC not only in salt-depleted puppies, 
as is observed in adult salt-depleted dogs, but also in normal puppies. 
PA did not change in both groups of puppies. Saralasin caused no change of 
MAP, and PRC and PA in salt-loaded puppies. 
We conclude that the high renin levels at young age contribute to 
the basal arterial pressure in puppies. 
IX.2. INTRODUCTION 
In the puppy the activity of the renin-angiotensin-aldosterone system 
(RAAS) is elevated compared to the adult dog (1-4). Angiotensin II (A II) 
is known as a potent arteriolar vasoconstrictor and stimulator of aldosterone 
secretion. The A II analog l-sarcosine-8-alanine-A II (saralasin) acts as 
an antagonist for both the pressor and the steroidogenic action of exogenous 
A II in the adult dog (5). In the normal adult dog, however, saralasin failed 
to reduce arterial pressure or to influence plasma renin activity (PRA). 
In contrast, in the acute and chronic salt-depleted dog with high circulating 
levels of renin and plasma aldosterone concentration (PA), A II antagonists 
reduced arterial pressure and PA, and further increased PRA (5-7). 
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The higher levels of renin and angiotensin II at young age could point 
to a more important role of the renin-angiotensin system (RAS) in the 
maintenance of blood pressure and in the control of aldosterone secretion 
compared to adult dogs. Therefore, a blood pressure lowering effect and a 
decrease in aldosterone secretion could be anticipated in the normal puppy 
treated with saralasin. 
Although saralasin infusion produced no change in mean arterial pressure 
(MAP) in the anesthetized 14-25 days old puppy on a normal diet (8), studies 
concerning the physiological role of the RAAS should be performed in the 
unanesthetized state, since anesthesia clearly influences both PRA, PA, and 
MAP even in trained dogs (9,10). 
The aim of this study was to determine the effects of A II blockade 
with saralasin on MAP, PRA, active plasma renin concentration (PRC), and 
PA in unanesthetized puppies under normal, salt-loaded and salt-depleted 
conditions. 
IX.3. MATERIALS AND METHODS 
ADULT DOGS 
Plasma renin activity (PRA) and active plasma renin concentration (PRC), 
plasma aldosterone concentration (PA), serum sodium (S.. ), serum potassium 
(Sj.) and serum osmolality (SQ ) were measured in 27 healthy adult beagles. 
In 10 of them, plasma angiotensin II ( A II) was also measured. Blood was 
collected between 8.30 and 9.30 AM. Posture and activity were not controlled 
and the dogs had free access to water and food. 
PUPPIES 
Experiments were performed on unanesthetized puppies of either sex from 
purebred beagle strains, ranging in age from 9 to 30 days and weighing 
between 460 and 1230 gram. The puppies were obtained from unweaned litters 
whelped in the animal quarters. The mothers were fed commercial dog food 
(Hope Farms complete dog food D-B), additional milk, and water ad libitum. 
The puppies were allowed free access to their mothers milk but not to other 
food or water. They were assigned to one of four groups: a salt-loaded and 
a salt-depleted group and two control groups. 
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Salt-loading was performed by daily intraperitoneal administration of 
0.9% saline in a dose of 10 mEq sodium /kg body weight for 5 days; the last 
administration was 6 to 8 hours prior to the experiment. 
Salt-depletion was induced by daily intramuscular administration of 
furosemide 1 mg/kg body weight for Ï days; the last injection was given 
6 to 8 hours prior to the experiment. 
The first control group consisted of animals which were only surgically 
manipulated; the second control group received in addition daily an intra-
peritoneal injection of 5 ml glucose 5% and should be compared with the 
salt-loaded group. 
ANIMAL PREPARATION 
The day before the experimental procedure the puppy was anesthetized 
with ether. Polyethylene tubings of 50 centimeter length (Intramedic, Clay 
Adams PE-50 or 60) were placed in the descending aorta and the inferior 
vena cava below the level of the renal arteries and veins. The catheters 
were introduced via the femoral vessels after a small incision in the groin. 
After filling with a heparin solution (500 units/ml), they were sealed and 
tunneled subcutaneously to the lower part of the upper leg. The wounds were 
closed with sutures and the exit wound was covered. The animal was allowed 
to awake and was returned to the litter in the animal quarters for a 
recovery period of at least 14 hours prior to the experiment. 
EXPERIMENTAL PROCEDURES 
All experiments were performed in unanesthetized animals in a quiet 
laboratory in either morning or afternoon. No significant difference in PRC 
has been observed between morning or afternoon samples (3). The puppies 
were kept warm and quiet in a supine posture on a padded laboratory table 
during the experiment. The aorta catheter was connected to a Statham PE3 Dd 
pressure transducer and MAP was recorded continuously on a Beekman RP Dyno-
graph recorder. The values for MAP were obtained at 1-minute intervals and 
averaged for the last 40 minutes of each period. 
The catheter in the inferior vena cava was connected to a pump for the 
infusion of glucose 5% or of saralasin. The experimental protocol is 
schematically summarized in Table 1. Each of the three periods, control, 
experimental and recovery, lasted 60 minutes. Glucose b% was infused at 
a rate of 1.2 ml/hr during the control and recovery period. 
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Table 1. Experimental procedure. For abbreviations: see text 
Period Control Experimental Recovery 
Time (min) 0 60 120 180 
Infusion in 
v.cava inf. 
Glucose 5% 
1.2 ml/hr 
Saralasin 6 /¿g/kg/min 
or glucose 5% 
both: 0.1 ml/min 
Glucose 5% 
1.2 ml/hr 
Arterial 
Sample 
I (3 ml) 
PRA - PRC 
PA 
JNa К 
S
n
 - Hct Osm 
II (2 ml) 
PRA - PRC 
PA 
III (3 ml) 
PRA - PRC 
PA 
JNa S. 
S,, - Hct Osm 
Saralasin at a rate of 6/¿g/kg/min in 0.1 ml/min glucose 5% or glucose 5% 
alone was administered in the experimental period. At the end of each period, 
blood samples were collected from the aorta catheter and the amount of blood 
was replaced with an equal amount of Ringer's solution containing the 
resuspended packed cells of the previous sample. At the end of the control 
period, blood samples (I) were collected for the determination of PRA, PRC, 
PA, SN , SK, SQ , and hematocrit (Hct). At the end of the experimental 
period, blood samples (II) were collected for the determination of PRA, PRC 
and PA, and after the recovery period (III) for the determination of PRA, PRC, 
PA, S N a, SK, S 0 s m, and hematocrit. 
Since in puppies no data on basal values of A II are available, an 
additional experiment was performed in 4 controls of 10 to 22 days of age. 
In these puppies after a 60 min infusion of glucose 5% at a rate of 1.2 ml/hr, 
plasma A II was measured. 
ANALYTICAL METHODS 
Blood was collected into ice-cooled tubes. The tubes for the determina-
tion of A I and A II contained as inhibitors 0.125 M EDTA and 0.025 M 
0-phenanthroline in distilled water (0.25 ml per 7 ml blood). 
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The tubes for the determination of PRA and PA contained 10 mg potassium 
EDTA, and for the determination of ACE heparin. Plasma was immediately 
separated in a refrigerated centrifuge, quickly frozen and kept stored at 
-20° С until time of assay. Hematocrit, S- , S N and S.. were determined 
with standard laboratory tests. 
PRA was measured with a commercial kit (Clinical Assays) in which the 
enzymatical step was scaled down to one third of the volumes prescribed by 
the manufacturer. Briefly, the sample was incubated at pH 6.0 and 370C in 
the presence of angiotensinase inhibitors, and the A I generated was 
measured by radioimmunoassay. 
For PRC assay excess of homologous dog renin substrate, obtained 
48 hours after bilateral nephrectomy, was added to the plasma sample. All 
samples were corrected for the renin still present in the substrate pool. 
Plasma aldosterone concentration was measured by a direct radio­
immunoassay (11). 
Plasma A II concentration was measured as previously described (12). 
Sensivity of the assay for PRA was 0.15 and for PRC 5 ng A I/ml/hr, 
for PA 5 ng/100 ml, for A II 4 pg/ml. 
STATISTICAL ANALYSIS 
To obtain Gaussian distribution, the original data of the RAAS were 
statistically analyzed after logarithmic transformation (13). The mean and 
the one-standard deviation range were then transformed back to the model 
median (equal to the geometric mean) and the one-standard deviation range 
of the raw data. Statistical analysis of the other measurements: MAP, S.. , 
S^ ,, S
n
 , hematocrit, and age was performed on the original data. i\ usm 
Differences between groups of animals were tested with one-way analysis 
of variance. A possible influence of age was taken into account. If there 
was a significant difference in case of more than two groups, the 
simultaneous method of Scheffé indicated which of the groups differed from 
the others. 
The influence of glucose or of saralasin infusion on MAP was evaluated 
with a mixed two-way analysis of variance with interaction. The influence 
on blood chemistry and hormone levels was evaluated with the Hotelling T2 
test (14), a multivariate generalization of the Student's paired data t-test. 
Significant differences between sampling times were evaluated further with 
simultaneous methods. 
Significance was accepted at a P<0.05 level. 
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IX.4. RESULTS 
ІХ.4Л. BASAL VALUES IN THE GROUPS OF DOGS 
A. CONTROL PUPPIES 
Taking into account the difference in age, basal values for PRA, PRC, 
PA, S N , Sj., S« , hematocrit and MAP were not significantly different 
between the 2 control groups and were therefore combined. 
Figs la and lb depict PRA and PA values at different ages in the control 
puppies. No correlation between PRA and age existed, while PA increased with 
age (r=0.54
>
 P=0.03, N=17). It should be noted that the PRA levels in the 
puppies were considerably higher (P<0.01) than in the adult dogs. In the 
four additional experiments where only glucose was infused, A II levels 
(median value of 50.1 pg/ml, range 22 to 114) were higher (P<0.01) than in 
adult dogs in which a median value of 9.2 pg/ml (range 4 to 20, n=10) was 
obtained. In contrast, PA levels in the puppies ranged from 7 to 51 ng/100 ml 
and were not different (P>0.10) from the values in the adult dogs. 
In addition, in control puppies no significant sex differences in PRA or PRC 
were found. 
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Fig.l. Plasma renin activity (PRA) and plasma aldosterone concentration (PA) 
in unanesthetized normal puppies and in adult dogs. 
Symbols: different litters. 
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Table 2. Basal values of age, MAP, S.. , SK, SQ and hct in different groups of puppies (PP) and in adult 
dogs. Statistically significant differences between control puppies, salt-loaded puppies and adult dogs, 
or between control and salt-depleted puppies are indicated. Numbers between brackets. 
All values in salt-loaded puppies were significantly (P<0.001) lower compared to values in adult dogs. 
Age (days) 
MAP (mm Hg) 
SNa (mmole/1) 
SK (mmole/l) 
S0sm(0sm/kg) 
Hct (1/1) 
Control PP 
N 
17 
17 
13 
13 
13 
13 
Mean 
17.0 
64.1 
135.7 
3.78 
282.9 
0.282 
+ 
+ 
+ 
+ 
+ 
+ 
SD 
5.3 
14.1 
2.6 
0.39 
7.9 
0.038 
Adult dogs 
Mean 
** 
151.8 ± 
** 
4.48 ± 
** 
313.4 ± 
0.380 ± 
(27) 
SD 
2.1 
0.20 
5.8 
0.028 
Salt-loaded PP(10) 
Mean 
** 
23.5 
62.1 
136.9 
3.63 
282.8 
0.258 
+ 
+ 
+ 
+ 
+ 
+ 
SD 
7.0 
7.5 
2.4 
0.38 
6.4 
0.031 
Salt-depl 
Mean 
19.8 ± 
75.0 ± 
132.3* ± 
3.15 * ± 
283.3 ± 
0.253 ± 
eted PP(4) 
S.D. 
3.4 
17.7 
3.0 
0.47 
6.7 
0.036 
*: 0.01<P<0.05; **: P<0.01 
Table 3. Model medians and one-standard deviation ranges (between brackets) for basal values of plasma renin 
activity (PRA) and active plasma renin concentration (PRC), and plasma aldosterone concentration (PA) in 
different groups of puppies (PP) and in adult dogs. Statistically significant differences (**) between control 
puppies, and salt-loaded puppies, and adult dogs, or between control and salt-depleted puppies are indicated. 
Differences between salt-loaded puppies and adult dogs are indicated with +. 
Control PP (N=17) Adult dogs (N=27) Salt-loaded PP (N=10) Salt-depleted PP (N=4) 
Age (days) 17.0 23.5** 19.8 
(11.7 - 22.3) (16.5 - 30.5) (16.4 - 23.2) 
** ** ++ ** 
PRA (ng AI/ml/hr) 9.66 1.59 3.65 ' 47.06 
(5.53 - 16.90) (1.08 - 2.36) ( 2.22 - 6.01) (27.45 - 80.68) 
PRC (ng AI/ml/hr) 12.1 2.6** 5.2**,+ 153.8** 
(6.7 - 21.9) (1.3 - 5.0) (3.1 - 8.8) (38.8 - 609.8) 
PA (ng/100ml)§ 19.2 17.5 15.9** 44.5 
(10.8 - 34.1) (13.0 - 23.7) (12.1 - 20.7) (32.1 - 61.7) 
* * : P<0 .01 ; +: 0.01<P<0.05; ++: P<0.01 
§: In statistical calculations the influence of age has been taken into account. 
In 9 to 28 days old control puppies, no correlation could further be 
established between age and MAP; the latter was also not correlated with 
PRA. PA was only significantly correlated with PRA (r=0.45, P=0.07) and PRC 
(r=0.60, P=0.01), but not with S N a or S^. 
B. INFLUENCE OF DIFFERENT SALT-INTAKES 
The basal values of all variables in the different groups of puppies 
and in the adult dogs are summarized in Tables 2 and 3. As can be seen from 
Table 2 lower basal values for S N , S.., S. and hematocrit were observed in 
control puppies compared to adult dogs. 
Salt-loading resulted in significantly lower values for PRA, PRC and PA 
(Table 3) compared to control salt-intake, but had no significant influence 
on the mean plasma levels of S,, , S,., S 0 , and hematocrit (Table 2). When 
salt-loaded puppies were compared to adult dogs, values for PRA and PRC were 
higher (Table 3), and S N , S K, SQ and hematocrit lower (Table 2), while PA 
levels were not different from PA levels in the adult dogs (Table 3). 
Salt-depleted puppies had significantly higher PRA and PRC levels than 
control puppies (Table 3), and lower values of S N and S^ (Table 2). After 
correction for the influence of age PA (Table 3), S~ , and hematocrit 
(Table 2) were not different between control and salt-depleted puppies. 
The mean MAP was not significantly different between the 3 groups of 
puppies. 
Fig.2. Estimates of and simultaneous 95% confidence intervals for median 
absolute or percental changes ( Δ ) from control values of mean arterial 
pressure (MAP), plasma renin activity (PRA) and active plasma renin con­
centration (PRC), and plasma aldosterone concentration (PA) during ( Π ) 
and after [Щ) glucose infusion in control puppies, and during (•) and 
after (Щ) saralasin infusion in three different groups of puppies: control, 
salt-loaded, and salt-depleted puppies. 
P-values for changes in MAP (analyzed with a mixed two-way analysis of 
variance with interaction) and for changes in PRA, PRC and PA (analyzed with 
Hotel ling T 2 test) are indicated. 
* : N = 5 for PRA, PRC, and PA. 
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IX.4.2. EFFECTS OF GLUCOSE AND SARALASIN INFUSION (Figs 2 and 3). 
A. MEAN ARTERIAL PRESSURE 
A.l. GLUCOSE INFUSION 
In the control experiments with glucose infusion alone (Fig 2a), the 
overall MAP did not change consistently. As can be noted from Fig 3a, 7 of 
the 9 animals responded with a slight increase in blood pressure; 2 animals 
showed a decrease of MAP. During the recovery period, the MAP remained 
further unchanged. 
A.2. SARALASIN INFUSION 
In the saralasin experiments in control puppies (Fig 2b), the overall 
MAP decreased significantly with a mean of 6.6 mm Hg during the infusion 
and returned towards control value during recovery compared to the control 
period. The decrease in MAP was significantly correlated with basal PRC 
levels (r=0.76, P<0.01). Fig 3b summarizes the individual changes in MAP 
during and after saralasin administration. In these 11 animals during 
saralasin, 8 responded with a fall while only 1 showed a slight increase in 
MAP. In 2 animals the MAP was not influenced. During recovery, most animals 
responded with a return towards the original blood pressure or showed no 
further change. Therefore, in contrast with glucose infusion, saralasin was 
able to induce a fall in blood pressure. 
Compared to the normal animals, all 4 salt-depleted puppies showed a 
more pronounced reduction of MAP during saralasin infusion (Figs 2d and 3d), 
and also an almost complete return of the MAP to control values during 
recovery. 
On the other hand, the increase of MAP in the salt-loaded animals 
(Figs 2c and 3c) during saralasin was not significant. 
B. PLASMA RENIN ACTIVITY AND CONCENTRATION, PLASMA ALDOSTERONE 
The influence of either glucose or saralasin infusion on the hormonal 
changes is also shown in Fig 2. 
B.l. GLUCOSE INFUSION 
In the glucose experiment all changes in PRA, PRC, and PA were not 
statistically significant. 
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Fig.3. Absolute changes from control values of mean arterial pressure (MAP) 
during glucose or saralasin infusion in the experimental period (II) and at 
the end of the recovery period (III). 
B.2. SARALASIN INFUSION 
Saralasin in the control puppies resulted in a significant increase in 
PRA and PRC with a median of 80% and 163% respectively. Both values returned 
towards normal after stopping the saralasin infusion. 
In the salt-depleted group the median PRC increased while the median PRA 
remained unchanged. The difference between PRA and PRC in this group depends 
on substrate limitation in the PRA assay. 
In salt-loaded animals no significant changes in either PRA or PRC were 
observed in the experimental period. 
In none of the groups caused saralasin a significant change in PA in the 
experimental period. 
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IX.5. DISCUSSION 
As could be expected, the basal levels of PRA, PRC, and A II were 
higher in unanesthetized puppies than in adult dogs. No correlation was 
found between PRA or PRC and age in the range of 9 to 28 days. This is in 
contrast with other reports in dogs (2-4). It is possible that the age 
range in our puppies was too small or that the results were influenced by 
differences between litters. Significant differences in PRC between litters 
at each age between 1 day to 3 weeks have been reported. However, these 
observations could not explain the age-related changes in PRC (3). 
Basal PRC values were in general higher than PRA values, especially at 
higher levels. Median PRA level in salt-depleted puppies did not increase 
with saralasin infusion (Fig 2d), but after the addition of excess 
homologous renin substrate median PRC rose clearly. Maximal PRA is substrate 
limited in puppies, as has been reported for the newborn lamb (15). The 
influence of the amount of substrate on the generation of A I in newborn 
puppies has been shown by Drukker (2). Plasma renin substrate concentrations 
in puppies from birth to 3 weeks of age were similar to adult values (2). 
In view of the persistently high PRA levels in our puppies, our finding 
of a positive correlation between PA and age is unexpected. This observation 
is in contrast with the reported decrease in PA with advancing age in man 
(16-25) and animal (4,26-34). Although direct comparison with PA data in 
unanesthetized puppies is impossible due to lack of this information in the 
literature, an effect of differences in PA of puppies between litters, as 
is reported for PRC (3), is not excluded. It is also possible that equally 
high levels of renin resulted in lower PA concentrations in young animals, 
as the aldosterone response to actual plasma A II concentrations was 
diminished in younger lambs (35). In any case, the median PA levels in the 
puppies were not different from the levels obtained in our adult dogs. 
Aldosterone secretion in adult dogs could probably have been stimulated by 
the uncontrolled posture compared to the supine posture of the puppies. 
However, PRA levels of adult dogs were low. The lower serum К levels in 
puppies might have resulted in a lower adrenal aldosterone secretion. 
It is known that longterm infusion of A II in adult dogs fails to maintain 
elevated aldosterone levels whereas prolonged infusion of potassium may 
increase PA with 400% (36). 
Although salt-loading significantly decreased PRA, values as low as 
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in adult dogs were not reached. In addition, salt-loading resulted also in a 
lower PA compared to controls.This confirms the data of John et al (4) and 
Ito et al (34). 
On the other hand, despite the already high baseline RAAS activity, 
salt-depletion resulted in a significant further stimulation of PRA and PRC. 
Variation in salt intake did not significantly alter the basal MAP in 
our puppies. This is in contrast with results obtained by Siegel (37) in 
newborn lambs, where acute and chronic extracellular volume expansion by 
salt-loading caused an unexpected decrease in MAP. This was associated with 
a fall in PRA of about 70% in chronic salt loading, which is quite similar 
with the decrease in PRA noted in our volume expanded puppies. Although the 
explanation for this different blood pressure behaviour must remain 
speculative, it is clear that the adaptation of the blood pressure to chronic 
salt loading in the puppy is different from the newborn lamb. 
Saralasin infusion not only decreased MAP in the salt-depleted puppy, 
as is reported for the adult dog (5,6) but also in the puppy on bitch milk 
only. This has also been reported in the conscious newborn lamb during the 
first two weeks of life (15,37) but was not seen in the anesthetized 14 to 
25 days old puppy (8). Anesthesia influences MAP and PRA (9) and therefore, 
studies concerning the role of the RAS in the maintenance of blood pressure 
should be performed in unanesthetized animals. In 4-38 days old lambs, the 
ACE inhibitor Captopril also resulted in a significant decrease in MAP (38). 
However, changes in the bradykinin-kinin system may be induced by converting 
enzyme blockade with Captopril. In any case, the decline in arterial 
pressure in response to saralasin or Captopril in young animals suggests 
that the increased activity of the RAS at young age contributes to the 
basal blood pressure. 
Similar to adult dogs (5,6) no decrease in MAP by saralasin in salt-
loaded puppies was noted. This confirms the results obtained by Siegel in 
salt-loaded lambs (37). 
Normal and salt-depleted puppies responded to saralasin infusion with 
a marked increment in PRC (Fig 2b and 2d), as was also reported in the 
newborn lamb (15). This might be the result of either a blockade of the 
short-loop negative-feedback of angiotensin on the juxtaglomerular cells 
or of the fall in arterial pressure or of a combination of both mechanisms. 
However, in a minority of our puppies the rise in PRA and PRC was 
dissociated from a fall in blood pressure. This observation suggests that 
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an activation of the RAS after angiotensin II blockade in the young animal 
is not only due to a change in blood pressure. 
Salt-loaded puppies with suppressed renin showed no increment in PRA 
and PRC, and therefore responded similar to saralasin as conscious normal 
adult dogs (6). 
On the other hand, PA remained unchanged during saralasin infusion 
in control, salt-loaded as well as in salt-depleted puppies. It should be 
noted that saralasin has been reported to cause a fall in PA in the salt-
depleted adult dog (6). 
In summary, the present study was an attempt to evaluate the importance 
of the increased activity of the RAAS in the young animal. Where higher 
basal 
levels of PRA and PRC were found in the normal puppy, similar PA levels as 
in the adult dog were observed. 
The importance of the increased activity of the RAS in the control of 
basal blood pressure was shown by the hypotensive action of saralasin, 
a potent angiotensin II antagonist. Variations in salt intake dramatically 
influenced both the response of blood pressure and the levels of PRA and PRC. 
It is therefore concluded that the enhanced activity of the RAS in the 
young animal significantly contributes to the maintenance of the normal 
blood pressure. It must be recognized that other vasoactive or neurogenic 
factors may play a role in the regulation of the blood pressure. 
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X. RENIN DISAPPEARANCE RATE IN PUPPIES 
X.l. ABSTRACT 
The disappearance rate of endogenous renin from the circulating blood 
after bilateral nephrectomy was studied in 4 puppies aged 16-21 days. 
Mean half-times of the fast and slow component of the disappearance 
curves of renin were 9.15 min ± 0.87 (SD) and 84.0 min ± 16.8 (SD), 
respectively. These values are not different from the values reported for 
adult dogs by Michelakis et al. The metabolic degradation of renin is not 
different between young and adult dogs and does not contribute to the 
elevated plasma renin activity in the puppy. 
III.2. INTRODUCTION 
Compared to adults, the elevated plasma renin activity (PRA) or 
concentration (PRC) at young age is well documented in several species. 
Since renin is primarily metabolized in the liver, immature metabolic 
function at young age might contribute to the elevated PRA. 
Several, but conflicting results have been reported on renin half-
lives in fetal and young animals. No differences were found in renin half-
lives between fetal sheep (118-124 days of gestation) and their mothers (1) 
and between young (1-5 days) and more mature (45-50 days) piglets (2). 
On the other hand, a significantly longer renin half-time was found in rats 
under 16 days of age compared to older (4-6 weeks) or mature rats (3). 
However, no adequate method was used for the determination of renin half-
life in these piglets and rats. As far as we know, no data are available on 
plasma renin disappearance rate in puppies. 
As part of a systematic investigation on the significance of the high 
PRA level in the maintenance of a normal blood pressure in the puppy, the 
renin disappearance immediately after bilateral nephrectomy was determined 
in puppies with an age between 16-21 days. 
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X.3. MATERIALS AND METHODS 
The disappearance rate of endogenous renin from the circulating blood 
was studied in 4 puppies with an age of 16, 19, 20 and 21 days, respectively. 
Two puppies, 20 and 21 days old, were salt depleted by daily intramuscular 
administrations of furosemide 1 mg/kg of body weight during 4 days. A third 
puppy, 19 days old, received one furosemide injection 6 hours before the 
experiment. The fourth puppy, 16 days old, received no furosemide. All 
animals were allowed free access to their mother's milk but not to other food 
or water.The animals were anesthetized with sodium pentobarbital (25 mg/kg 
i.V.), a tracheostomy was performed and catheters were inserted in the 
descending aorta and the inferior vena cava below the level of the renal 
vessels. Renin release into the circulation was then further stimulated by 
an intravenous bolus injection of saralasin (200itg/kg) in all animals. 
Both kidneys were removed via lumbotomy. The time of ligation of the renal 
artery and vein of the second kidney was considered as zero time, and an 
arterial blood sample was immediately collected. Subsequent blood samples 
were collected at 5, 10, 15, 30, 45, 60, 75, 90, 105 and 120 minutes post-
nephrectomy. The sample volume (1 ml) was replaced with Ringers solution. 
Blood for PRA measurement was collected into ice-cooled tubes containing 
10 mg potassium EDTA. Plasma was immediately separated in a refrigerated 
centrifuge, quickly frozen and kept stored at -20° С until time of assay. 
PRA was measured with a commercial kit (Clinical Assays) using a 
micro modification. Briefly, the sample was incubated at pH 6.0 and 37°C in 
the presence of angiotensinase inhibitors, and the generated A I was 
measured by radioimmunoassay. Sensitivity of this assay was 0.15 ng A I/ml/h. 
The within-run coefficient of variation at level <10 ng A I/ml/h was 5%, 
and at level > 1 0 ng A I/ml/h 4%. 
For PRC assay, excess of homologous dog renin substrate plasma, obtained 
48 hours after bilateral nephrectomy, was added to the plasma sample. 
All samples were corrected for the renin present in the substrate pool. 
Sensivity of the assay for PRC was 5 ng A I/ml/h. The within-run coefficient 
of variation for the PRC assay was 3.5% at level>40 ng A I/ml/h and at level 
< 4 0 ng A I/ml/h the standard deviation was 1.0. 
Hematocrit was determined with a micro-hematocrit centrifuge.Because of 
decreasing hematocrit in the course of the experiment, PRC obtained at each 
point of time was corrected to the initial hematocrit value at zero time. 
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For analysis of the kinetics of renin disappearance, the corrected PRC 
was plotted as percentage of zero time value on semi logarithm!с graph against 
time. The resulting disappearance curve was graphically resolved into two 
exponential components. The slope of the slow component was calculated by 
linear regression (method of least squares) using the log of the experimental 
values at 45, 60, 75, 90, 105 and 120 minutes. This linear portion of the 
curve was extended to the Y-axis and values at time 0, 5, 10 and 15 min on 
this extrapolated line were subtracted from the values on the orginal curve. 
The differences were plotted against time and the slope of the rapid component 
of the disappearance curve of renin was obtained by fitting a straight line 
(linear regression). 
X.4. RESULTS 
The Table presents the PRA and PRC data, not corrected for hematocrit, 
of all animals, and the Figure shows a typical curve of the disappearance 
rate of endogenous renin from the circulating blood immediately after 
bilateral nephrectomy in the 16 days old puppy. 
remaining PRC(e/o)-
1 0 0 - · 
ι ι ι 
О 51015 120 time in minutes 
Fig. Semilogarithmic plot of percentage of remaining plasma renin concentra­
tion (closed circles) against time in a 16 days old puppy after bilateral 
nephrectomy. Solid line is drawn between experimental values. The dashed 
lines give the slopes of the two components. Open circles represent the 
calculated values for the first component, t, = half-time. 
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Maximal PRA is substrate limited in puppies, as has been reported for 
the newborn lamb (4). The zero values of PRA and PRC were obtained after 
stimulation and anesthesia, and cannot be compared with the values for PRA 
and PRC obtained in normal puppies 9 to 28 days of age (n=17). The basal 
geometric mean values for PRA and PRC that we measured in these puppies were 
9.66 ng A I/ml/h (one SD range 5.53 - 16.90) and 12.1 ng A I/ml/h (one SD 
range 6.7 - 21.9), respectively. In adult dogs (n=27) these values were 
1.59 (one SD range 1.08-2.36), and 2.6 (one SD range 1.3-5.0), respectively. 
Mean value of the half-times of the fast component of the curves was 
9.15 min ± 0.87 (SD), and of the slow component it was 84.0 min ± 16.8 (SD). 
Table. Uncorrected levels of plasma renin activity (PRA, ng A I/ml/h) and 
plasma renin concentration (PRC, ng A I/ml/h) in canine puppies at the time 
(min) of removal of the second kidney (0) and various points of time later. 
Corresponding half-times (T,, min) of the fast and the slow component of the 
renin disappearance curve. * 
Puppy: I (16 days) II (19 days) III (20 days) IV (21 days) 
Time PRA PRC PRA PRC PRA PRC PRA PRC 
0 
5 
10 
15 
30 
45 
60 
75 
90 
105 
120 
40.1 
29.8 
24.3 
21.1 
20.9 
14.7 
14.6 
13.2 
10.8 
10.2 
10.2 
106 
85 
69 
58 
41 
31 
25 
21 
20 
17 
13 
68.8 
57.5 
49.1 
42.9 
32.5 
25.6 
22.3 
18.3 
16.6 
16.3 
275 
207 
172 
142 
106 
81 
62 
56 
48 
46 
51.2 
49.9 
45.9 
47.7 
44.5 
41.5 
38.5 
33.3 
32.8 
29.5 
29.8 
704 
621 
525 
454 
372 
290 
221 
188 
168 
153 
152 
39.6 
35.3 
32.5 
28.1 
22.5 
17.5 
16.0 
15.7 
188 
152 
123 
104 
74 
64 
52 
53 
8.1 9.7 10.0 8.8 
67 76 87 106 
yfast 
T,-slow 
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Χ.5. DISCUSSION 
Inactive renin was not measured in the puppies. If conversion of 
inactive to active renin had occurred in the circulation, it might have 
slowed down the disappearance rate of active renin in puppies, and perhaps 
at a different degree compared with adult dogs. It is not clear whether 
inactive renin is activated to active renin, and how such activation is 
regulated. Because of the abundance of protease inhibitors in plasma, it is 
unlikely that physiological conversion of inactive to active renin occurs 
in the circulation. In addition, Siegel and Parkhill (5) found no evidence 
of in vivo conversion of infused exogenous inactive-high-molecular-weight 
renin to low-molecular-weight renin either systemically or in the tissues 
of the newborn canine puppy 3-4 weeks of age. 
The disappearance curve of endogenous or exogenous renin activity from 
plasma after bilateral nephrectomy can be expressed as the sum of two 
exponential components in dog (6-8), sheep (1), possum (9), rat (10) and man 
(8, 11). Other investigations on the disappearance of renin activity in rat 
(3), piglet (2) and man (12, 13) did not resolve the curves in two components 
and dealt exclusively with its half-life as the time at which the initial 
activity was reduced to 50%. 
Michelakis et al (8) suggest that the rapid component of the 
disappearance curve of renin represents its distribution into a non plasma 
compartment from the plasma compartment, while the slow component represents 
the metabolic degradation of renin and reflects thus the true half-life of 
plasma renin. In the present study the mean half-times of the fast and slow 
components obtained in 4 puppies aged 16-21 days were 9.15 min ± 0.87 (SD) 
and 84.0 min ± 16.8 (SD), respectively. These values were in the range of 
the 9 adult dogs studied by Michelakis et al (8): 9.7 min ± 3.0 (SD) and 
93 min ± 17.3 (SD), respectively. 
Only three investigations have so far dealt with this problem in fetal 
(1) or young (2, 3) animals. Oakes et al (1), using an adequate method, found 
no difference in renin half-life between fetal sheep and their mothers. In 
the experiments of Osborn et al (2) the plasma half-life of renin was not 
different between young (1-5 days) and more mature piglets (45-50 days). As 
these authors did not resolve the disappearance curves into components and 
renin in most of the piglets was only determined up to 30 min after 
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nephrectomy, half-lives of renin calculated in this study represent mainly 
the diitribution of renin, and do not allow to make conclusions on its 
metabolic degradation. Solomon et al (3) reported a significantly longer 
half-time in rats under 16 days of age than in older (4-6 weeks) or mature 
rats. Again, their disappearance curves were constructed from values up to 
20-30 min postnephrectomy and they were also not resolved into components. 
Moreover, littermates of an single litter were used to obtain one dis­
appearance curve in the youngest rats, while in the older and mature rats 
each animal produced a single curve. The well-known scatter of PRA values 
at younger age (14, unpublished observations) might have influenced the 
results. 
The results of the present study and those of Michelakis et al (8) 
indicate that the metabolic degradation rate of renin is not different 
between young and adult dogs. Therefore, immature hepatic metabolism is not 
a factor in the control of renin and is not responsible for the higher PRA 
in puppies compared to adult dogs. 
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XI. GENERAL DISCUSSION 
The general discussion on the renin-angiotensin-aldosterone system will 
be concentrated on the following points: 
1. Standardization of the activity of the renin-angiotensin-aldosterone 
system (RAAS). 
2. The RAAS in basal conditions. 
3. The RAAS in stimulated conditions. 
4. The role of the RAAS in sodium homeostasis. 
5. The role of the renin-angiotensin system (RAS) in the control of blood 
pressure. 
6. Miscellaneous. 
XI.1. STANDARDIZATION OF THE ACTIVITY OF THE RENIN-ANGIOTENSIN-ALDOSTERONE 
SYSTEM (RAAS) 
The RAAS can be influenced by various factors including volume balance, 
salt intake, posture, physical and mental exercise, activity of the 
sympathico-adrenomedullary system, circadian rhythm, and different 
pharmacological agents. Therefore, for estimations of basal values of the 
components of the RAAS, the conditions of blood sampling will have to be 
standardized. After at least 3 hours fasting and supine posture prior to 
sampling, we collect blood samples for basal values at about 8.30 in the 
morning under conditions of usual hospital diet. The venepuncture has to be 
performed as quickly as possible and with a minimum of discomfort. 
The main effector of the renin-angiotensin system (RAS) at the receptor 
level is angiotensin II (A II). Because of the cumbersome measurement of 
circulating A II levels, the activity of the RAS is generally determined 
by measuring the value of plasma renin activity (PRA). Like others, we 
found a good correlation between PRA and plasma A II concentrations 
(chapter IV). This reflects that PRA values provide relevant information 
on the physiological activity of the RAS. 
The handling and storage of blood samples can influence PRA values 
(chapter II.6.3.). Therefore, it is recommended that collection and handling 
of samples are performed under cold conditions, and samples should be 
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stored at -20°C or lower. 
For comparison of PRA values with those obtained in other laboratories 
with different assay procedures, it is necessary to use an international 
reference preparation of renin. The preparation available is the WHO 
standard, the First International Reference Preparation of Human Renin 
coded 68/356 (chapter II.6.6). In our assay system a PRA equivalence 
resulted of 1 ng A I/ml/h with about 11.0 μΙΙΙ renin/ml ± 1.5 (SD) for plasma 
samples of both infants and adults. This conversion factor, however, can be 
different when renin substrate concentrations are beyond the normal ranges, 
since the renin-renin substrate reaction in man is limited by the renin 
substrate concentration. 
XI.2. THE RAAS IN BASAL CONDITIONS 
In all investigations reported plasma renin activity in infants and 
children is increased compared to values in adults. We confirmed the age-
related decrease in PRA (chapter III) with a striking scatter of values 
especially in infancy. It was only possible to compare our basal PRA values, 
when we converted them into units of the international human renin 68/356 
standard, with the data on plasma renin concentration (PRC) of Brdns and 
Thayssen (1). These authors measured PRC using endogenous renin substrate 
and the international renin 68/356 preparation as an internal standard. 
The median values in their age groups are about twice as high as in ours. 
The conditions of sampling seem to be similar. 
Plasma renin concentration (PRC) showed the same age-related decrease 
as was seen for PRA (chapter V). Therefore, in spite of the substrate-
limitation of the renin-renin substrate reaction, the decline of PRA with 
age reflects a decline of renin concentration. Most publications concerning 
the renin system in childhood deal with PRA; only a few investigations 
report data on PRC (1-4). We measured PRC in the usual way, namely after 
incubation of the sample with excess sheep renin substrate. These values 
can only be compared to a certain degree with those of Krause et al (2), 
Hayduk et al (3), and Broughton Pipkin et al (4). In two investigations 
(2, 3) the conditions of sampling were not standardized for all infants 
and children, and the authors used a bioassay procedure for measurement of 
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angiotensin. In the study of Broughton Pipkin et al (4) the posture of the 
children was also not standardized and the international human renin 
standard was not used. The PRC was distinctly higher in children than in 
adults and fell with increasing age. 
A significant age-related decrease was also observed for the basal 
levels of angiotensin I and II but not for plasma angiotensin-converting 
enzyme activity (chapter IV). 
As far as we know, angiotensin I (A I) levels in infancy and childhood 
have not been described. Our values of A I in supine children 8 to 13 years 
old (model median 100 pg/ml, range 70-212, n=10) were higher than the values 
reported by Lijnen et al (5) in male ambulant adults in a sitting position 
between 8.30 and 10.00 AM and measured with the same methods (mean 66 pg/ml, 
range 25-143, n=24). Since the sitting posture of these ambulant adults has 
probably stimulated the RAS, it can be concluded that basal A I levels in 
8 to 13 years old children are still higher than in adults. Although we did 
not measure PRA levels in adults, we can assume on the basis of these data 
that PRA in the age group 8 to 13 years will be higher than in adults. 
Angiotensin II levels in infancy beyond the newborn period and in 
childhood have only been described by Broughton Pipkin et al (4). Mean A II 
levels in their group of children between 2 months and 12 years of age were 
higher than in adults. However, when the girls (n=43) and boys (n=20) were 
divided in roughly numerically-equal groups on the basis of age, mean A II 
levels in girls younger than 8 years were not different from those in older 
girls, while mean A II levels in boys older than 8 years were higher than 
in younger boys. These data are conflicting with our results, most likely 
because in the group examined by Broughton Pipkin et al only a minority of 
infants were represented. Moreover, the blood sampling was performed in 
unstandardized posture. Our values of A II in supine children 8 to 13 years 
old (model median 22 pg/ml, range 12-67, n=10) were similar to the values 
reported by Lijnen et al (6) in ambulant adults between 2 and 3 PM in the 
sitting position (mean 25 pg/ml, range 10-51, n=10). Because of the probable 
influences from both posture and circadian rhythm on PRA and therefore on 
A II levels, these values cannot be compared with ours. 
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Plasma angiotensin-converting enzyme (ACE) activity was comparable with 
values in adults and not related to age. Apart from the question whether 
plasma ACE activity reflects the A I conversion capacity of the body, we 
found neither an indication that ACE activity in vivo was rate-limiting in 
the generation of A II nor that the conversion of A I to A II was age-
related. 
There are only a few reports concerning plasma renin substrate 
concentrations (PRS) in infancy and childhood (1, 7, 8). Kotchen et al (7) 
found no change in PRS between birth and 6 weeks of age. Plasma renin 
substrate was about 1.5-fold higher compared to values in normal adults. 
Irrrionen et al (8) reported that PRS at the age over 15 years was higher 
than in children 0-15 years of age. Finally, Brtfns and Thayssen (1) found 
PRS to be inversely correlated with age in 3 days to 14.5 years old 
children, while PRS values in children older than 4 years were similar to 
values in adults. 
The reaction between renin and its substrate is dependent on both the 
concentration of renin and of renin substrate (9-11). When the substrate 
concentration decreases with age, this decline might, apart from the 
decline in renin concentration, contribute to the lowering of PRA with age. 
We found no indications for a significant age-dependent influence of 
substrate concentration on PRA values. First, addition of the same amounts 
of standard renin to plasma samples of young infants and of adults resulted 
in a similar generation of A I (chapter II.6.6). Second, the relationship 
between PRA and PRC which reflects the rate of conversion between renin and 
endogenous substrate, was not different between infants under one year of 
age and children 1 to 16 years old (chapter V). We have recently measured 
substrate concentrations in infants and children. The renin substrate 
concentration in young infants was only slighty higher than in older 
infants. In addition, the values in children older than 6 months were in 
the same range as found in adults. 
It should always be realized that PRA is the result of the interaction 
of renin and renin substrate. Therefore, PRA may have the same value in a 
situation with elevated renin concentration and normal or decreased 
substrate concentration when compared with a normal or low renin situation 
and a high substrate concentration. Determination of renin or substrate 
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concentration will indicate the difference. 
A completely inactive form of renin has been isolated from both the 
kidney and plasma (chapter V). The plasma inactive renin is generally named 
prorenin. It can be activated in vitro by appropriate exposure to acid pH 
or to limited proteolysis, and by prolonged exposure to cold (cryoactivation). 
All activation methods have limitations. Probably the most reliable method 
of activation is that of trypsin in controlled amounts (12). We made use of 
this activation procedure of inactive renin for its determination in infants 
and children. 
An age-related decrease in inactive and total plasma renin concentration 
was found. The values of inactive renin reached, however, adult levels at a 
younger age than was observed for active renin concentration, for PRA, and 
for A I and A II. In addition, the proportion of renin in the inactive form 
was not related to age, and the overall percentage of 79% in the whole group 
of infants and children was lower than reported for adults. 
The nature and function of prorenin still remain to be established. At 
present it is not clear whether prorenin represents a biosynthetic precursor 
secreted into the plasma from mainly renal sources, or whether it is a later 
modification of active renin after its secretion into the plasma, or a 
combination of both mechanisms. Reversible interconversion between active 
and inactive renin has been reported (13). 
There are conflicting opinions on the questions of whether, where, how 
much, and under what conditions prorenin is activated in vivo. 
As for the biological significance, prorenin either might have no 
biological function or it might have a more local effect. Prorenin in the 
circulation might act as renin precursor and serve as a mechanism to 
modulate the available amount of active renin in response to stimuli and 
thereby supplement the process of active renin release. Conflicting results 
have appeared whether reciprocal changes in active and inactive renin occur 
in response to acute stimuli (14, 15). Chronic stimuli to the RAS cause 
parallel changes in both fractions (16), suggesting increased secretion and/ 
or synthesis of both active and inactive renin. The influence of stimulation 
of the RAAS by sodium restriction and postural change (chapter III) in 
infants and children will be investigated. 
Because of the abundance of protease inhibitors in plasma, it is 
unlikely that physiological conversion of inactive to active renin occurs 
in the circulation. 
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The observed in vitro activation of prorenin by the factor Xll-kallikrein 
pathway (16-18), and the plasmin-mediated activation (17) have been 
suggested to mediate in vivo the prorenin activation in tissues especially 
intrarenally and in the blood vessel wall, for the local generation of A II. 
The attractive postulation that the vasoconstrictor RAS interacts with the 
opposing vasodilator kinin system to regulate regional blood flow remains 
unproven. 
Whatever the nature or function of prorenin may be, its concentration 
in plasma is much higher than that of active renin. Under physiological and 
pathological steady state conditions its levels appear to be positively 
correlated to those of active renin. 
In a stimulated RAS as is present in infancy and childhood, the higher 
levels of prorenin found by us, might be expected. The observed lower 
proportion of renin in the inactive form when compared to adults might 
implicate a different degree of prorenin conversion at younger age. 
In the syndrome of hyporeninemic hypoaldosteronism a defect in the 
conversion or activation of inactive renin has been suggested. In the 
infant with this syndrome (chapter VIII), almost all of the circulating 
renin existed in the inactive form. 
An age-related decrease was also observed in urinary aldosterone 
excretion expressed per unit body weight or body surface area, and in plasma 
aldosterone concentration (PA) (chapter III). However, only the plasma 
concentration of free aldosterone provides a measure of the biologically 
active fraction of aldosterone. In the guinea pig the aldosterone binding 
to plasma proteins (in this animal only to albumin) increased between birth 
and adulthood from 21.4% ± 2 to 35.4% ± 3.7 (19). Such data are not present 
in infancy and childhood and wait to be studied. If salivary aldosterone 
reflects the plasma concentration of free aldosterone, the investigation of 
the active fraction of aldosterone in children will become easy (20). 
A striking scatter in basal levels of PRA, PRC, A I, A II, and PA was 
observed especially in infants and young children. Since the conditions of 
sampling were standardized, factors which may influence renin release such 
as uncontrolled posture and differences in salt- and fluid balance, are not 
responsible for this scatter. Although every stress, including that of 
venepuncture, may activate the RAAS, we showed that a well performed vene-
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puncture does not systematically affect the PRA values obtained (chapter VI). 
We conclude that the stress of venepuncture is not an explanation for the 
greater scatter of basal levels of the components of the RAAS observed in 
infants and young children. A different degree of biological maturation 
seems a more reasonable explanation for the diversity of activity of the 
RAAS at young age. 
XI.3. THE RAAS IN STIMULATED CONDITIONS 
The RAAS in infants and children was studied during stimulation by 
standardized sodium restriction (10 mmol sodium/1.73 mz/24 h) during 4 days, 
followed by a second stimulus of change in posture (90 min sitting posture) 
(chapter III). 
The increase in PRA, PA, and urinary aldosterone excretion by salt 
restriction as well as by postural change is well-known, and has been 
studied in infancy and childhood. However, neither data of these values 
during standardized salt restriction nor during standardized postural change 
in both infants and children are available. 
Since the sodium intake in young infants may be less than the imposed 
amount of 10 mmol/1.73 m2/24 h (equivalent to about 0.3 mmol/kg/24 h), salt 
restriction according to our protocol might not be an adequate stimulus to 
the RAAS in these infants. 
During sodium restriction a rise of PRA was noted in all age groups. 
The correlation of PRA with age decreased, and disappeared completely after 
subsequent change in posture. Therefore, posture seems to have a greater 
influence on PRA with increasing age. Since the sympathetic nervous system 
is at least partly involved in the renin release during both sodium 
restriction and change in posture (21, 22), an increasing degree of 
sympathetic activity with age could play a role. 
In all age groups also an increase in urinary aldosterone excretion 
during sodium restriction was found, but a rise in PA could not be 
demonstrated in infants under 6 months of age. We are unaware of studies 
on the metabolic clearance rate of aldosterone during salt depletion in 
childhood, as have been performed in adults (22), which could explain this 
discrepancy. The influence of posture on PA in our study was only 
significant in children above 4 years of age. The lack of rise in younger 
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children remains unexplained. 
Since the correlation between PRA and PA, after elimination of the 
effect of age on both values, increased during sodium restriction and 
during change in posture, PA seems more dependent on PRA in these 
stimulated conditions. The fact that in adults Captopril completely 
suppressed the sodium-restricted levels of both angiotensin II and 
aldosterone into the high sodium range, led Swartz et al to the conclusion 
that the renin-angiotensin system is the prime mediator of the adrenal 
response to sodium restriction (23). 
Values of simultaneously measured PRA and PA levels during stimulation 
in infancy and childhood have been reported by van Acker et al (24). These 
authors used the administration of furosemide accompanied by upright posture 
as a stimulus. It is suggested that the main stimulus for renin release 
after furosemide is arteriolar dilatation. Increased sodium chloride 
delivery to the macula densa could be another mechanism (25). 
A low salt intake as was imposed in our protocol, is a more physiological 
stimulation to the RAAS than that obtained with diuretics. 
The establishment of the normal physiological profile of the RAAS upon 
standardized stimulation, at different ages, should allow a better 
assessment of the role of this system during maturation. In addition, the 
obtained data are very useful for the evaluation of diseases, such as salt-
wasting syndromes of various origin, and of patients with hypertension. 
This is illustrated by our recent experiences. 
Salt-wasting is a prominent feature in the syndrome of pseudohypo-
aldosteronism. Contrary to salt-wasting of adrenal origin, these patients 
show high levels of both PRA and PA when compared with values in age-matched 
controls during sodium restriction. Supplemental salt gifts will normalize 
these values. During the last year, two infants with this disorder, as yet 
not described in The Netherlands, could be treated in our clinic. 
The syndrome of hyporeninemic hypoaldosteronism in an infant presented 
also with salt-wasting (chapter VIII). PRA and PA values were low when 
compared to basal values in age-matched controls, and very low when compared 
to values in infants during sodium restriction. Mineralocorticoid treatment 
is effective in this disorder. 
Hyporeninemic hypoaldosteronism was also found in a child with symptoms 
of aldosteronism and hypertension (chapter VII). In this case the RAAS could 
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not be stimulated by our usual protocol. In addition, an abnormality in 
Cortisol metabolism was demonstrated in this child. 
XI.4. The ROLE OF THE RAAS IN SODIUM HOMEOSTASIS 
A relatively constant positive sodium balance, within a wide range of 
sodium intake, is one of the characteristics of sodium homeostasis in the 
growing organism (26). During gestation the placenta acts as a hemodialyser 
perfectly adapted to the fetal needs. After birth the kidney must assume 
its independent function. 
Full term infants have a positive sodium balance on normal feedings (27). 
In contrast, sodium homeostasis in very preterm newborns fed similarly, is 
characterized, during the first 2 postnatal weeks, by a less efficient 
intestinal sodium absorption (28) and a high urinary excretion of sodium, 
associated with a negative sodium balance and a high incidence of 
hyponatraemia (27, 29-33). The least mature infants have the highest 
fractional sodium excretion and require a longer period to achieve a 
positive sodium balance (33). In the study of Al-Dahhan et al (33) sodium 
conservation was possible in infants older than 33 weeks' gestation because 
of a favourable balance between glomerular filtration rate (GFR) and tubular 
reabsorption. Before this age GFR exceeded the limited sodium reabsorption 
capacity. In a recent study, Rodriguez-Soriano et al (34) demonstrated that 
the urinary sodium loss observed in very preterm infants depended on the 
incapacity of the distal tubule to cope with the arrival of an increased 
fractional load of sodium. Very preterm infants have an increased sodium 
requirement/kg body weight as shown by Al-Dahhan et al (33). In the study 
of Aperia et al (27) the postnatal rise in aldosterone excretion was 
generally higher in preterm infants with their negative sodium balance than 
in full term infants with a positive sodium balance. The salt-wasting in 
the very preterm newborns might be explained by a low responsiveness of the 
renal distal tubule to aldosterone at this developmental stage. This is 
supported by the high correlation between aldosterone excretion and urinary 
potassium/sodium ratio (r=0.87) in full term infants and the absence of this 
correlation in preterm infants (28 to 34 weeks gestational age), 1 to 10 
days old (27). The immature tubule may lack receptors for the hormone, or 
the sodium transporting enzyme Na-K-ATPase may be deficient. A decreased 
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proximal fractional sodium reabsorption is also involved (32). The Na-K-ATP-
ase activity, which is assumed to be responsible for the active sodium 
transport across the renal tubular cells, is low in the different nephron 
segments of the newborn rabbit (35) and in the proximal tubule of the young 
rat (36) and can be stimulated by aldosterone and glucocorticoids (36, 37). 
The immature proximal tubular cells are more sensitive to the inductive 
effect compared to the more mature ones (36). 
The maturation of proximal tubular function in childhood is documented 
by Rodriguez-Soriano et al (38) using clearance methods during hypotonic 
saline diuresis. Their data support a role of the RAAS in the control of 
sodium homeostasis during the first two years of life. The fractional 
reabsorption of sodium by the renal proximal tubules increased during that 
period and remained constant thereafter. In contrast, the fractional distal 
sodium reabsorption was increased during the first two years of life, and a 
constant percentage of the sodium load delivered to the distal tubules was 
reabsorbed (38). Therefore, despite proximal tubular salt-loss due to 
immaturity of proximal tubular function, sodium homeostasis is maintained 
by a compensatory increase in distal tubular fractional sodium reabsorption. 
The higher fractional sodium delivery to the distal tubules and therefore 
threatening sodium-loss, might stimulate, in one way or another, the renin-
mediated aldosterone secretion which enhances distal tubular sodium 
reabsorption. This role of the RAAS is supported by clinical observations. 
Sodium-wasting and so-called salt-crises in the syndrome of pseudohypo-
aldosteronism, in the salt-losing forms of adrenogenital syndromes, and in 
the syndrome of hyporeninemic hypoaldosteronism, are most pronounced in the 
first two years of life when the child is more dependent on distal tubular 
function for his sodium conservation than thereafter. 
On the other hand, the reduced tolerance to salt and the blunted natri-
uretic response to volume expansion at young age (26) can also be explained 
by the enhanced distal tubular sodium reabsorption at that age. Normal 
newborn infants have a blunted natriuretic response to salt loading (39). 
Apart from the influence of aldosterone, the earlier development of the 
distal tubular basal and lateral cell membrane surface area as compared to 
the more proximal parts of the nephron (40) might also be a cause of the 
higher distal fractional sodium reabsorption at young age. 
The maturation of proximal tubular sodium reabsorption in the first 
two years of life might contribute to the increased activity of the RAAS 
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during that period. After this age span PRA, PA and aldosterone excretion 
are still increased. They decrease with advancing age. We found no relation 
between basal sodium excretion and PRA, PA, and aldosterone excretion. 
Within the normal range of sodium intake and under normal conditions, the 
RAAS seems not involved in the normal control of sodium excretion after the 
age of two years. However, with changing sodium intakes the activity of the 
RAAS also changes, and seems to exert a regulatory effect on sodium 
excretion (41). 
XI.5. THE ROLE OF THE RENIN-ANGIOTENSIN SYSTEM (RAS) IN THE CONTROL OF 
BLOOD PRESSURE 
The contribution of the RAS to the control of blood pressure at young 
age was studied during A II blockade by infusion of saralasin in 
unanesthetized canine puppies under different salt-intakes (chapter IX). 
A similar study has recently been reported in the newborn lamb by 
Siegel (42). In the control lambs a significant decrease in blood pressure 
was observed during saralasin infusion from 86.2 mm Hg ±1.8 (mean±SE) to 
75.7±1.8, as well as during acute salt-loading (10 mEq/kg in 20 ml glucose 
5% infused over 60 min) from 86.6±1.0 to 76.6+0.9. In addition, in chronically 
salt-loaded lambs the mean arterial blood pressure (79.6±1.0) was lower 
compared to the control lambs (86.2±1.8), and did not change during saralasin 
infusion. Siegel concluded that the suppression of the basal RAS levels and 
of the mean arterial blood pressure supported the important role of the RAS 
in the control of basal blood pressure in the newborn lamb. 
Inhibition of the angiotensin-converting enzyme by Captopril also 
resulted in a significant decrease in arterial pressure in young lambs (43). 
In our study with puppies, chronic salt-loading resulted in significant 
lowering of PRA and PRC values, and the percental decrease agreed quite 
well with the results reported in lambs (42). Contrary to the lambs, no 
difference in the mean arterial blood pressure was observed between control 
and salt-loaded puppies. During saralasin infusion blood pressure decreased 
significantly in control animals with a mean of 6.6 mm Hg, but not in the 
salt-loaded group. 
The decline in arterial pressure in response to a blockade of the RAS 
in normal young animals, contrary to adults, suggests that the enhanced 
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activity of the RAS at young age contributes to the basal blood pressure. 
Arterial blood pressure rises progressively during infancy and child­
hood (44). The physiological role and the mechanisms involved in this 
age-dependent rise have not yet been elucidated. 
Blood pressure is the dynamic result of many variables with complex 
interrelationships. The contributions of different systems may shift during 
maturation. The most simple statement on blood pressure is given by the 
classical hemodynamic formula: 
Blood pressure = Cardiac output χ Systemic vascular resistance. 
Alterations in peripheral resistance are predominantly influenced by 
changes in the radius of arterioles, since the radius is magnified to the 
fourth power in Poiseuille's formula. Changes in the radius are influenced by 
the sympathetic nervous system and by various vasoactive substances including 
angiotensin, noradrenaline, prostaglandins, kinins, and vasopressin. 
In a longitudinal hemodynamic follow-up study on conscious puppies, 
Magrini showed a progressive and simultaneous decrease in the cardiac output 
expressed per kg of body weight, and an increase in mean arterial pressure, 
resulting in an increase in calculated peripheral resistance (45). Therefore, 
a marked increase in peripheral resistance was responsible for the rise in 
blood pressure during maturation. An increase in total peripheral vascular 
resistance standardized for body surface area has also been reported in 
early childhood by Rudolph (46). This increase might result from parallel 
or opposite changes in various vascular beds and might reflect a different 
distribution of blood flow. 
The powerful vasoconstrictor A II is one of the vasoactive substances 
that affect vascular resistance. Since the activity of the RAAS decreases 
with age, an age-dependent change in vascular responsiveness to A II might 
play a role. This could not be shown in the lamb during maturation (47). 
The roles of the sympathetic nervous system and of various vasoactive 
agents on the age-associated rise in blood pressure remain to be explored. 
Apart from nervous and humoral influences on the arteriolar radius, 
anatomical factors may be involved. A progressive growth of smooth muscle 
in the systemic arteries and arterioles has been observed during fetal and 
postnatal life by Naeye (48). 
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XI.6. MISCELLANEOUS 
It was not the purpose of this study to investigate the causes of the 
increased activity of the RAAS at young age. Some small contributions 
however, were made. 
The influence of venepuncture on PRA values and its role in the scatter 
of levels of RAAS components observed at young age were described in 
section XI.2. 
Since the mean half-time of the slow component of the renin disappearance 
curve, representing the metabolic degradation of renin, was not different 
between puppies and adult dogs (chapter X), the elevated PRA in puppies is 
not the result of a lower degradation rate of renin due to an immature 
hepatic function. 
Other causes suggested for the increased activity of the RAAS in infancy 
and childhood compared to adults, have been discussed in chapter III. 
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SUMMARY 
In this thesis various components of the renin-angiotensin-aldosterone 
system (RAAS) in infancy and childhood were studied both under well-defined 
basal conditions and during standardized stimulation of the system. 
The clinical application of the results was demonstrated by the study 
in two patients with particular diseases. 
The significance of the RAAS for the regulation of blood pressure at young 
age was investigated in an animal model. 
A short survey of the RAAS is given in chapter I. The different 
components of this system are discussed: renin and its substrate 
(angiotensinogen), the angiotensins I, II, and III, converting enzyme, and 
the angiotensinases. 
Subsequently, attention is paid to the mechanisms involved in the 
control of renin release, such as the intrarenal vascular receptor, the 
macula densa, and neural and humoral factors. 
The physiological role of the RAAS is discussed in the light of the 
peripheral vascular resistance, the renal hemodynamics, and the renal 
excretion of sodium. 
In the second chapter the renin assay used is discussed, and the 
validity of this assay is established. The influence of sample collection 
and storage on the renin value is demonstrated. 
Since renin is not uniformly determined by various laboratories, we 
calibrated our renin assay against the WHO international reference 
preparation of human renin. In our assay system a plasma renin activity 
value of 1 ng A I/ml/h equals 11 μΙΙΙ of the renin standard per ml plasma 
for blood samples of both infants and adults. 
The well-known age-dependent decrease in basal values of plasma renin 
activity (PRA), plasma aldosterone concentration (PA), and urinary 
excretion of aldosterone (chapter III) was extended to angiotensin I and II 
(chapter IV), and to active and inactive plasma renin concentration 
(chapter V). These findings emphasize the necessity to relate data from 
patients to age-matched control values before attempting interpretation. 
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The data about angiotensin I during infancy and childhood are the 
first reported in the literature. The angiotensin II levels complement the 
values published by Broughton Pipkin et al. 
As reliable data on inactive renin in childhood were missing, this aspect 
was also studied (chapter V). Inactive renin was activated by trypsin. 
The inactive to active renin ratio was similar in the different age-groups. 
The overall proportion of renin in the inactive form (79%) was lower than 
reported for adults. 
Plasma converting enzyme activity was not related to age (chapter IV). 
In addition, the in vivo conversion of angiotensin I to II appeared to be 
not rate-limited by the angiotensin I conversion capacity of the body. 
The results of standardized stimulation of the RAAS by salt-restriction 
followed by postural change are also presented in chapter III. Such an, in 
our opinion physiological, stimulation has as yet not been published. The 
results suggest a stronger influence on PRA and PA by postural change with 
increasing age. 
The knowledge of the normal physiological profile of the RAAS during 
standardized stimulation is important in the differential diagnosis of 
diseases accompanied by salt-wasting, and of hypertension. This is 
demonstrated by the report on two patients (chapter VII and VIII). 
In chapter VII a patient is presented with a so-called low-renin, low-
aldosterone hypertension. No increase in PRA and PA was seen in this child 
during stimulation. In addition, an abnormal Cortisol metabolism was 
demonstrated in this case. 
In chapter VIII an other child is described with low values of PRA and 
PA compared to both basal and stimulated values from age-matched controls. 
Salt-wasting was a characteristic symptom in this infant. The PRA-PA profile 
was valuable in discriminating between renal and adrenal causes of the salt-
loss. In this syndrome of hyporeninemic hypoaldosteronism a defect in the 
conversion, or activation, of inactive to active renin has been suggested. 
The great scatter of basal values of the RAAS was striking, especially 
in infancy. The stress of venepuncture might have played a role. We made, 
however, plausible that the stress of blood sampling during a well-performed 
venepuncture could not account for this scatter (chapter VI). 
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In chapter IX we report the results of the investigation on the 
significance of the RAAS for the regulation of blood pressure at young age. 
Saralasin (an angiotensin II-antagonist) infusion caused a significant 
decline in blood pressure and a rise in plasma renin concentration. This 
was the case not only in canine puppies during salt-depletion, as was 
observed in adult dogs, but in normal puppies too. Hence, it is concluded 
that the RAAS contributes to the basal arterial pressure in normal puppies. 
The slow component of the renin disappearance curve after bilateral 
nephrectomy (chapter X), which reflects the metabolic degradation of renin, 
was not different between four 16-21 days old canine puppies and normal 
adult dogs. Therefore, an immature hepatic function does not play a role in 
the higher plasma renin levels observed at young age. 
The investigations reported in this thesis allow us a better 
comprehension of the renin-angiotensin-aldosterone system in infancy and 
childhood, and appear to be valuable in clinical practice. 
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SAMENVATTING 
In dit proefschrift werden verschillende componenten van het renine-
angiotensine-aldosteron systeem (RAAS) bestudeerd op de zuigelingen- en 
kinderleeftijd, zowel onder welomschreven basale omstandigheden als tijdens 
gestandaardiseerde stimulatie van het systeem. 
De toepassing van de resultaten werd gedemonstreerd aan twee patiënten 
met bijzondere ziektebeelden. 
De betekenis van het RAAS voor de regulatie van de bloeddruk op jonge 
leeftijd werd onderzocht in een dierexperimenteel model. 
In het eerste hoofdstuk wordt een kort overzicht gegeven van het RAAS. 
De verschillende componenten ervan worden besproken: renine en zijn 
substraat (angiotensinogeen), de angiotensinen I, II en III, converting 
enzyme, en de angiotensinasen. 
Vervolgens wordt aandacht besteed aan mechanismen die betrokken zijn 
bij de regulatie van de renine afgifte zoals de intrarenale vaatreceptor, 
de macula densa, en de nervale en humorale faktoren. 
De fysiologische betekenis van het RAAS wordt besproken in het licht 
van de perifere vaatweerstand, de doorbloeding van de nier, en de renale 
natrium uitscheiding. 
In het tweede hoofdstuk wordt de gebruikte methode voor de bepaling 
van plasma renine besproken, en wordt de validiteit van de methode 
vastgesteld. De invloed van het verzamelen en bewaren van bloedmonsters 
op de renine uitslag wordt aangegeven. 
Aangezien renine niet op uniforme wijze door diverse laboratoria wordt 
bepaald, calibreerden wij onze bepalingsmethode met het internationale 
referentie preparaat voor humaan renine van de WHO. Een door ons gemeten 
plasma renine aktiviteit van 1 ng A I/ml/uur komt overeen met 11 μΐυ van de 
renine standaard per ml plasma, zowel voor bloedmonsters van zuigelingen 
als voor die van volwassenen. 
De welbekende afname van basale waarden van plasma renine aktiviteit 
(PRA), plasma aldosteron concentratie (PA), en urine uitscheiding van 
aldosteron (hoofdstuk III) werd uitgebreid met eenzelfde vaststelling 
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ten aanzien van angiotensine I en II (hoofdtuk IV), en t.a.v. de plasma 
concentratie van aktief en inaktief renine (hoofdstuk V). Deze bevindingen 
benadrukken de noodzaak om gegevens van patiënten te interpreteren aan de 
hand van kontrole waarden van leeftijdsgenoten. 
Gegevens over angiotensine I en II werden op deze schaal nog niet 
gepubliceerd. 
Betrouwbare gegevens over het inaktief renine op kinderleeftijd 
(hoofdstuk V) ontbreken tot nu toe. Inaktief renine werd geaktiveerd met 
trypsine. De ratio inaktief-aktief renine was konstant tussen de leeftijds-
groepen, en het gemiddelde percentage renine in de inaktieve vorm (79%) was 
lager dan bij volwassenen werd gemeld. 
De plasma converting enzyme aktiviteit was niet gerelateerd aan de 
leeftijd (hoofdstuk IV). Bovendien bleek de in vivo conversie van 
angiotensine I tot II op kinderleeftijd niet beperkt door de in het lichaam 
aanwezige enzym aktiviteit. 
De resultaten van gestandaardiseerde stimulatie van het RAAS door 
zoutbeperking gevolgd door houdingsverandering worden eveneens vermeld in 
hoofdstuk III. Een dergelijke, naar onze mening fysiologische, stimulatie 
werd niet eerder gepubliceerd. De resultaten suggereren een sterkere 
beïnvloeding van de PRA en PA door houdingsverandering met toenemende 
leeftijd. 
De kennis van het normale fysiologische reaktiepatroon van het RAAS 
op gestandaardiseerde stimulatie is van belang bij de differentiële 
diagnose van ziektebeelden welke gepaard gaan met zoutverlies, en bij 
hypertensie. Dit wordt toegelicht met de beschrijving van twee patiënten 
(hoofdstuk VII en VIII). 
In hoofdstuk VII wordt een kind beschreven met een zogenaamde low-renin, 
low-aldosterone hypertensie. Tijdens stimulatie werd geen stijging gezien 
van de renine en aldosteron spiegels in het bloed. Bij dit kind werd tevens 
een gestoord Cortisol metabolisme aangetoond. 
In hoofdstuk VIII wordt een zuigeling beschreven met eveneens lage 
waarden voor PRA en PA in vergelijking met zowel basale als gestimuleerde 
waarden van leeftijdskontroles. Zoutverlies was een karakteristiek symptoom. 
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Het PRA-PA profiel was waardevol bij de discriminatie tussen een renale en 
een adrenale oorzaak van het zoutverlies. In dit hyporem'nemische hypoaldo 
steronisme syndroom wordt een defekt in de omzetting of aktivatie van 
inaktief tot aktief renine gesuggereerd. 
De grote spreiding van de basale waarden van het RAAS was vooral 
opvallend op de zuigelingenleeftijd. De stress van venapunktie zou hierbij 
een rol kunnen spelen. We toonden evenwel aan dat de stress van het bloed 
prikken bij een goed uitgevoerde venapunktie deze spreiding niet kon 
verklaren (hoofdstuk VI). 
In hoofdstuk IX worden de resultaten vermeld van het onderzoek naar 
de betekenis van het RAAS voor de bloeddruk regulatie op jonge leeftijd. 
Infusie van saralasine (een angiotensine H-antagonist) veroorzaakte een 
significante daling van de bloeddruk en een stijging van de plasma renine 
concentratie. Dit was het geval niet alleen bij jonge honden tijdens 
zoutdepletie, zoals bij volwassen honden wordt waargenomen, maar ook bij 
normale jonge honden. Hieruit werd gekonkludeerd dat het RAAS bij normale 
hondjes bijdraagt tot de basale arteriële bloeddruk. 
De langzame component van de renine verdwijnkurve na bilaterale 
nefrectomie (hoofdstuk X), die een parameter is voor de metabole afbraak 
van renine, was bij vier 16-21 dagen oude hondjes niet verschillend van 
de waarden bij normale volwassen honden. Een onrijpe leverfunktie speelt 
dus geen rol bij de hogere plasma renine concentratie op jonge leeftijd. 
Het in dit proefschrift gepresenteerde onderzoek heeft ons inzicht 
in het renine-angiotensine-aldosteron systeem op de zuigelingen- en kinder 
leeftijd vergroot, en het blijkt waardevol voor klinische toepassing. 
187 

DANKWOORD 
Woorden van dank wil ik op deze plaats betuigen aan allen die mij in de 
verschillende fasen van dit onderzoek direkt of indirekt terzijde hebben 
gestaan, van dienst zijn geweest, of die in welke zin dan ook uiteindelijk 
hebben bijgedragen aan dit proefschrift. Ook ongenoemd kunnen zij zich van 
mijn erkentelijkheid verzekerd weten. 
Allereerst wil ik de inspirerende, hulpvaardige en kritische leiding van 
het onderzoek en dit proefschrift door het hoofd van de afdeling Kinder-
nefrologie memoreren. Hij was een bijzondere leermeester. Helaas mag mijn 
dank op deze plaats slechts naamloos gebeuren. 
Aan de verpleegkundigen, de arts-assistenten, en mijn collegae kinder-
artsen van de verschillende afdelingen van de kinderkliniek ben ik dank 
verschuldigd voor de bereidwillige hulp die ze mij in de afgelopen jaren 
hebben verleend bij het verzamelen van de gegevens. Zowel hun als mijn PRA 
zal door stress ongetwijfeld vaker verhoogd zijn geweest. 
Onmisbare hulp werd verleend door de medewerkers/sters van het klinisch-
chemisch laboratorium van Kindergeneeskunde en Chirurgie (hoofd: Dr. P.J.J. 
van Munster) met het uitvoeren van diverse bepalingen. 
Het hoofd van dit laboratorium bewaakte de laboratorium-technische kant 
van het onderzoek en leverde ook anderszins waardevolle en gewaardeerde 
bijdragen. 
Vervolgens gaat mijn bijzondere dank uit naar mevr. M.J.H. Jansen. Zij 
heeft een wezenlijke bijdrage geleverd aan de opzet en de uitvoering van de 
renine bepaling. Haar inzet en enthousiasme waren geweldig. Tijdens haar 
afwezigheid werd ik behulpzaam geholpen door mevr. J.J.H.M. Ploegmakers-Poos. 
Zeer erkentelijk ben ik ook voor de bijdragen van andere laboratoria in 
binnen- en buitenland. Mijn dank in deze betreft vooral: 
- Prof. Dr. T.J. Benraad in Nijmegen wegens de hulp bij de bepalingen van 
aldosteron in plasma. 
- Dr. P.J. Lijnen in Leuven, België, wegens de bepalingen van angiotensine I 
en II, van converting-enzyme aktiviteit, en van aldosteron in urine. 
- Dr. F.H.M. Derkx in Rotterdam wegens de bepalingen van aktief en inaktief 
renine en van renine substraat. 
- Dr. E.J. Moerman in Gent, België, wegens de bepalingen van adrenaline en 
noradrenaline. 
189 
Dr. J.I.M. Drayer was voor zijn vertrek naar de U.S.A. ook betrokken 
bij het onderzoek. 
Het dierexperimentele gedeelte van dit proefschrift werd grotendeels 
verricht in het Akademisch Ziekenhuis te Gent in België vanuit de afdeling 
Nefrologie (hoofd: Prof. Dr. S. Ringoir) van de Dienst voor Inwendige 
Ziekten. Als de gastvrijheid van onze zuiderburen al niet spreekwoordelijk 
was, dan zou ze het door mijn ervaringen alsnog geworden zijn. 
Prof. Dr. N.H. Lameire was mijn bemiddelaar en gastheer. Mede dank zij 
hem denk ik met veel genoegen terug aan mijn verblijf in Gent en aan de 
vele wetenschappelijke en vriendschappelijke kontakten die ik toen en sinds-
dien met hem had. 
Prof. Dr. I. Leusen van het Laboratorium voor Normale en Pathologische 
Fysiologie van het Akademisch Ziekenhuis te Gent ben ik dank verschuldigd 
voor de faciliteiten die hij mij verschafte tijdens de uitvoering van de 
experimenten. Ik dank alle medewerkers van dit laboratorium en van het 
animalarium die behulpzaam waren in die periode. De veelvuldige assistentie 
van vooral de heer W. Lannau wil ik apart vermelden. 
Vrijwel ondenkbaar zouden de dierexperimenten geweest zijn zonder de 
veelzijdige en nimmer aflatende hulp van mevr. M-A. Goethals-Waterloos. In 
haar dank ik ook alle andere medewerkers/sters van de afdeling Nefrologie 
die mij terzijde stonden. 
De hulp van verschillende medewerkers van het Centraal Dierenlaboratorium 
in Nijmegen (hoofd: Dr. W.J.I. van der Gulden) wordt door mij zeer gewaardeerd. 
Graag wil ik de heren T.H.M. Arts en A. Peters afzonderlijk bedanken. 
De statistische bewerking van de resultaten werd deskundig en nauwgezet 
verricht door mevr. Drs. P.G.M. Peer van de Mathematisch-Statistische Advies-
afdeling (hoofd: Drs. Ph. van Eiteren). Haar uitleg en verklaring van de 
gebruikte methoden en van de mogelijkheden en beperktheden van statistische 
analysen waren significant relevant voor mij. De heer A. Reintjes zorgde 
voor de verschillende berekeningen. 
De heer J. Konings van de afdeling Medische Illustratie (hoofd: de heer 
M.N. Bollen) verdient alle lof voor de gemaakte tekeningen en voor de overige 
hulp die ik van hem mocht ontvangen. Ook de hulp van de heer A.T. van Uden mag 
niet onvermeld blijven. 
De afdeling Medische Fotografie (hoofd: de heer A.T.A. Reynen) verzorgde 
de fotografische verwerking van de tekeningen. 
Bij het verzamelen van de benodigde literatuur kon ik mij verheugen in 
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de deskundige hulp van de heer E. de Graaff en van de heer A.H.M, de Wolf van 
de Medische bibliotheek (hoofd: de heer E. de Graaff), en in die van de dames 
A. Jol ink van de bibliotheek Kindergeneeskunde en N. Latupeirissa van de 
bibliotheek van het Centraal Dierenlaboratorium. 
Bij het typen van verschillende versies van artikelen en bij de realisatie 
van het manuscript op de tekstverwerker mocht ik steunen op hulp van mede-
werksters van het secretariaat van de kinderkliniek, te weten de dames 
P.M. de Boer-Nijenhuis, C.A.W.R. van den Tempel, E.A.B, van den Heiligenberg-
de Vries, E.M. Ariaans, M.A.G.S. Titselaar, en G.L.M. Gommans. Ook de voor-
malige beheerder de heer H.W.T. Teunissen leverde in deze een eigen bijdrage. 
Dr. J.A.J.M. Bakkeren en Dr. J.F.M. Trijbels waren bereid enkele hoofd-
stukken kritisch op het engels door te nemen. 
Bijzondere dank ben ik ook verschuldigd aan mijn collegae van de algemene 
polikliniek Kindergeneeskunde, Drs. H.P.T. Werkman en Dr. C G . van Oostrom, 
voor de ruimte die ze mij steeds gegeven hebben. Zij hebben mij met hun 
loyaliteit en collegialiteit een grote dienst bewezen. 
Dat ik, last but not least, mijn vrouw en kinderen bedank, is vanzelf-
sprekend, alhoewel verontschuldigingen mogelijk meer op hun plaats zijn. 
Rechtvaardiging voor tekortkomingen kan ik niet aanvoeren, hooguit wil ik 
een beroep doen op verzachtende omstandigheden. 
Th.J.W. Fiselier 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren op 19 december 19^2 in 
Heeten (0). 
Na het eindexamen HBS-B in 1960 aan het Geert Groóte College in Deventer 
studeerde hij geneeskunde aan de Katholieke Universiteit te Nijmegen, waar 
in 1968 het artsexamen werd afgelegd. 
Vervolgens was hij, als voorbereiding op uitzending naar de tropen, 
werkzaam op de afdelingen Chirurgie en Verloskunde-Gynaecologie van het 
ziekenhuis de Stadsmaten te Enschede, en volgde de Nationale Voorbereidings-
kursus voor aanstaande Tropenartsen aan het Koninklijk Instituut voor de 
Tropen te Amsterdam. 
Van december 1970 tot april 1973 werkte hij, via Memisa en in dienst 
van het bisdom Kumasi, als medical officer in charge in het St. Martin's 
Hospital te Agroyesum, Ashanti, Ghana. 
In 1978 werd de opleiding tot kinderarts voltooid onder leiding van 
Prof.Dr. E.D.A.M. Schretlen aan het Instituut voor Kindergeneeskunde van 
het Sint Radboudziekenhuis te Nijmegen. 
Sindsdien is hij bij de Katholieke Universiteit verbonden aan het 
Instituut voor Kindergeneeskunde (destijds hoofd: Prof.Dr. E.D.A.M. Schretlen; 
huidig hoofd: Prof.Dr. G.B.A. Stoelinga) en werkzaam op de algemene 
polikliniek. 
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STELLINGEN 
I 
De invloed van fysiologische verschillen in plasma renine-substraat concen-
tratie op zuigelingen- en kinderleeftijd is verwaarloosbaar bij de interpre-
tatie van de plasma renine aktiviteit. 
Dit proefschrift 
II 
Aangezien borstvoeding en gehumaniseerde voeding onvoldoende natrium bevatten 
om de excretie van natrium in de urine bij premature zuigelingen tot 35 weken 
te compenseren, is extra zoutsuppletie bij deze groep in de eerste twee weken 
aan te bevelen. 
J. Al-Dahhan e.a. Arch Dis Child 58: 335-345, 1983 
III 
De klinische chemie kan slechts zijn vooraanstaande plaats blijven behouden 
in het onderzoek bij het jongere kind, wanneer zij zich blijft toeleggen op 
bepalingen in kleine hoeveelheden bloed. 
IV 
Poliklinische kontrole van de bloeddruk door de ouders bij het jonge kind dat 
behandeld wordt met chronische ambulante peritoneaal dialyse is noodzakelijk 
om hypotensie te kunnen vaststellen en te behandelen. 
V 
Door het gebruik van Echo- en Dopplercardiografie kan het aantal hartkathe-
terisaties bij congenitale hartafwijkingen worden beperkt. 
VI 
In tegenstelling tot de opvatting van het Medisch Adviescollege van de Ver-
eniging van Ouders van SIDS-kinderen zijn wij van mening dat na een wiegedood 
(SIDS) of een bijna wiegedood (near SIDS) elk volgend kind in dit gezin recht 
heeft op het thuis bewaken met een apnoe monitor. 
J. Huber. Ned Tijdschr Geneeskd 126: 2305-2306, 1982. 
P. Duffty e.a. Pediatrics 70: 69-74, 1982. 
VII 
Het plotseling overlijden van kinderen met het cerebro-hepato-renale syndroom 
van Zellweger zou verklaard kunnen worden door bijnierinsufficientie. 
L. Govaerts e.a. Aangeboden voor publikatie. 
VIM 
Voor het vaststellen van de diagnose neonatale hyperviscositeit is bepaling 
van de hematocriet in capillair bloed, 4-6 uur na de geboorte, aangewezen. 
Navelstrengbloed is hiervoor niet geschikt. 
W.E. Hathaway. Pediatrics 72: 567-569, 1983. 
IX 
De studie van Breu e.a. betreffende de diagnostiek en behandeling van de 
ziekte van Hodgkin bij kinderen biedt een goede bijdrage om, met behoud van 
optimale genezingskansen, de ongewenste werkingen van radiotherapie en van 
chemotherapie te minimaliseren. 
H. Breu e.a. Klin Pädiatr 194: 223-241, 1982. 
С. Haanen. Ned Tijdschr Geneeskd 127: 252-256, 1983. 
H. Behrendt. Ned Tijdschr Geneeskd 127: 521, 1983. 
С Haanen. Ned Tijdschr Geneeskd 127: 521, 1983. 
χ 
In de handboeken voor kindergeneeskunde wordt de prognose van chorea minor 
(Sydenham's chorea, St. Vitusdans) ongefundeerd als gunstig weergegeven. 
Recente artikelen vermeld in de neurologische litteratuur logenstraffen deze 
opvatting. 
P.A. Nausieda e.a. Neurology 33: 750-754, 1983. 
XI 
Een kind heeft binnen de Afrikaanse traditie een absoluut recht op bestaan. 
In de westerse wereld, daarentegen, moet een kind dat recht konstant zelf 
bevechten in voortdurende rivaliteit en competitie met anderen. 
XII 
Waar de jeugd volgens het gezegde de toekomst heeft, is het te betreuren dat 
het blikveld van opvoeders en volwassenen nog vaak wordt bepaald door een 
korte neuslengte. 
XIII 
De door de Bescheurkalender op 9 febr. 1983 genoemde "Ziekte van Adidas", 
"Kaakbenbitis" en "Maximal Audiovisual Brain Dysfunction" verdienen grotere 
aandacht dan alleen via deze kalender. 
Nijmegen, 18 mei 1984 Th.J.W. Fiselier 



